Last updated: Aug 15, 2020 - 02:00 BST

Title Indication Intervention Actions PatientSelection Sponsor Collaborator Country StartDate EndDate Identifiers Phase Recruitment Status Sites Trial Duration Enrollment Count Contacts LastChanged
FREEDOM COVID: FREEDOM COVID-19 Anticoagulation Strategy Coronavirus disease 19 infection apixaban alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Mount Sinai Medical Center US 2020-09-30 2021-06-30 FREEDOM COVID, GCO 20-2115, NCT04512079 Phase 4 Clinical Not yet recruiting 0 9 Months 3600 Anu Lala, MD, Debra Fitzpatrick, MS, Valentin Fuster, MD, PhD, Valentin Fuster, MD,PhD 2020-08-14
Scaling Mental Healthcare in COVID-19 With Voice Biomarkers Anxiety disorder, Coronavirus disease 19 infection, Depression Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Kintsugi Mindful Wellness Inc 2020-09-01 2021-06-30 COV-1, NCT04510519 Phase Not Applicable Not yet recruiting 0 10 Months 50 2020-08-14
COVID-19 in Immunosuppressed Children Coronavirus disease 19 infection, Kidney transplantation, Liver transplantation Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) D'Or Institute for Research and Education Hospital Estadual da Criança, Hospital Federal de Bonsucesso, Rio de Janeiro State Research Supporting Foundation Brazil 2020-06-30 2021-04-30 062-2020, NCT04511429 Phase Not Applicable Recruiting 0 10 Months 200 Antonio José L A da Cunha, MD, PhD, Arnaldo Prata-Barbosa, MD, PhD, Jaqueline LS Gouveia, MD, Thais L Cleto-Yamane, Thais L Cleto-Yamane, MD, MSc 2020-08-14
MentCovRMD: Mental Health Consequences of COVID19 Infection in the French RMD Cohort Autoimmune disease, Autoinflammatory disease, Coronavirus disease 19 infection, Inflammatory disease, Musculoskeletal disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Regional Universitaire de Lille FAI²R (Auto-immune and auto-inflammatory rare diseases French network) France 2020-09-30 2021-02-28 2020-A02058-31, 2020_75, MentCovRMD, NCT04510467 Phase Not Applicable Not yet recruiting 0 5 Months 1313 Eric Hachulla, MD,PhD 2020-08-14
A clinical study to assess the effects of Meditation (Mindful Happiness) as an additional therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases Coronavirus disease 19 infection Meditation (Mindful Happiness) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sonalika Social development Society India 2020-08-11 CTRI/2020/08/027032, TG/PRO/CLI/034 Version 1.0 dated 10 July 2020 Phase Not Applicable Not yet recruiting 0 40 Dr Bhageerathi Byrapura Lakshmegowda, Dr Vishwas Vijayadev, Meena Dalal 2020-08-14
COLHEART-19: Colchicine versus Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury Coronavirus disease 19 infection, Heart injury Covid-19 standard of care alone, colchicine (oral, gout/familial Mediterranean fever), Takeda alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Miami Cardiac and Vascular Institute University of California Los Angeles US 2020-09-01 2022-01-01 152247, COLHEART-19, NCT04510038 Phase 2/Phase 3 Clinical Not yet recruiting 0 16 Months 75 Raul E Herrera, MD, Sandra Chaparro, MD 2020-08-14
AI-COV-19: Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms Coronavirus disease 19 infection CT scans alone, Chest x-ray imaging alone, ECGs alone, RTPCR assay alone, heart tracings alone, machine learning algorithms alone, train artificial intelligence alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Imperial College London Chelsea and Westminster Hospital, Imperial College Healthcare NHS trust, London North West Healthcare NHS Trust UK 2020-05-26 2022-05-01 20HH5967, AI-COV-19, NCT04510441 Phase Not Applicable Recruiting 0 23 Months 2000 Abtehale Al-Hussaini, MRCP PhD, Emmanuel Ako, MRCP PhD, Fu Siong Ng, Jaymin Shah, MRCP PhD, Kiran Patel 2020-08-14
A clinical trial of CYC-065 and seliciclib as potential early treatments for the inflammatory response observed in patients with COVID-19 disease Coronavirus disease 19 infection, Inflammatory disease fadraciclib plus seliciclib Cyclin E inhibitor, Cyclin-dependent kinase-2 inhibitor, Cyclin-dependent kinase-5 inhibitor, Cyclin-dependent kinase-7 inhibitor, Cyclin-dependent kinase-9 inhibitor, MCL1 gene inhibitor Cyclacel Pharmaceuticals Inc University of Edinburgh Phase Not Applicable Planned 0 2020-08-14
CanCovDia: Canakinumab in Patients With COVID-19 and Type 2 Diabetes Coronavirus disease 19 infection, Non-insulin dependent diabetes canakinumab alone Immunoglobulin G1 agonist, Interleukin-1 beta ligand inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Hospital Basel Novartis AG, Swiss National Science Foundation Switzerland 2020-09-30 2023-09-30 2020-02008, ME20DONATH2, CanCovDia, NCT04510493 Phase 3 Clinical Not yet recruiting 0 36 Months 112 Alain Golay, MD, Prof., Beat Müller, MD, Prof., Christoph Henzen, MD, Prof., Christoph Stettler, MD, Prof., Felix Beuschlein, MD, Prof., François Jornayvaz, MD, PD, Jonathan Mudry, MD, Lukas Burget, MD, Manuel Battegay, MD, Prof., Marc Donath, MD, Prof., Markus Laimer, MD, Prof., Matthias Hepprich, MD, Michael Brändle, MD, Prof., Nelly Pittteloud, MD, Prof., Patrick Hunziker, MD, Prof., Peter Kopp, MD, Prof., Philipp Schütz, MD, Prof., Roger Lehmann, MD, Prof., Stefan Bilz, MD, PD, Stefan Fischli, MD 2020-08-14
FAMICOV: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID Disease Coronavirus disease 19 infection COVID-19 IgG / IgM rapid test (manufactured by the firm AAZ) alone, COVID-PRESTO alone Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida France 2020-07-12 2020-11-30 CREPATS 012, FAMICOV, NCT04511949 Phase Not Applicable Recruiting 0 4 Months 500 Christine Katlama, Yasmine Dudoit 2020-08-14
A phase II to assess safety, tolerability and pharmacokinetics (PK) of PLN-74809, as well as exploratory clinical outcome measures in patients hospitalized with severe and critical COVID-19 associated with acute respiratory distress syndrome (ARDS) Coronavirus disease 19 infection, Respiratory distress syndrome PLN-74809 alone Integrin alpha-V/beta-1 antagonist, Integrin alpha-V/beta-6 antagonist Pliant Therapeutics Inc US 2020-12-31 Phase 2 Clinical Planned 0 2020-08-14
Effect of Prolectin-M, a Food Supplement, on SarsCoV2 Viral Copy Numbers: A Proof of Concept, Randomized, Open-Label, Controlled Trial (Prolectin) Coronavirus disease 19 infection Prolectin (Pharmalectin - M) alone, standard of care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Composite Interceptive Med-Science Laboratories Pvt Ltd Pharmalectin Inc India 2020-09-01 2020-09-30 CIMED - 002- 2020, NCT04512027 Phase Not Applicable Not yet recruiting 0 1 Month 10 2020-08-14
STAR-COVID: Telmisartan in Respiratory Failure Due to COVID-19 Coronavirus disease 19 infection, Hypoxia, Respiratory failure, Tachypnea standard care alone, telmisartan alone Angiotensin II receptor antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital Regional de Alta Especialidad de Zumpango Instituto Politecnico Nacional Mexico 2020-08-31 2021-04-30 CI/HRAEZ2020/05, NCT04510662, STAR-COVID Phase 2 Clinical Recruiting 0 8 Months 60 Abraham Edgar Gracia-Ramos, MD MSc, Maria Jose Pecero Hidalgo, MD, Maria Jose Pecero-Hidalgo, MD 2020-08-14
PSY-CO-ICU: Psychological Impact of COVID-19 Outbreak on Caregivers Anxiety disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire de Nimes France 2020-09-30 2021-09-30 LOCAL/2020/JYL-03, NCT04511780, PSY-CO-ICU Phase Not Applicable Not yet recruiting 0 12 Months 5000 Alexandre OUATTARA, Antoine ROQUILLY, Audrey DE JONG, Aurélie GOUEL, Belaid BOUHEMAD, Benoit PLAUD, Benoit VEBER, Bernard ALLAOUCHICHE, Bernard CHOLLEY, Bérangère VIVET, Claire DAHYOT FIZELIER, Claude ECOFFEY, Corentin LACROIX, Emmanuel FUTIER, Emmanuel SAMAIN, Eric PIKNIS, Etienne GAYAT, Francis REMERAND, Frédéric AUBRUN, Gael PITON, Guillaume BESCH, Guylaine LABRO, Gérald CHANQUES, Géralde CHANQUES, Gérard AUDIBERT, Hervé DUPONT, ICHAI Carole, Jacques ALBANESE, Jacques DURANTEAU, Jean Etienne BAZIN, Jean François PAYEN, Jean Luc FELLAHI, Jean Michel CONSTANTIN, Jean Yves LEFRANT, Julien POTTECHER, Jérôme MOREL, Karim ASEHNOUNE, Karim LAKHAL, Lionel VELLY, Mar Olivier FISCHER, Marc LAFFON, Marc LEONE, Marie reine LOSSER, Matthieu BIAIS, Matthieu LE DORZE, Nathalie NATHAN-DENIZOT, Nathan FERRAND, Nicolas BRUDER, Nicolas MONGARDON, Olivier BARBOT, Olivier FOURCADE, Olivier HUET, Olivier JOANNES BOYAU, Olivier LANGERON, Philippe GUERCI, Philippe MONTRAVERS, Philippe SEGUIN, Pierre François PERRIGAULT, Rémy BELLIER, Samir JABER, Sigismond LASOCKI, Sébastien PILI-FLOURY, Thomas KERFORNE, Thomas RIMMELE, Xavier CAPDEVILA, Yazine MAHJOUB, marc GARNIER 2020-08-14
C-MORE: Capturing Multi-organ Effects of COVID-19 Brain injury, Coronavirus disease 19 infection, Heart injury, Liver injury, Lung injury, Renal injury, Respiratory distress syndrome, Viral pneumonia 6 min walk test alone, blood test alone, cardiopulmonary exercise test alone, computed tomography alone, magnetic resonance imaging alone, spirometry alone, transthoracic echocardiography alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Oxford UK 2020-05-13 2023-05-01 282608, C-MORE, NCT04510025 Phase Not Applicable Recruiting 0 35 Months 616 Betty Raman, MBBS, DPhil, FRAC, Betty Raman, MBBS, DPhil, FRACP, Betty Raman, MBBS, FRACP, DPhil, Mark Cassar, MBBS, Stefan Neubauer, MD, FMedSCi 2020-08-14
A clinical study to assess AR-701 in the treatment of patients with COVID-19 Coronavirus disease 19 infection AR-701 alone COVID19 Spike glycoprotein inhibitor Aridis Pharmaceuticals Inc Phase Not Applicable Planned 0 2020-08-14
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients Coronavirus disease 19 infection, Lung infection 18F-FDG alone, Vereos digital hybrid system (Philips) alone, computed tomography alone, positron emission tomography alone, viral testing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Central Hospital, Nancy, France France 2020-03-15 2020-07-30 2020PI153, NCT04512118 Phase Not Applicable Completed 0 4 Months 22 Antoine VERGER 2020-08-14
Dysphagia Management During COVID-19 Pandemic Coronavirus disease 19 infection, Dysphagia Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Hacettepe University Turkey 2020-08-20 2020-11-30 DYSPHAGIA DURING COVID-19, NCT04509752 Phase Not Applicable Not yet recruiting 0 3 Months 50 NUMAN DEMİR, SELEN SEREL ARSLAN 2020-08-14
Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects Coronavirus disease 19 infection povidone-iodine alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Brigham & Women's Hospital 3M Co US 2020-08-31 2021-04-30 2020P002323, NCT04510402 Phase 1/Phase 2 Clinical Not yet recruiting 0 8 Months 50 Mark D Hornstein, MD, Raymond M Anchan, MD, PhD, Raymond Manohar Anchan, M.D.,Ph.D. 2020-08-14
A phase III clinical trial to assess Ad5-nCOV for the treatment of patients with COVID-19 infection Coronavirus disease 19 infection Ad5-nCoV alone COVID19 Spike glycoprotein modulator CanSino Biologics Inc Saudi Arabia Phase 3 Clinical Planned 0 5000 2020-08-14
CHARTER-Irl: Nebulized Heparin to Reduce COVID-19 Induced Acute Lung Injury Acute lung injury, Coronavirus disease 19 infection nebulized unfractionated heparin alone, standard care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University College Galway Ireland 2020-09-30 2022-01-31 CHARTER-Irl, NCT04511923, NUIG-2020-003 Phase 1/Phase 2 Clinical Not yet recruiting 0 16 Months 40 David Cosgrave, John Laffey 2020-08-14
Transparent Elastomeric Respirator for Aerosol-based Protection Coronavirus disease 19 infection reusable elastomeric respirator with dual N95 filter alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Brigham & Women's Hospital Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center US 2020-07-25 2020-12-31 2020P000852, NCT04511390 Phase Not Applicable Recruiting 0 5 Months 100 C. Giovanni Traverso, Giovanni Traverso, MB, BChir, PhD, Manish Gala, MD, Paul Zel 2020-08-14
LOSVID: Losmapimod Safety and Efficacy in COVID-19 Coronavirus disease 19 infection, Inflammatory disease, Respiratory failure losmapimod alone, standard of care alone Double homeobox protein 4 inhibitor, p38 MAP kinase alpha inhibitor, p38 MAP kinase beta inhibitor, p38 MAP kinase inhibitor Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Fulcrum Therapeutics Inc Mexico, US, Brazil 2020-08-31 2020-11-30 FIS-001-2020, LOSVID, NCT04511819 Phase 3 Clinical Not yet recruiting 0 3 Months 410 Call Center, Daniela Pereira Mendes, David Rubio, MD, Diego Cadavid, MD, Folusakin Ayoade, MD, Iram Abbasi, Jose' Flores, MD, Karel Calero, MD, Natiana Nalin Vizioli, Rayo Morfin, MD, Rebecca Zash, MD, Rosie Magallon, Veronica Martin 2020-08-14
RESCUE: A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) Coronavirus disease 19 infection razuprotafib alone Protein tyrosine phosphatase beta inhibitor, Tek tyrosine kinase receptor stimulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Aerpio Therapeutics Inc Medical Technology Enterprise Consortium 2020-09-30 2021-02-28 AKB-9778-CI-6001, NCT04511650, RESCUE Phase 2 Clinical Not yet recruiting 0 5 Months 180 Ashley Best, PhD 2020-08-14
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection Coronavirus disease 19 infection bicalutamide alone Androgen receptor antagonist Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Florida US 2020-09-30 2022-09-30 IRB202001669-A, NCT04509999, OCR38162 Phase 3 Clinical Not yet recruiting 0 24 Months 100 Elizabeth Piantadosi, Frederic Kaye, MD 2020-08-14
Evaluation of the effectiveness of hydroxychloroquine and clarithromycin in dyspnea and cough caused by COVID-19 in recovery phase Coronavirus disease 19 infection, Cough, Dyspnea clarithromycin (Tehran shimi company) alone, hydroxychloroquine (Rooz daroo company) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Iran University of Medical Sciences Iran 2020-08-22 IR.IUMS.FMD.REC.1399.244, IRCT20200718048129N1 Phase 3 Clinical Not yet recruiting 0 45 Dr Sima Bahrami, Dr. Seyed Abbas Motavlian, Sima Bahrami 2020-08-14
Helmet versus Face Mask in Patients With Acute Respiratory Distress Syndrome Coronavirus disease 19 infection, Respiratory distress syndrome non invasive ventilation via helmet alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hamad Medical Corp Qatar 2020-08-31 2021-08-31 MRC-01-20-616, NCT04507802 Phase Not Applicable Not yet recruiting 0 12 Months 60 Abdulqadir J Nashwan, MSc, Abdulqadir J. Nashwan, MSc, Ahmed A Soliman, BSc, Ahmed S Mohamed, BSc, Ahmed S. Mohamed, BSc, Dore C Ananthegowda, MD, Hani S Elzeer, MD, Karimulla S Shaik, MD, Mohamad Y Khatib, MD, Mohamed Z Peediyakkal, MD, Moustafa S Elshafei, MD, Muhsen A Shahen, MD, Nevin Kannappilly, MD, Wael I Abdaljawad, MD 2020-08-13
Evaluating the effectiveness of intravenous ozonized saline in COVID-19 disease Coronavirus disease 19 infection Medozon device alone, Variable regimens including IFN beta-1a , IFN beta-1b , atazanavir + ritonavir , chloroquine phosphate , dexamethasone , enoxaparin sodium , heparin , hydroxychloroquine , lopinavir + ritonavir , ozonized saline HIV protease inhibitor, Low molecular weight heparin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ahvaz University of Medical Sciences Iran 2020-08-22 IR.AJUMS.REC.1399.363, IRCT20200730048253N1 Phase 3 Clinical Not yet recruiting 0 60 Dr. mohammad Badavi, Dr.Najme dareini, Najme dareini, Shokrollah Salmanzadeh Ramhormozi 2020-08-13
ONCOVID-21: Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19 Coronavirus disease 19 infection Bio-Rad SARS-CoV-2 ddPCR Test alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Leon Berard France 2020-09-30 2021-03-31 NCT04510454, ONCOVID-21, ONCOVID-21 - ET20-118 Phase Not Applicable Not yet recruiting 0 6 Months 200 Bénédicte MASTROIANNI, MD, Ellen BLANC 2020-08-13
Profile of hospitalized patients with Covid-19 and repercussions of physiotherapy Coronavirus disease 19 infection physiotherapy alone Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Brazil 2020-06-18 33351020.2.0000.0068, 4.091.795, 4.172.084, RBR-2f9k8p, U1111-1255-6608 Phase Not Applicable Recruiting 1 2000 Clarice Tanaka 2020-08-14
A survey to analyze the understanding about the use of face mask among the general public during COVID 19 Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Kasturba Medical College and Hospital India 2020-08-20 CTRI/2020/08/027046 Phase Not Applicable Not yet recruiting 1 697 Dr Ranita Ghosh Dastidar, Dr Vaishali K 2020-08-14
Nursing students perception of out of the classroom learning during the period of COVID-19 Coronavirus disease 19 infection Adolescents (13-17 yrs), Young Adults (18-44 yrs) Manipal College of Nursing India 2020-08-31 CTRI/2020/08/027047 Phase Not Applicable Not yet recruiting 1 380 Linu Sara George, Prima Jenevive Jyothi DSouza 2020-08-14
Yoga for Police personnel Coronavirus disease 19 infection Pranayama and Yoga Nidra alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sri Devaraj Urs Academy of Higher Education and Research India 2020-08-17 CTRI/2020/08/027048 Phase 3 Clinical Not yet recruiting 1 60 Dr Patil NJ 2020-08-14
Effect of hemoperfusion on short-term outcome of critical ill COVID-19 Acute stress disorder, Coronavirus disease 19 infection, Delirium ABCDE protocol alone, CytoSorb filter alone, anticoagulant therapy alone, antiviral therapy alone, blood sugar management alone, complementary medication therapy alone, corticosteroid therapy alone, face mask alone, hemoperfusion therapy alone, heparin alone, low tidal volume ventilation alone, non-invasive mechanical ventilation alone, proton pump inhibitor therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Tabriz University of Medical Sciences Iran 2020-08-22 IR.TBZMED.REC.1399.493, IRCT20091012002582N22 Phase 3 Clinical Not yet recruiting 1 160 Ata Mahmoodpoor, Dr. khosro Adibkia, Mojtaba Mohammadzadeh 2020-08-14
Study of families who travelled from another place and had COVID-19 Coronavirus disease 19 infection Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Dr TMA Pai Hospital India 2020-08-20 CTRI/2020/08/027049 Phase Not Applicable Not yet recruiting 1 19 Shashikiran Umakanth 2020-08-13
PPE Study: Assessment of PPE usage pattern and the associated Surgeon Discomfort and Fatigue Study Coronavirus disease 19 infection, Fatigue Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Tata Memorial Centre India 2020-08-20 CTRI/2020/08/027050, PPE Study Phase Not Applicable Not yet recruiting 1 500 DrShivakumar Thiagarajan 2020-08-13
Survey of challenges faced by pain and palliative physicians working in cancer set up during corona virus disease time Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) All India Institute of Medical Sciences India 2020-08-10 CTRI/2020/08/027051 Phase Not Applicable Not yet recruiting 1 200 Dr Seema Mishra 2020-08-13
Evaluation of the effect of curcumin in improving patients with covid -19 Coronavirus disease 19 infection curcumin-piperine alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Bandare-abbas University of Medical Sciences Iran 2020-08-05 IR.HUMS.REC.1399.187, IRCT20200514047445N1 Phase 3 Clinical Recruiting 1 60 Majid Teremmahi Ardestani, Timur Agha Molai 2020-08-13
GlobalSurg-CovidSurg Week Coronavirus disease 19 infection surgery alone The University of Birmingham Association of Coloproctology of Great Britain and Ireland, Bowel Disease Research Foundation of ACPGBI, Bowel and Cancer Research, British Association of Surgical Oncology: Breast Group, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, National Institute for Health Research (NIHR), Sarcoma UK, Vascular Society for Great Britain and Ireland, Yorkshire Cancer Research UK 2020-10-01 2020-12-01 GS-CSWEEK.20200713, NCT04509986 Phase Not Applicable Not yet recruiting 0 2 Months 1000 Aneel Bhangu, PhD, Dmitri Nepogodiev, Master 2020-08-13
Virtual Teaching Kitchen Coronavirus disease 19 infection, Metabolic syndrome X Virtual Nutritional Education alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Boston University US 2020-09-30 2021-06-30 H-39597, NCT04509206 Phase Not Applicable Not yet recruiting 0 9 Months 25 Iniya Rajendran, Naomi M Hamburg, MD 2020-08-14
KAND-567 Versus Placebo in Subjects Hospitalized with COVID-19. A Phase II, Randomized, two-Arm, Parallel-Group, Double-blind Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics Coronavirus disease 19 infection KAND-567 alone, best standard treatment alone CX3CR1 chemokine antagonist, Fractalkine ligand inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Kancera AB Capio S:t Görans Hospital, Scandinavian CRO, Scandinavian Development Services AB, Science For Life Laboratory Sweden 2020-07-02 2020-002322-85, KAN0006 Phase 2 Clinical Recruiting 1 40 Anna Runeson 2020-08-14
Effect of erythropoietin on COVID-19 Coronavirus disease 19 infection, Hypoxia, Lung disease, Lymphocytopenia, Tachypnea Variable regimens including atazanavir , atazanavir + ritonavir , chloroquine phosphate , enoxaparin sodium , epoetin alfa (Procrit/Eprex), Johnson & Johnson , hydroxychloroquine sulfate , lopinavir + ritonavir Erythropoietin ligand, HIV GAG POL polyprotein inhibitor, HIV GAG protein inhibitor, HIV protease inhibitor, HIV-1 protease inhibitor, Low molecular weight heparin Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Bandare-abbas University of Medical Sciences Iran 2020-06-21 IR.HUMS.REC.1399.165, IRCT20200509047364N1 Phase 2 Clinical Recruiting 1 20 Dariush Hooshyar, Dr. Mehdi Hassaniazad, Dr. Mitra Kazemijahromi, Dr. Teamur Aghamolaei 2020-08-14
Evaluation of the effect of shallomin on the treatment and improvement of symptoms in patients with Covid 19 Coronavirus disease 19 infection, Respiratory disease approved COVID19 protocol treatment alone, shallomin (Sadra Noor Biotechnology Pharmaceutical Company) alone Dezful University of Medical Sciences Iran 2020-08-10 IR.DUMS.REC.1399.014, IRCT20200725048199N1 Phase 2 Clinical Recruiting 0 146 Mahnaz Nosratabadi, Maysam Mardsoltani, mahnaz nosratabadi 2020-08-13
ARBS CORONA I: Host-Response Mediators in Coronavirus (COVID-19) Infection Coronavirus disease 19 infection angiotensin II type 1 receptor blocker therapy alone, angiotensin-converting enzyme inhibitor therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of British Columbia British Columbia Centre for Disease Control, Canadian Institutes of Health Research, McGill University Health Center, Peking Union Medical College Hospital, Research Institute of the McGill University Health Centre, University of Alberta, University of Calgary, University of Ottawa, University of Pennsylvania, University of Toronto, University of Victoria, Wuhan University Canada 2020-03-17 2022-06-30 ARBS CORONA I, H20-00600, NCT04510623 Phase Not Applicable Recruiting 15 27 Months 500 Allison McGeer, MD, Ari Joffe, MD, Brent Winston, MD, David Maslove, MD, David Sweet, MD, Francois Lamontagne, MD, Gregory Haljan, MD, James A Russell, MD, Jim Russell, John Marshall, MD, Lynda Lazosky, Matthew Cheng, MD, Nataly Farshait, Oleksa Rewa, MD, Puneet Mann, MSc, Robert Fowler, MD, Todd Lee, MD 2020-08-14
Canine COVID-19 Detection Coronavirus disease 19 infection traditional sniffer dog medical-detection alone Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Arthropod Control Product Test Center (ARCTEC) Cardiff University, Medical Detection Dogs, University of Durham UK 2020-07-02 2020-10-31 LSH1285, NCT04509713 Phase 1 Clinical Recruiting 1 3 Months 16250 James Logan, James Logan, PHD 2020-08-14
A phase III clinical trial of Brexanolone in patients with advanced COVID-19 related acute respiratory distress syndrome (ARDS) Coronavirus disease 19 infection, Respiratory distress syndrome brexanolone alone GABA A receptor modulator SAGE Therapeutics Inc 2020-12-31 Phase 3 Clinical Planned 0 2020-08-13
COVIDSTEROID2: Higher Versus Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia Coronavirus disease 19 infection, Hypoxia betamethasone alone, dexamethasone (Dexavit) alone, standard care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Scandinavian Critical Care Trials Group Aalborg Universitetshospital, Aarhus University Hospital, Centre for Research in Intensive Care (CRIC), Copenhagen Trial Unit, Rigshospitalet, Denmark, The George Institute for International Health Switzerland, Denmark, India, Sweden 2020-08-17 2022-02-17 2020-003363-25, 2020-07-16, COVIDSTEROID2, H-20051056, NCT04509973, RH-ITA-009 Phase 3 Clinical Not yet recruiting 51 18 Months 1000 Amit Shobhavat, Anders Møller, Anders Perner, MD PhD, Anders Perner, MD, PhD, Professor, Andreas Wiklund, Anna Nilsson, Anne Sofie Andreasen, Bharath KT Vijayaraghavan, Binila Chacko, Buster Mannheimer, Carl-Johan Treutiger, Farhad Kapadia, Fredrik Schiöler, Fredrik Sjövall, Iben S Darfelt, J V Divatia, Jacob Hollenberg, Jonathan Oras, Kapil Boraoke, Kedar Toraskar, Magnus Gisslen, Magnus Hedenstierna, Margit Smitt, MD, Marie Warrer B Petersen, MD, Marie Warrer Petersen, MD, Michelle Chew, Neeta B Nayak, Olof Wall, Omender Singh, Pontus Naucler, Pravin Amin, Rajesh Chawla, Saif M Khan, Sanjith Saseedharan, Sara Tehrani, Syed M Ahmed, Thomas Mohr, Urvi Shukla, Vibeke RL Jørgensen, MD, PhD, Zubair U Mohamed, Åke Norberg 2020-08-14
Ivermectin Nasal Spray for COVID-19 Patients Coronavirus disease 19 infection ivermectin alone, standard care alone Chloride channel modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Tanta University Egypt 2020-09-30 2020-12-31 IVRINH, NCT04510233 Phase 2 Clinical Not yet recruiting 1 3 Months 60 Kamal Okasha, PhD, Nahla El-Ashmawy, PhD 2020-08-14
Characterizing the Immune Response and Neuronal Damage in COVID-19 Coronavirus disease 19 infection, Inflammatory disease, Nerve injury Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Hospital Inselspital, Berne University of Bern Switzerland 2020-03-05 2021-03-05 NCOV19, NCT04510012 Phase Not Applicable Recruiting 1 12 Months 150 Cédric Hirzel, MD, Denis Grandgirard, PhD, Franziska Suter, PhD, Jörg C Schefold, MD, Leib L Stephen, MD, Ronald Dijkman, PhD, Thibaud Spinetti, PhD 2020-08-14
COVID SAFE: COVID SAFE Enrollment Coronavirus disease 19 infection Opt-in Recruitment Email alone, Opt-out Recruitment Email alone, saliva-based viral testing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pennsylvania US 2020-08-31 2020-09-30 843565, COVID SAFE, NCT04506268 Phase Not Applicable Not yet recruiting 0 1 Month 1200 Chalanda N Evans, BS, Mitesh S Patel, MD 2020-08-14
RAAS-COVID: The McGill RAAS-COVID-19 Randomized Controlled Trial Coronavirus disease 19 infection, Viral pneumonia anti-hypertensive medication alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Research Institute of the McGill University Health Centre McGill University Health Center, Sir Mortimer B Davis Jewish General Hospital, Université De Lorraine Canada 2020-08-01 2021-09-01 MP-37-2021-6614, NCT04508985, RAAS-COVID Phase Not Applicable Not yet recruiting 1 13 Months 40 Abhinav Sharma, MD, Julie Lebel, PM 2020-08-14
Technology-assisted Index on Improving Hand Hygiene of Registered Nurses Coronavirus disease 19 infection 3M Clean-Trace Surface ATP test alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Taiwan University Hospital Taiwan 2020-08-31 2022-05-31 202006019RINB, NCT04508114 Phase Not Applicable Not yet recruiting 1 21 Months 120 Man-Rong Hsu, BSN, Wei-Wen Wu, PhD 2020-08-13
CoviDep: Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 Coronavirus disease 19 infection, Depression Brief Behavioral Activation with Mental Imagery alone Aged Adults (65-79 yrs), Elderly Adults (80 and over) Uppsala University Vastmanland County Council (Landstinget) Sweden 2020-08-31 2021-07-31 2020-02079, CoviDep, NCT04508868 Phase Not Applicable Not yet recruiting 0 11 Months 154 Johnny Pellas, MSc, Mattias Damberg, MD, PhD 2020-08-14
COVID-19 GDI: COVID-19 Germ Defence: a website to improve infection control during the COVID-19 pandemic Coronavirus disease 19 infection, Influenza virus infection, Respiratory tract infection COVID-19 Germ Defence website alone, digital behavioral change intervention alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Bristol NIHR Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, National Institute for Health Research, Applied Research Collaboration West (NIHR ARC West), United Kingdom Research & Innovation UK 2020-03-30 2021-04-30 COVID-19 GDI, CPMS 46740, IRAS 287978, ISRCTN14602359, UKRI (MRC) MC_PC_19068, UOB 2020-3213 Phase Not Applicable Not yet recruiting 0 13 Months 6822 Dr Jeremy Horwood, Dr Melanie Chalder 2020-08-13
OMA-COVID-19: Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support Coronavirus disease 19 infection, Inflammatory disease, Respiratory distress syndrome, Viral pneumonia anakinra alone Type I IL-1 receptor antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sultan Qaboos University Oman 2020-05-25 2020-08-15 ISRCTN74727214, OMA-COVID-19 Phase 2 Clinical No longer recruiting 2 2 Months 75 Dr Balkhair 2020-08-14
Japan COVID-19 Study of the psychosocial impacts of the postponement/cancellation of reproductive medicine Acute stress disorder, Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Dokkyo Medical University, Saitama Medical Center, Japan Japan Society for Reproductive Psychology Japan 2020-08-17 UMIN000041387 Phase Not Applicable Not yet recruiting 1 1100 Kouhei Sugimoto, Tomoe Koizumi 2020-08-14
COVER: Randomized, Double-blind, Multi Centre Phase II, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19 Studio clinico randomizzato, in doppio cieco, multicentrico, di fase II, per l'individuazione del dosaggio di impiego dell'Ivermectina per il trattamento precoce del COVID-19 Coronavirus disease 19 infection ivermectin alone Chloride channel modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ospedale Sacro Cuore don Calabria Italy 2020-06-12 2020-002283-32, 2020-34, COVER Phase 2 Clinical Recruiting 1 122 Unità per la Ricerca Clinica 2020-08-13
Camphora in COVID: A clinical study to evaluate efficacy and safety of Camphora tablets in Covid positive patients Coronavirus disease 19 infection Camphora alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) TNMC and BYL Nair Hospital India 2020-08-17 CTRI/2020/08/027045, Camphora in COVID Phase 2 Clinical Not yet recruiting 1 Dr Ashish Agarwal, Dr Renuka Munshi 2020-08-13
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study (COVID) Coronavirus disease 19 infection breath biopsy face masks with removable filters and fitted PVA strip alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Owlstone Nanotech Inc Onze Lieve Vrouwe Gasthuis Amsterdam, Universiteit Maastricht 2020-08-31 2020-12-31 NCT04508556, SARS-COV-2 STUDY Phase Not Applicable Not yet recruiting 0 4 Months 500 Alexandra DeSaedeleer, Amerjit kang, Paul Bresser, Paul Savelkoul, 2020-08-13
To observe the outcome of Classical Ayurvedic medicine for the treatment of COVID-19 Coronavirus disease 19 infection Maha-Sudarshana Ghan Vati alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Shri Krishna Ayush University India 2020-08-14 CTRI/2020/08/027044 Phase 2/Phase 3 Clinical Not yet recruiting 1 100 Professor Dr Anil Sharma, Professor Dr Ashish Mehta, Professor Dr Baldev Kumar 2020-08-13
COREG: The McMaster Multi-Regional COVID-19 Hospital Case Registry Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) McMaster University Canadian Institutes of Health Research, Grand River Hospital, Hamilton Academic Health Sciences Organization, Hamilton Health Sciences Corp, Niagara Health System, St Josephs Healthcare Hamilton, St. Mary’s General Hospital Canada 2020-04-15 2021-07-31 172754, COREG, NCT04508959 Phase Not Applicable Recruiting 4 15 Months 1500 Andrew P Costa, PhD, Darly Dash, MSc, Jessica Kapralik, MD (PGY5), Marla Beauchamp, PhD, Mats L Junek, MD, MSc, MyLinh Duong, MBBS, MSc, FRACP, Rebecca J Kruisselbrink, MD, MPH, FRCPC, Terence Ho, MD, FRCP, Tyler Pitre, MA, MD (PGIM) 2020-08-13
PREVENT-HD: A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection Cerebrovascular disease, Coronary artery disease, Coronavirus disease 19 infection, Ischemic stroke, Peripheral vascular disease, Thromboembolism rivaroxaban alone, standard of care alone Factor Xa antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Janssen Research & Development LLC US 2020-08-12 2021-04-06 39039039DVT3004, CR108849, NCT04508023, PREVENT-HD Phase 3 Clinical Not yet recruiting 3 7 Months 4000 Study Contact 2020-08-13
A clinical trial of eravacycline for potential treatment of SARS-CoV-2 infection (COVID-19) Coronavirus disease 19 infection repurposed eravacycline (COVID-19), SOM Biotech alone COVID19 replicase polyprotein 1a inhibitor, COVID19 replicase polyprotein 1ab inhibitor, Viral protease inhibitor SOM Biotech SL US, Europe Phase Not Applicable Planned 1 2020-08-12
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD-7442 in Healthy Adults Coronavirus disease 19 infection AZD-7442 alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) AstraZeneca plc PAREXEL International UK 2020-08-17 2021-09-14 D8850C00001, NCT04507256 Phase 1 Clinical Not yet recruiting 1 12 Months 48 AstraZeneca Clinical Study Information Center, Muna Albayaty, MBChB, FFPM, MSc 2020-08-13
Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment Coronavirus disease 19 infection, Surgical procedure auscultation alone, electronic stethoscope alone, endobronchial blocker alone, endotracheal tube alone, fiberscope alone, general anesthesia alone, traditional stethoscope alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Taiwan University Hospital Taiwan 2020-08-14 2021-07-31 202005104RINC, NCT04507958 Phase Not Applicable Not yet recruiting 1 11 Months 80 Chun-Yu Wu, PhD 2020-08-14
Online meditation as an aid in reducing symptoms of Depression, Anxiety and Psychological Stress in Resident Physicians during COVID-19 pandemic in Brazil Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression on-line meetings for meditation training alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) University of Sao Paulo Brazil 2020-07-20 2020-09-30 33585620.0.0000.0045, 4.129.324, RBR-2w7ghc, U1111-1255-3186 Phase Not Applicable Recruiting 1 2 Months 44 Maria do Rosário Toscano von Flach 2020-08-13
A Survey to Assess Effects of Covid-19 on Cardiovascular Patients Cardiac failure, Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centro en Insuficiencia Cardiaca Fundación Clínica Médica Sur, Instituto Nacional de Cardiologia Ignacio Chavez Mexico 2019-05-15 2021-07-15 20-1156, NCT04508920 Phase Not Applicable Recruiting 1 26 Months 76 ALAN FUENTES, MD, ALAN FUENTES-MENDOZA, MD, CHUQUIURE-VALENZUELA EDUARDO, MD, MSc, EDUARDO CHUQUIURE-VALENZUELA, MD, EDUARDO CHUQUIURE-VALENZUELA, MD MSc 2020-08-13
COVID SAFE: COVID-19 Screening Assessment for Exposure Coronavirus disease 19 infection saliva-based testing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pennsylvania US 2020-08-31 2021-03-31 843565-OBS, COVID SAFE, NCT04508777 Phase Not Applicable Not yet recruiting 1 7 Months 600 Chalanda N Evans, BS, Mitesh S Patel, MD 2020-08-14
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection Coronavirus disease 19 infection enoxaparin sodium alone Low molecular weight heparin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital Regional de Alta Especialidad de Ixtapaluca Mexico 2020-06-20 2020-12-30 NCT04508439, NR-CEI-HRAEI-19-2020 Phase 2 Clinical Recruiting 1 6 Months 130 Omar O Ramos-Peñafiel, Omar Ramos-Peñafiel, Omar Ramos-Peñafiel, MD, PhD 2020-08-13
A clinical study to assess IgG1 Ab1 for the potential treatment of SARS-CoV-2 infection Coronavirus disease 19 infection IgG1 Ab1(COVID-19 infection) Abound bio/Saudivax alone University of Pittsburgh Medical Center Phase Not Applicable Planned 0 2020-08-12
Long-term Outcomes in Patients With COVID-19 Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Renji Hospital China 2020-08-10 2021-08-31 COVID-19 PROGNOSIS, NCT04508712 Phase Not Applicable Not yet recruiting 1 12 Months 900 Diansan Su, MD,PhD, Weifeng Yu, MD,PhD 2020-08-13
COVID-19 Associated Coagulopathy in Egypt Blood clotting disorder, Coronavirus disease 19 infection Assiut University Egypt 2020-08-07 2020-10-31 17300413, NCT04507230 Phase Not Applicable Recruiting 1 2 Months 100 Azza Abdelaal, MD, PhD, Azza Ezzeldin, MD,PhD, Hanan Galal, MD, PhD 2020-08-13
MITIGATE COVID-19: A Pragmatic, Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults in the Era of Coronavirus Disease 2019 Atherosclerosis, Coronavirus disease 19 infection, Influenza virus infection, Ischemic stroke, Myocardial infarction, Peripheral vascular disease, Upper respiratory tract infection icosapent ethyl, Amarin alone Apolipoprotein B antagonist, Phospholipase A2 inhibitor Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Kaiser Permanente Amarin Corp plc US 2020-08-07 2023-02-28 1597940, MITIGATE COVID-19, NCT04505098 Phase 4 Clinical Recruiting 1 30 Months 16500 Alan Go, MD, Alan S Go, M.D., Andrew Ambrosy, M.D., Andrew P Ambrosy, M.D. 2020-08-14
The C3I COVID-19 Project Coronavirus disease 19 infection, Dyspnea, Viral pneumonia University of Wisconsin-Madison National Cancer Institute US 2020-08-10 2021-12-31 2020-069, A534253, CTRI, NCT04506528, OISE-20-66590-1, SMPH/MEDICINE Phase Not Applicable Recruiting 26 16 Months 170000 Amy Conlon, MPH, Betsy Rolland, PhD, MLIS, MPH, Michael C Fiore, MD, MPH, MBA, Rob Adsit, MEd, Stevens S Smith, PhD, Tanya R Schlam, PhD 2020-08-13
EXPLORE COVID-19: An exploratory translational research study to analyze the immune response of COVID-19 patients at varying stages of disease Coronavirus disease 19 infection Innate Pharma SA Assistance Publique Hopitaux De Marseille, Hôpital de la Timone (UPCET/CIC) EXPLORE COVID-19 Phase Not Applicable Status not specified 0 2020-08-12
COVRehab: The Usability, Feasibility and Tolerability of Virtual Reality for Rehabilitation From COVID-19 Cognitive disorder, Coronavirus disease 19 infection, Psychiatric disorder cognitive rehabilitation alone, physical rehabilitation alone, psychological rehabilitation alone, standard physiotherapy alone, virtual reality headset rehabilitation alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Radboud University Netherlands 2020-09-01 2021-01-01 COVREHAB, COVRehab, NCT04505761 Phase Not Applicable Not yet recruiting 1 4 Months 40 Bart Staal, PT, PhD, Harry van Goor, MD, PhD, Merlijn Smits, Msc 2020-08-12
Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III Coronavirus disease 19 infection, Respiratory distress syndrome macronutrient intake alone, nutritional support system alone, standard diet alone, Variable regimens including Cyanomax Ultra , L-arginine , Neurobion , Saccharomyces Bourllardii , Spirulina Maxima , ascorbic acid , cholecalciferol , folic acid , glutamine , magnesium , omega 3 fatty acid , resveratrol , selenium , zinc Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Anahuac University Mexico 2020-08-31 2020-12-31 202036, NCT04507867 Phase Not Applicable Not yet recruiting 1 4 Months 240 Fernado Leal Martínez, Ph.D, Fernando Leal Martínez, Ph.D 2020-08-13
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19) Coronavirus disease 19 infection CoronaVac alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Bio Farma National Institute Of Health Research & Development (Nihrd)- Ministry Of Health Of The Republic Of Indonesia, Sinovac Life Sciences Co., Ltd., Universitas Padjadjaran Indonesia 2020-08-10 2021-09-30 COV2-0320, NCT04508075 Phase 3 Clinical Not yet recruiting 1 13 Months 1620 Eddy Fadlyana, MD, PhD, Novilia Sjafri Bachtiar, MD, PhD, Prof Kusnandi Rusmil, MD, PhD, Prof. Kusnandi Rusmil, MD, PhD 2020-08-13
Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and 'Typical' ARDS Patients Coronavirus disease 19 infection, Respiratory distress syndrome transpulmonary thermodilution (TPTD) technique alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Istanbul University-Cerrahpasa Turkey 2020-09-01 2020-12-31 0308202247, NCT04508933 Phase Not Applicable Not yet recruiting 1 4 Months 10 Olcay Dilken, MD, Yalım Dikmen, Prof 2020-08-13
VOICE-COVID: The VOICE-COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Study World Health Organization (WHO) Coronavirus disease 19 infection Alexa (Amazon) alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) McGill University Health Center, Research Institute of the McGill University Health Centre Amazon Web Services Canada 2020-07-01 2020-11-01 2020-6583, NCT04508972, VOICE-COVID Phase Not Applicable Recruiting 1 4 Months 50 Abhinav Sharma, MD, Abhinav h Sharma, MD, Julie Lebel 2020-08-14
Bursa Postgraduate Hospital Coronavirus disease 19 infection low molecular weight heparin alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Bursa Postgraduate Hospital Turkey 2020-05-15 2020-07-15 BURSA POSTGRADUATE HOSPITAL, NCT04507282 Phase Not Applicable Completed 1 2 Months 80 Hasan ARI 2020-08-13
Mesenchymal Stem Cell Therapy For Covid 19 Coronavirus disease 19 infection, Viral pneumonia mesenchymal stem cells therapy alone, standard care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Neurogen Brain and Spine Institute, Reelabs Private Ltd India 2020-08-10 CT-06/2020, CTRI/2020/08/027043 Phase 1 Clinical Not yet recruiting 1 20 Dr Abhijit Bopardikar, Dr Alok Sharma, Dr Rohit Kulkarni 2020-08-13
Comparison Between Positive and Negative COVID-19 Pneumonia Coronavirus disease 19 infection, Respiratory disease, Viral pneumonia PCR assay alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Palermo Italy 2020-03-15 2020-12-01 ACPM26, NCT04507893 Phase Not Applicable Recruiting 3 8 Months 80 Antonio Carroccio, MD, Enzo M Farinella, MD, Giuseppe Arcoleo, MD, Pasquale Mansueto, Clinical Professor 2020-08-13
A compassionate-use study evaluating narsoplimab, Omeros investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), in the treatment of COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS) Coronavirus disease 19 infection, Respiratory distress syndrome narsoplimab alone Complement cascade inhibitor, Mannan-binding lectin serine protease-2 inhibitor Middle-aged Adults (45-64 yrs) Omeros Corp Italy Phase not specified Status not specified 1 Alessandro Rambald 2020-08-13
PSIMCOV: Psychological Impact of COVID-19 Pandemic in Healthcare Workers Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Hospital General Universitario de Valencia Spain 2020-04-09 2020-04-30 COV2-2020, NCT04506515, PSIMCOV Phase Not Applicable Completed 1 3000 Carolina Soledad Romero Garcia, MD, PhD 2020-08-13
Anti-thrombotics for Adults Hospitalized With COVID-19 Coronavirus disease 19 infection Variable regimens including dalteparin sodium , enoxaparin sodium , heparin , tinzaparin sodium , unfractionated heparin Antithrombin III, Factor IIa antagonist, Factor Xa antagonist, Low molecular weight heparin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pittsburgh National Heart Lung and Blood Institute US 2020-08-31 2021-12-31 ACTIV-4 ACUTE, NCT04505774 Phase 4 Clinical Not yet recruiting 1 16 Months 2000 Judith Hochman, MD, Matthew Neal MD, Matthew Neal, MD 2020-08-14
Secondary attack rate of COVID-19, Kerala Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Government Medical College Kannur India 2020-09-01 CTRI/2020/08/027042 Phase Not Applicable Not yet recruiting 1 Anitha S S 2020-08-13
An Observational Study of Guduchi Extract Tablet Coronavirus disease 19 infection Guduchi extract tablet alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ministry of Ayush India 2020-08-15 CTRI/2020/08/027034 Phase Not Applicable Not yet recruiting 1 1200 Dr Sanjay Srivastava, Prof Dr Abhimanyu Kumar 2020-08-13
etrospective Analysis of 245 COVID-19 Cases from a Government Teaching Hospital of North India Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Superspeciality Pediatric hospital and Postgraduate Teaching Institute India 2020-08-19 CTRI/2020/08/027036 Phase Not Applicable Not yet recruiting 1 245 Dr Divya Jain 2020-08-13
Effect of yoga for COVID-19 patients in addition to regular treatment Coronavirus disease 19 infection pranayama yoga nidra alone, standard care alone, yoga alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sri Devaraj Urs Academy of Higher Education and Research India 2020-08-17 CTRI/2020/08/027037 Phase 3 Clinical Not yet recruiting 1 60 Nitin Patil 2020-08-13
Study to assess effects of nano-ozonised hydrogen peroxide nebulization on results of RT-PCR for novel coronavirus thus infectivity and clinical course among mild to moderate sick COVID-19 patients Coronavirus disease 19 infection Triozone alone, nano-ozonised hydrogen peroxide nebulization alone Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Dr. S.N. Medical College, Jodhpur India 2020-08-20 CTRI/2020/08/027038 Phase 3 Clinical Not yet recruiting 1 Dr Ashish Gautam, Dr Prabhat Kumar Agrawal 2020-08-13
An interventional study to access the effect of ayurvedic medicine in positive cases of COVID-19 Coronavirus disease 19 infection Variable regimens including Lavangadi vati , Mahasudarshan ghana vati , Samsamani vati Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ministry of Ayush India 2020-08-12 CTRI/2020/08/027040 Phase 3 Clinical Not yet recruiting 2 200 Dr Bishnu Choudhury, Prof Dr Pradip Kumar Goswami 2020-08-13
Clinical Trial on COVID-19 Patients to Improve Immunity Coronavirus disease 19 infection herbivor syrup alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Venkat Pharma Ltd India 2020-08-14 CTRI/2020/08/027041, Herbovir/CT/2020 Version 1.0 Phase 4 Clinical Not yet recruiting 1 40 Dr A Gopal Rao, Sri H Srinivas 2020-08-13
Multicenter, randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia Coronavirus disease 19 infection, Viral pneumonia Pharmenterprises LLC Russian Federation 2020-08-06 2021-03-31 COVID-TRE-03 Phase 2 Clinical Status not specified 12 7 Months 67 2020-08-13
ENSEMBLE: A Study of Ad26.COV2-S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants Coronavirus disease 19 infection JNJ-78436735 alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Janssen Vaccines & Prevention BV, Johnson & Johnson Biomedical Advanced Research and Development Authority (BARDA), Burroughs Wellcome Inc, National Institutes of Health, The Ragon Institute Philippines, Chile, Mexico, Ukraine, Colombia, Brazil, US, Peru, South Africa 2020-09-05 2023-03-10 CR108876, ENSEMBLE, NCT04505722, VAC31518COV3001 Phase 3 Clinical Not yet recruiting 178 30 Months 60000 Janssen Vaccines & Prevention B.V. Clinical Trial, Study Contact 2020-08-12
COST-NHS: Burden for Staff Working in the NHS Coronavirus disease 19 infection, Psychiatric disorder Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sheffield Teaching Hospitals NHS Foundation Trust University of Sheffield UK 2020-06-02 2022-04-26 COST-NHS, NCT04506632, STH21373 Phase Not Applicable Recruiting 1 22 Months 100 Colette Mann, Loretta Chantry-Groves, Sarah Danson, Professor 2020-08-13
STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19 Coronavirus disease 19 infection Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Instituto de Investigación Sanitaria de la Fundacion Jimenez Diaz Fundacion De Investigacion Hospital 12 De Octubre, Hospital Universitario 12 de Octubre, Hospital Universitario Infanta Elena, Hospital Universitario Virgen de la Arrixa, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca, Jimenez Diaz Foundation Spain 2020-08-01 2021-08-01 COV20/00181, NCT04505709, STOP-CORONAVIRUS, STOP-Coronavirus Phase Not Applicable Recruiting 4 12 Months 1000 2020-08-12
LPSARS2: Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia Coronavirus disease 19 infection, Respiratory tract infection, Viral pneumonia Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Groupe Hospitalier Paris Saint-Joseph Centre Hospitalier Victor Dupouy France 2020-05-14 2020-11-30 LPSARS2, LPSARS2, NCT04505605 Phase Not Applicable No longer recruiting 1 6 Months 200 2020-08-12
GenCov: Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function Coronavirus disease 19 infection Whole exome sequencing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Texas Cardiac Arrhythmia Research Foundation US 2020-08-31 2021-09-30 GenCov, NCT04506229, TCAI_GENCOV Phase Not Applicable Not yet recruiting 1 13 Months 60 Andrea Natale, Bryan MacDonald, Sanghamitra Mohanty 2020-08-12
SARS-COV-2 and COVID-19 - a randomized, controlled trial (unblinded) Coronavirus disease 19 infection Variable regimens including aadathodai manapagu , amukara chooranam , kabasura kudineer , muthu parpam , nilavembu kudineer , pavala parpam , seenthil chooranam , silasathu parpam , sivanar amirtham , swasakudori maathirai , thippili rasayanam , thoothuvalai legiyam Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Government Kilpauk Medical College China 2020-08-07 CTRI/2020/08/027033 Phase 2 Clinical Not yet recruiting 1 100 Dr A Shiyam ranjith, Dr N Anbu, Dr P Vasanthamani 2020-08-14
An Open Label Physician Initiated 28 Day Phase 2a Study Of Ifenprodil On Lung Function In Confirmed Covid-19 Infected Patients With Severe Pneumonia Coronavirus disease 19 infection, SARS coronavirus infection ifenprodil alone Noncompetitive NMDA antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Dong-A University Hospital, NOVOTECH ASIA KOREA CO. LTD. Dong-A University Hospital South Korea 2020-09-30 AGN120-2, KCT0005307 Phase 2 Clinical Recruiting 3 40 Dong Sik Jung 2020-08-12
MITIGATE COVID-19: A clinical trial of icosapent ethyl(VASCEPA) in patients with established atherosclerotic cardiovascular disease who are at elevated risk of experiencing moderate to severe COVID-19 Atherosclerosis, Cardiovascular disease, Coronavirus disease 19 infection icosapent ethyl alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Amarin Corp plc, Kaiser Permanente MITIGATE COVID-19 Phase Not Applicable Status not specified 0 1500 Dr. Alan S. Go, Dr. Andrew P. Ambrosy, 2020-08-11
Tenecteplase in Patients With COVID-19 Coronavirus disease 19 infection, Respiratory failure heparin plus tenecteplase Tissue plasminogen activator stimulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Mount Sinai Medical Center Genentech Inc US 2020-08-31 2021-04-30 GCO 20-1764, NCT04505592 Phase 2 Clinical Not yet recruiting 1 8 Months 60 Denise Balili, MS, Hooman Poor, MD, J Mocco, MD, Lisa Genadry, Sukaina Davdani 2020-08-12
A Randomized, Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of severe COVID-19 Coronavirus disease 19 infection, Respiratory distress syndrome PLX stem cell therapy, Pluristem/Cha Bio & Diostech alone IL-6 receptor agonist Pluristem Therapeutics Inc Germany Phase 2 Clinical Not yet recruiting 1 40 2020-08-13
A trial to evaluate Organicell Flow in patients with COVID-19 admitted to the ICU Coronavirus disease 19 infection Organicell Flow alone Organicell Regenerative Medicine US Phase Not Applicable Status not specified 1 1 2020-08-11
A trial to evaluate Organicell Flow in patient with COVID-19 related respiratory impairment and acute kidney injury Coronavirus disease 19 infection, Renal injury, Respiratory disease Organicell Flow alone Organicell Regenerative Medicine Georgia Phase Not Applicable Status not specified 1 1 2020-08-11
SISCOVID: Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 Coronavirus disease 19 infection, Viral pneumonia Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Groupe Hospitalier de la Region de Mulhouse et Sud Alsace France 2020-06-10 2021-06-30 GHR 1052, IDRCB 2020-A01089-30, NCT04505631, SISCOVID Phase Not Applicable Recruiting 14 12 Months 100 Acya Bizieux, MD, Amélie Leurs, MD, Cécile Carvallo, MD, Cécilia Nocent-Ejnaini, MD, Didier Debieuvre, MD, François Goupil, MD, George-Daniel Calcaianu, MD, Hugues Morel, MD, Jean-Philippe Oster, MD, Johanna Claustre, MD, Laurent Portel, MD, Marie Diesel, Marie-Germaine Legrand, MD, Nadine Paillot, MD, Stéphane Hominal, MD, Stéphanie Romanet, MD 2020-08-12
A trial to evaluate Organicell Flow in patients with mild to moderate respiratory distress due to COVID-19 Coronavirus disease 19 infection, Respiratory distress syndrome Organicell Flow alone Organicell Regenerative Medicine US Phase Not Applicable Status not specified 1 1 2020-08-11
A phase I/IIa clinical study to assess UMSC-01 for the treatment of patients with COVID-19 infection Coronavirus disease 19 infection UMSC-01 alone Ever Supreme Bio Technology Co Ltd US ES-CMSC01-C1101 Phase 1/Phase 2 Clinical Not yet recruiting 1 2020-08-11
A clinical trial of JAN-101 for the potential treatment of vascular complications in COVID-19 patients Coronavirus disease 19 infection, Vascular disease JAN-101 alone Cato Holding Ltd, JanOne Inc US Phase Not Applicable Planned 1 Dr. Amol Soin 2020-08-11
CorKid: CorKid (COVID19/ SARS-CoV-2 seroconversion in kids) Coronavirus disease 19 infection Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Universitätskinderklinik im St.-Josef Hospital Klinikum der Ruhr-Universität-Bochum German Federal Ministry of Education and Research, Ruhr Universitat Bochum Germany 2020-06-08 20-6927, CorKid, DRKS00022434 Phase Not Applicable Recruiting 3 3000 Corkid Studienteam, Thomas Lücke 2020-08-12
Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients Coronavirus disease 19 infection famotidine (Famotac) alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Chattogram General Hospital The First Affiliated Hospital of Xi'an Jiaotong University Bangladesh 2020-08-01 2020-10-30 10000753/980, NCT04504240 Phase 3 Clinical Recruiting 2 2 Months 200 Abu Taiub Mohammed Mohiuddin Chowdhury, Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD, Aktar Kamal, MD, PhD, H.M. Hamidullah Mehedi, MBBS, FCPS, H.M.Hamidullah Mehedi, H.M.Hamidullah Mehedi, MMBS, FCPS 2020-08-13
Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support Coronavirus disease 19 infection Hospital Clinic of Barcelona Spain 2020-05-15 2020-06-06 MEDICALITZED HOTEL COVID-19, NCT04503434 Phase Not Applicable Completed 1 517 Carme Hernandez, PhD 2020-08-12
DenutCOVID: Nutritional Assessment of Hospitalized Patients With COVID-19 Coronavirus disease 19 infection, Nutritional disorder nutrition testing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Lille Catholic University France 2020-05-25 2021-06-30 DenutCOVID, NCT04503525, RC-P00100 Phase Not Applicable Recruiting 1 13 Months 50 Amel Boulafa, Master, Amelie LANSIAUX, MD, PhD, Arnaud CORTET, PhD, Arnaud Cortet, MD 2020-08-12
A clinical study to assess the safety and efficacy of ANA-001 (niclosamide capsules) as well as its ability to show a clinical improvement in hospitalized patients with COVID-19 Coronavirus disease 19 infection repurposed niclosamide (oral/capsule, COVID-19), ANA Therapeutics alone ANA Therapeutics US Phase Not Applicable Not yet recruiting 2 400 2020-08-14
An observational study on the optimization of hydroxychloroquine dosing for the treatment of patients with COVID-19 Coronavirus disease 19 infection hydroxychloroquine alone, azithromycin plus hydroxychloroquine University of California San Francisco Phase Not Applicable Status not specified 0 116 2020-08-12
Ultrafast Screening of novel coronavirus pneumonia (COVID-19) by Machine Learning Analysis of Exhaled NO Coronavirus disease 19 infection, Viral pneumonia preliminary screening( Machine Learning Analysis of Exhaled NO ) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Liyuan Hospital Shandong University China 2020-03-01 2021-06-30 ChiCTR2000035342 Phase 0 Clinical Recruiting 2 16 Months Jing Ma, Wei-Qiao Deng 2020-08-11
Covid-19 Messaging to Underserved Communities - Second Experiment Coronavirus disease 19 infection AMA Acknowledgement Drug Pricing alone, Acknowledgement Racial Injustice AMA alone, Acknowledgement alone, Informational Videos alone, No Racial Inequality Highlighting alone, Racial Inequality Highlighted alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), African Ancestry National Bureau of Economic Research Inc Harvard University, Massachusetts General Hospital, Stanford University, Yale University US 2020-08-31 2021-09-30 2029880, NCT04502056 Phase Not Applicable Not yet recruiting 1 13 Months 20000 Esther Duflo 2020-08-13
Parent Telehealth Intervention for Children With Autism Autism, Coronavirus disease 19 infection Responsive training alone, Video feedback alone Healthy volunteers accepted, Infants (6-23 months), Preschool Children (2-5 yrs) Northwestern University US 2020-03-06 2021-07-31 NCT04501588, STU00201708 Phase 2 Clinical Recruiting 1 16 Months 40 Laura Sudec, MSW, Megan Y Roberts, PhD 2020-08-13
Western Kenya Integrated COVID-19 Response Coronavirus disease 19 infection Training clinicians in basic critical care alone, Training of youth, community health assistants and community health workers. alone, management of severe COVID-19 cases alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) SURGICAL SYSTEMS RESEARCH GROUP Tropical Institute of Community Health and Development (TICH), Wellcome Trust Kenya 2020-05-18 2020-08-19 001, NCT04501458 Phase Not Applicable Recruiting 1 3 Months 200000 Neema Kaseje, MD 2020-08-12
Psychological Symptoms and Families of COVID-19 Patients Anxiety disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder, Psychiatric disorder Post-ICU discharge survey and Interview alone, Written Summary of Rounds alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Rush University Medical Center US 2020-08-20 2021-09-15 20071101, NCT04501445 Phase Not Applicable Not yet recruiting 1 12 Months 100 Jared A Greenberg 2020-08-12
COVID-19 Project ECHO in Nursing Homes Coronavirus disease 19 infection Project ECHO alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Milton S. Hershey Medical Center US 2020-08-31 2022-07-31 NCT04499391, PCORI NURSING HOMES Phase Not Applicable Not yet recruiting 1 23 Months 100 Erica Francis, Jennifer Kraschnewski 2020-08-14
BONSAI: Burnout and Distress prevention With cannabidiol in Front-line Health Care workers dealing with COVID-19 Acute stress disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder cannabidiol alone, fitness video watching alone, supporting motivational video watching alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) University of Sao Paulo Brazil 2020-06-16 2020-09-30 30504620.4.0000.5440, BONSAI, BONSAI Study, NCT04504877 Phase 2/Phase 3 Clinical Recruiting 1 3 Months 102 Jose A. Crippa, MD, PhD, Jose Alexandre de Souza Crippa, Julia C Pacheco, MsC, Julia C. Pacheco, MsC 2020-08-12
CovAb: COVID-19 Seroprevalence Study in ITM Staff Coronavirus disease 19 infection Anti-SARS-CoV-2 ELISA (EUROIMMUN) alone, WANTAI SARS-CoV-2 Ab ELISA (WANTAI SARS-CoV-2 Diagnostics) alone Institute of Tropical Medicine, Belgium Belgium 2020-08-01 2020-09-30 CovAb, NCT04503447, SARSCOV2SEROPREVALENCEITMSTAFF Phase Not Applicable Recruiting 1 2 Months 430 Bart Karl Jacobs, Lut Lynen, Marie Laga, Marjan Van Esbroeck, Marjan Van Esbroeck, MD, Nikki Foqué, Sarah Gils 2020-08-12
A randomized, placebo-controlled, double-blind, phase II clinical trial to assess CAP-1002 in patients with severe or critical COVID-19 infection Coronavirus disease 19 infection CAP-1002 alone Capricor Therapeutics Inc US 2020-09-30 Phase 2 Clinical Planned 1 60 2020-08-10
300BCG: A study to evaluate BCG vaccine in a group of healthy subjects Coronavirus disease 19 infection BCG vaccine alone Healthy volunteers accepted Radboud University Netherlands 300BCG Phase Not Applicable Status not specified 1 2020-08-11
A Randomized, Controlled, Phase IIb Trial to Evaluate Safety and Efficacy of Rivaroxaban Coronavirus disease 19 infection rivaroxaban alone Factor Xa antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Bill & Melinda Gates Medical Research Institute 2020-08-31 2020-12-31 GATES MRI - COD-01-T01-01, NCT04504032 Phase 2b Clinical Not yet recruiting 0 4 Months 600 Gates MRI, GatesMRI 2020-08-12
VisVasc COVID-19: Visualizing blood vessel disease in the eye in COVID-19 Coronavirus disease 19 infection, Retinopathy, Vascular disease fundal photography alone, optical coherence tomography alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) North Bristol NHS Trust Southmead Hospital, Wellcome Trust UK 2020-08-06 2021-08-05 IRAS 286315, ISRCTN59449699, VisVasc COVID-19 Phase Not Applicable Not yet recruiting 2 12 Months 30 Dr Rice 2020-08-14
CANCOVID-19: Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug Versus Hydroxychloroquine in Uncomplicated COVID-19 Patients Coronavirus disease 19 infection Variable regimens including Cospherunate (artesunate + amodiaquine) , azithromycin , phytomedicine tablet (Asen) Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Institute for Research and Development of Medicinal and Food Plants of Guinea Guinea 2020-06-01 2020-09-30 CANCOVID-19, NCT04502342, RDIMFPG Phase 2 Clinical Recruiting 1 4 Months 30 Mamadou A Baldé 2020-08-10
A large-scale trial to evaluate Gam-COVID-Vac for the prevention of Covid-19 Coronavirus disease 19 infection Sputnik V alone COVID19 Spike glycoprotein modulator Gamalei Institute of Epidemiology and Microbiology Phase 3 Clinical Planned 0 2020-08-13
Pred-MAKER: Prediction of Major Adverse Kidney Events and Recovery Coronavirus disease 19 infection, Renal disease KidneyIntelX alone Mount Sinai School of Medicine, Renalytix AI plc US Pred-MAKER Phase Not Applicable Status not specified 1 Dr. Steven Coca 2020-08-10
MASKeD-COVID: Multicenter Assessment of Survivors for Kidney Disease After COVID-19 Coronavirus disease 19 infection, Renal disease, Renal failure KidneyIntelX alone Mount Sinai School of Medicine, Renalytix AI plc US 2020-08-03 MASKeD-COVID Phase Not Applicable Recruiting 2 4000 F. Perry Wilson, Matthias Kretzler 2020-08-10
PERSONAL-COVIDBP: Personalised Electronic Record Supported OptimisatioN when ALone for Patients with Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic Coronavirus disease 19 infection, Hypertension amlodipine alone Calcium channel inhibitor L-type Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Queen Mary University of London Technology Strategy Board UK 2020-07-17 2020-002494-10, PERSONAL-COVIDBP Phase 4 Clinical Recruiting 1 1000 Dr David Collier 2020-08-10
CLiCK Study: A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19 Coronavirus disease 19 infection clazakizumab alone IL-6 receptor antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Imperial College London Vitaeris Inc UK 2020-07-24 2020-002476-13, 20HH5958, CLiCK Study Phase 2 Clinical Recruiting 1 20 2020-08-11
Effects of Tocilizumab and its combination with Vitamin D to treat the increased defensive response in COVID-19 Coronavirus disease 19 infection tocilizumab (intravenous), Roche/Chugai alone IL-6 receptor antagonist, IL-6 receptor modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital Universitario de Móstoles Servicio Madrileño de Salud (SERMAS) Spain 2020-06-10 2020-001903-17, HMos-012020 Phase 3 Clinical Recruiting 1 120 MEDICAL DIRECTOR 2020-08-10
An initial study to evaluate the accuracy of NeuCovix for the detection of neutralizing antibodies in patients with COVID-19 infection Coronavirus disease 19 infection NeuCovix alone Axim Biotechnologies Inc Phase Not Applicable Status not specified 0 2020-08-10
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19) Coronavirus disease 19 infection montelukast sodium alone Leukotriene D4 antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Porto Portugal 2020-07-06 2020-001747-21, ISPUP2020CT1 Phase 4 Clinical Recruiting 1 160 Clinical trials information 2020-08-10
ARCADIA: A Phase II clinical trial to assess how safe and how effective AZD-1656 is in treating COVID-19 in diabetic patients compared to placebo Coronavirus disease 19 infection AZD-1656 alone Glucokinase stimulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) St George Street Capital UK 2020-07-31 2020-002211-21, ARCADIA, SGS.1656.201 Phase 2 Clinical Recruiting 1 150 Clinical Trials 2020-08-11
SPESELPIS: A Trial of NT-I7 in COVID-19 Coronavirus disease 19 infection efineptakin alfa alone, standard of care alone IL-7 receptor agonist, Interleukin-7 ligand Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) National Institute of Allergy and Infectious Diseases, National Institutes of Health, NeoImmuneTech Inc, University of Nebraska Medical Center National Institute of Allergy and Infectious Diseases US 2020-08-31 2021-12-31 NCT04501796, NIT-116 (SPESELPIS), SPESELPIS, SPESELPIS Phase 1 Clinical Recruiting 2 16 Months 30 Amy Haberman, Andre Kalil, M.D., M.P.H, Anela Kellogg, Megan Anderson, NgocDiep 2020-08-10
TICO/ACTIV-3: Therapeutics for Inpatients With COVID-19 Coronavirus disease 19 infection LY-CoV555 plus remdesivir COVID19 Spike glycoprotein modulator, COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Institute of Allergy and Infectious Diseases, National Institutes of Health AIDS Clinical Trials Group, Cardiothoracic Surgical Trials Network, Copenhagen University, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Centre in HIV Epidemiology and Clinical Research, National Heart Lung and Blood Institute, Prevention and Early Treatment of Acute Lung Injury (PETAL), US Department of Veterans Affairs, Washington D.C. Veterans Affairs Medical Center US 2020-08-04 2021-07-31 014 / ACTIV-3, NCT04501978, TICO/ACTIV-3 Phase 3 Clinical Recruiting 2 11 Months 10000 Alan Moskowitz, M.D, Annetine Gelijns, Ph.D, Do not include personal information in email, Jens Lundgren, M.D, Prof. James Neaton, Rachel Ramoni, D.M.D, Sc.D, Taylor Thompson, M.D 2020-08-11
Effectiveness of gargle and nasal spray with Hydrogen Peroxide as an auxiliary treatment for corona virus Coronavirus disease 19 infection Hydrogen Peroxide alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidado de Passo Fundo Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Brazil 2020-06-26 2020-08-30 31752720.1.0000.5342, 4.071.153, RBR-6sx3sz, U1111-1254-2210 Phase 1/Phase 2 Clinical Recruiting 1 2 Months 240 Henrique Cesca, Marielle Bazzo Di Domênico, Pedro Henrique Corazza 2020-08-07
Behavior During and After COVID-19-crisis Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Bern University of Applied Sciences Switzerland 2020-04-01 2022-12-31 BFH CORONA, NCT04502108 Phase Not Applicable Recruiting 2 33 Months 1000 Heiner Baur, Ph.D, Slavko Rogan, Slavko Rogan, Ph.D 2020-08-11
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting Coronavirus disease 19 infection remdesivir alone COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gilead Sciences Inc 2020-09-30 2021-01-31 2020-003510-12, GS-US-540-9012, NCT04501952 Phase 3 Clinical Not yet recruiting 0 4 Months 1230 Gilead Clinical Study Information Center, Gilead Study Director 2020-08-13
PHYTCOVID-19: Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic COVID-19 Patients Coronavirus disease 19 infection azithromycin alone, plant species powder alone, Variable regimens including Quinquina-Stevia , azithromycin , hydroxychloroquine Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Institute for Research and Development of Medicinal and Food Plants of Guinea Guinea 2020-06-01 2020-09-30 IRDPMAG, NCT04501965, PHYTCOVID-19 Phase 2 Clinical Recruiting 1 4 Months 231 Mamadou A Baldé, Mohamed Cissé, Saliou Sow 2020-08-14
Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes Coronavirus disease 19 infection, Non-insulin dependent diabetes antidiabetic treatment alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pisa Italy 2020-03-11 2020-06-30 AS0007, NCT04501991 Phase Not Applicable Completed 1 3 Months 114 Anna Solini, MD, PhD 2020-08-11
Effect of finasteride on COVID-19 treatment Coronavirus disease 19 infection, Viral pneumonia Variable regimens including ceftriaxone , finasteride , hydroxychloroquine 5-Alpha-reductase inhibitor Male, Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Qazvin University Of Medical Sciences Iran 2020-03-20 IR.QUMS.REC.1399.016, IRCT20200505047318N1 Phase 3 Clinical No longer recruiting 2 80 Abbas Allamy, Dr.Abbas Allami, Dr.Abbas Allamy 2020-08-10
Impact of Spectacles on Compliance to Mask-wearing Directives Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Of Thrace Greece 2020-06-25 2020-08-14 ES8/TH5/25-06-2020, NCT04501172 Phase Not Applicable No longer recruiting 1 1 Month 1214 Labiris Georgios, MD, PhD 2020-08-12
Prospective Study initiated by University Hospital Rostock concerning COVID-19 in mothers, nursery and school teachers of children in Rostock Coronavirus disease 19 infection biological sampling alone, polymerase chain reaction alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Universitätsmedizin Rostock Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research, Land Mecklenburg-Vorpommern Germany 2020-08-10 A 2020-0090, DRKS00022504 Phase Not Applicable Recruiting 1 600 Emil C. Reisinger, Hilte Geerdes-Fenge 2020-08-10
Evaluating the effect of Ivermectin on COVID-19 patients Coronavirus disease 19 infection ivermectin alone Chloride channel modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ahvaz University of Medical Sciences Iran 2020-07-30 IR.AJUMS.REC.1399.322, IRCT20200404046937N4 Phase 2 Clinical Recruiting 2 60 Mehran Varnaseri, Mehran Varnasseri, Mohammad Badavi 2020-08-10
A clinical study to evaluate the effect of BioTech Life Sciences proprietary formulas on long-term patient symptoms related to COVID-19 Post-Viral Fatigue (long-haulers) and chronic fatigue syndrome Chronic fatigue syndrome, Coronavirus disease 19 infection proprietary formulas, BioTech Life Sciences alone BioTech Life Sciences Phase Not Applicable Recruiting 0 2020-08-07
A phase II clinical trial of VBI-2900 for the potential treatment of SARS-CoV-2 infection Coronavirus disease 19 infection VBI-2901 alone VBI Vaccines Inc 2020-12-31 Phase 2 Clinical Planned 0 2020-08-07
Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 Coronavirus disease 19 infection, Respiratory disease cholecalciferol alone Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) Coordinacion de Investigacion en Salud Hospital General de Mexico, Hospital Infantil de Mexico Federico Gomez Mexico 2020-07-15 2021-04-30 NCT04502667, R-2020-3603-020 Phase 3 Clinical Recruiting 1 9 Months 40 Carla Castuera Martinez, Carmen Espinosa-Sotelo, MD, Guadalupe Miranda-Novales, PhD, JESSIE ZURITA-CRUZ, JESSIE ZURITA-CRUZ, PhD, Jessie N ZURITA-Cruz, Jessie ZURITA-CRUZ, Mardia Lopez-Alarcon, PhD, Miguel Angel Villasis-Keever, Miguel Villasis-Keever, PhD 2020-08-10
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients Coronavirus disease 19 infection, Respiratory disease PulmoVista 500 (Draeger) alone, bronchoalveolar lavage analysis alone, electrical impedance tomography alone, fiberoptic bronchoscopy alone, multiple arterial blood gas test alone, realtime thoracic impedance analysis alone, sodium chloride alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Erasme Hospital Belgium 2020-08-06 2020-09-30 NCT04502368, P2020/375, SRB2020-289 Phase Not Applicable Recruiting 3 1 Month 15 Francesco Ricottilli,, Francesco Ricottilli, MD, Leda Nobile, MD 2020-08-11
ACTIV-2: A Phase II clinical trial to evaluate the safety and efficacy of LY-CoV555 for COVID-19 Coronavirus disease 19 infection LY-CoV555 alone COVID19 Spike glycoprotein modulator National Institute of Allergy and Infectious Diseases, National Institutes of Health US ACTIV-2 Phase 2 Clinical Recruiting 1 Davey Smith, David Wohl, Kara W. Chew 2020-08-11
One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia Cardiovascular disease, Coronavirus disease 19 infection, Viral pneumonia clinical test alone, instrumental test alone, laboratory diagnostics tests alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Federal Noe G Bjudzhetnoe Uchrezhdenie Nii Onkologii Sib Otdel Rossijskoj Akademii Med Nauk Fgbu Nii Russian Federation 2020-07-19 2021-12-31 NCT04501822, TCRC-COVID Phase Not Applicable Recruiting 1 17 Months 380 Elena Yaroslavskaya, PhD, Ivan Bessonov, PhD 2020-08-10
Inova-CCP: Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Coronavirus disease 19 infection COVID-19 convalescent plasma (CCP) transfusion alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Inova Health Care Services US 2020-06-06 2021-12-31 INOVA COVID-19 CCP, Inova-CCP, NCT04502472 Phase 2/Phase 3 Clinical Recruiting 1 18 Months 200 Anne Brown, M.D., Anne W Brown, MD, Edwinia Battle, BSN, Merte Lemma-Woldehanna, BS, Merte Lemme-Woldehanna, BS 2020-08-10
Opaganib-RHB: Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen Coronavirus disease 19 infection, Viral pneumonia opaganib alone Dihydroceramide delta 4 desaturase inhibitor, Sphingosine kinase 2 inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) RedHill Biopharma Ltd Israel 2020-08-31 2021-06-30 ABC-112, NCT04502069, Opaganib-RHB Phase 1/Phase 2 Clinical Terminated 1 10 Months Mark L Levitt, MD 2020-08-12
A clinical trial of cannabinoid Sol-gel for the treatment of covid-19 Coronavirus disease 19 infection cannabinoid Sol-gel alone PreveCeutical Medical Inc, Veristat, Inc. Phase Not Applicable Planned 0 2020-08-07
Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS) Acute lung injury, Coronavirus disease 19 infection, Lung infection, Respiratory distress syndrome exhaled breath particles PCR test alone, real time particle flow rate prediction test alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Skåne University Hospital Sweden 2020-05-01 2024-05-01 NCT04503057, PEX ARDS Phase Not Applicable Recruiting 1 48 Months 300 Leif Pierre, PhD, Sandra Lindstedt Ingemansson, MD, PhD 2020-08-10
CODIS: Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 Cardiovascular disease, Coronavirus disease 19 infection cycle ergometry test alone, semi-structured qualitative interview alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ludwig Boltzmann Institute for Digital Health and Prevention Paracelsus Medical University Austria 2020-07-14 2020-12-31 23_CODIS, CODIS, NCT04501432 Phase Not Applicable Recruiting 1 5 Months 40 Josef Niebauer, Prof.Dr.Dr., Mahdi Sareban, Dr. Dr. med., Mahdi Sareban, Dr.Dr.med., Stefan T Kulnik, PhD MRes 2020-08-10
Studying the progression and the consequences of the new Coronavirus in Brazil Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Fundacao Oswaldo Cruz (Fiocruz) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq Brazil 2020-08-03 32874720.8.1001.5262, 4.148.652, RBR-8hmb2r, U1111-1255-9610 Phase Not Applicable Not yet recruiting 1 1200 André Siqueira, Giselle Duarte, José Moreira 2020-08-13
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19/SARS-CoV-2 Severe Pneumonia Complex Treatment Coronavirus disease 19 infection, Lung inflammation, Respiratory distress syndrome, Respiratory failure, Respiratory tract infection, Viral pneumonia Bioven (Biopharma Plasma LLC) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) BIOPHARMA PLASMA LLC Ukraine 2020-05-07 2020-09-30 2020-BV-BP, NCT04500067 Phase 3 Clinical Recruiting 8 4 Months 76 Anatolii M Deyneka, MD, Andrii R Rybakov, MD, Igor P Bernik, MD, Iryna V Kobylyan, MD, Kateryna Yu Romanchuk, MD, Khrystyna V Lewandowska, MD, Larisa V Moroz, MD, Lilia Ya Romaniv, MD, Liliya B Kurilyak, MD, Ludmila K Boshkova, MD, Maryana V Gurkivska, MD, Mikhail G Kuzyuk, MD, Natalia B Zhevoronko, MD, Nataliya O Ivanchenko, MD, Oksana I Paraschuk, MD, Oksana M Mazur, MD, Oksana Ya Kadubets', MD, Oleg K Yakovenko, MD, Olena Ya Kobrynska, MD, Olga V Pronina, MD, Pavlo A Gashchishin, MD, Roman M Fishchuk, MD, Ruslan V Mazur, MD, Sergii L Zanozdra, MD, Sergii O Solyarik, MD, Svitlana Y Lavryukova, MD, Taisiya V Vzhetson, MD, Tamila I Aleksanyan, MD, Vasyil S Kopcha, MD, Prof., Viktor P Tokarev, MD, Vitalii A Lukiyanchuk, MD, Yaroslav G Zhebelenko, Ph.D., MD 2020-08-10
A clinical trial of Interleukin-6 inhibitorsfor the effective treatment of Coronavirus disease 19 infection Coronavirus disease 19 infection sarilumab plus tocilizumab (intravenous), Roche/Chugai IL-6 receptor antagonist, IL-6 receptor modulator Boston Medical Center Corp, ROCHE/CHUGAI Pharma AG US Phase Not Applicable Status not specified 1 255 2020-08-14
Clinical outcome and psychological impact Covid-19 Coronavirus disease 19 infection Hospital Sungai Buloh Malaysia 2020-08-05 2021-08-05 NMRR-20-1701-55822 Phase Not Applicable Not yet recruiting 1 12 Months Dr NORASHIKIN BT. ABDUL FUAD, Dr Syarifah Nurul Ain Bt Syed Badaruddin, Professor Dr Zaleha Abdullah Mahdy 2020-08-10
A trial of NTR-441 to treat hyperinflammation and thrombosis in COVID-19 patients, including those with Acute Respiratory Distress Syndrome (ARDS) Coronavirus disease 19 infection, Inflammatory disease, Respiratory distress syndrome, Thrombosis NTR-441 alone Deoxyribonuclease gamma stimulator Neutrolis Therapeutics Inc Phase Not Applicable Planned 0 2020-08-06
Mental Health Screening during COVID-19 Pandemic among School Teachers in Kerian District Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression, Psychiatric disorder QUEST INTERNATIONAL UNIVERSITY PERAK Malaysia 2020-10-01 2020-12-31 55999, NMRR-20-1700-55999 Phase Not Applicable Not yet recruiting 1 3 Months Tan Sing Ying 2020-08-10
SCOT:REACH-HF: Understanding delivery of a new home rehabilitation programme for people with heart failure and their caregivers in Scotland Cardiac failure, Coronavirus disease 19 infection home cardiac rehabilitation program alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) NHS Greater Glasgow and Clyde Heart Research UK UK 2020-02-01 2021-08-31 IRAS 276172, ISRCTN53784122, SCOT:REACH-HF Phase Not Applicable Not yet recruiting 5 19 Months 280 Dr Purcell, Prof Rod Taylor 2020-08-12
DeSACCoS: Detection of SARS-CoV-2 Among Convalescent COVID-19 Patients Using Saliva Coronavirus disease 19 infection HOSPITAL SIBU Malaysia 2020-08-30 2021-08-31 DeSACCoS, NMRR-20-1684-56008 Phase Not Applicable Not yet recruiting 1 12 Months Dr Jeffrey Lee Soon Yit, Dr. Toh Teck Hock 2020-08-07
Impact of lockdown for COVID-19 pandemic towards glycemic control in paediatric diabetic patients Coronavirus disease 19 infection, Diabetes mellitus, Insulin dependent diabetes, Non-insulin dependent diabetes Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Putrajaya Hospital Malaysia 2020-08-17 2020-12-31 55949, NMRR-20-1678-55949 Phase Not Applicable Not yet recruiting 1 4 Months 80 Dr Cheng Hooi Peng 2020-08-07
Longitudinal COVID-19 Study Coronavirus disease 19 infection National Institutes of Health Malaysia Ministry of Health, Malaysia Malaysia 2020-08-17 2022-07-30 NMRR-20-1676-55108 Phase Not Applicable Recruiting 1 23 Months Dr MASITA BINTI ARIP, Dr Rafiza binti Shaharudin 2020-08-07
Longitudinal study of long-term immune response to SARS-CoV-2 in COVID-19 recovered patients Coronavirus disease 19 infection Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Tropical Infectious Diseases Research & Education Centre Malaysia 2020-09-01 2022-08-31 NMRR-20-1669-55712 Phase Not Applicable Not yet recruiting 1 24 Months Prof. Sazaly Abu Bakar 2020-08-07
Sickness absence in NHS staff during the time of COVID-19 Coronavirus disease 19 infection, Psychiatric disorder electronic staff records alone Healthy volunteers accepted Imperial College London Colt Foundation UK 2020-08-01 2021-03-01 IRAS 284146, ISRCTN36352994 Phase Not Applicable No longer recruiting 1 7 Months 800000 Prof Paul Cullinan 2020-08-12
Identification of inflammation-related gene polymorphisms associated with the severity of COVID-19 Coronavirus disease 19 infection Tropical Infectious Diseases Research & Education Centre Malaysia 2020-09-01 2022-08-31 55710, NMRR-20-1668-55710 Phase Not Applicable Not yet recruiting 1 24 Months Prof. Sazaly Abu Bakar 2020-08-07
A Phase I trial of recombinant bivalent second-generation adenovirus (hAd5) vector-delivered SARS-CoV-2 S + N protein vaccine in healthy volunteers Coronavirus disease 19 infection recombinant bivalent second-generation adenovirus (hAd5) vector-delivered SARS-CoV-2 S + N protein vaccine (subcutaneous, COVID-19), ImmunityBio alone COVID19 Spike glycoprotein modulator, COVID19 nucleoprotein modulator Healthy volunteers accepted ImmunityBio Inc US Phase 1 Clinical Planned 1 2020-08-11
IKN COVID-19 Task Force Strategies Coronavirus disease 19 infection National Cancer Institute - Malaysia Malaysia 2020-08-10 2021-02-19 NMRR-20-1665-56009 Phase Not Applicable Status not specified 1 6 Months Dr Sarah Pang Hui Li, Miss Siti Fatimah Zahra binti Mohd Anuar 2020-08-07
COVID-19 Sarawak Coronavirus disease 19 infection Sarawak General Hospital Malaysia 2020-08-03 2021-07-31 NMRR-20-1656-55896 Phase Not Applicable Not yet recruiting 1 11 Months Dr TONNII SIA LOONG LOONG 2020-08-07
Use of Herbal Medicine like Tulasi,Amruth(Giloy), Turmeric,Ashwagandha for Improving the Immunity among Health care workers Coronavirus disease 19 infection Variable regimens including Amruth tablet , Shakthi drops , TulsiArka , Turmeric Plus tablet Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sriveda Sattva PvtLtd India 2020-08-15 CTRI/2020/08/027009 Phase 4 Clinical Not yet recruiting 1 100 Dr C R Jayanthi, Dr M Ravi Kumar Reddy 2020-08-07
STANCE: COVID-19 Pandemic: A situational analysis on clinic appointment system in the New Normal within the Malaysian Healthcare System Coronavirus disease 19 infection Clinical Research Malaysia Malaysia 2020-07-31 2020-12-31 55650, NMRR-20-1654-55650, STANCE Phase Not Applicable Not yet recruiting 1 5 Months Mr. HING YEE LIANG 2020-08-07
A clinical trial of humanized neutralizing nano-antibodies (nanobody-based technology, COVID-19), Beroni Group/Tianjin University for the potential treatment of COVID-19 infection Coronavirus disease 19 infection humanized neutralizing nano-antibodies (nanobody-based technology, COVID-19), Beroni Group/Tianjin University alone COVID19 Spike glycoprotein inhibitor Beroni Group Ltd Phase Not Applicable Planned 0 2020-08-06
Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic Anxiety disorder, Coronavirus disease 19 infection, Depression, Psychiatric disorder Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) MD Anderson Cancer Center National Cancer Institute US 2020-06-11 2021-07-01 2020-0473, NCI-2020-04604, NCT04500600 Phase Not Applicable Recruiting 1 12 Months 50000 Lorenzo Cohen 2020-08-06
RCS-AYUSH: Retrospective cohort study in COVID-19 recovered patients Coronavirus disease 19 infection Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Central Council for Research in Homoeopathy India 2020-08-14 CTRI/2020/08/027000, RCS-AYUSH Phase Not Applicable Recruiting 1 5000 Dr Anil Khurana, Dr Anupriya, Dr Debadatta Nayak 2020-08-07
Advantage of Artificial Intelligence to detect COVID 19 using Chest X-Ray Coronavirus disease 19 infection Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Nirma University India 2020-08-17 CTRI/2020/08/027008 Phase Not Applicable Not yet recruiting 1 1000 Dr Asutosh N Dave 2020-08-07
An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19 Coronavirus disease 19 infection SEM-20 alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ministry of Ayush India 2020-07-31 CTRI/2020/08/027007 Phase 3 Clinical Not yet recruiting 1 200 Dr Abhishek Bhattacharjee, Prof Dr P K Goswami 2020-08-06
Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients > 90 Years of Age Coronavirus disease 19 infection Elderly Adults (80 and over) Brugmann University Hospital Belgium 2020-06-09 2020-12-31 CHUB-COVID-19-90+, NCT04499300 Phase Not Applicable Recruiting 1 6 Months 50 Murielle Surquin, Sophie Levy, Tracy Vandergraesen, MD 2020-08-10
ZIMCOV: Investigation of effect of homoeopathic remedy as add on therapy to standard of care (regular treatment) in adult patients with moderate to severe COVID-19 Coronavirus disease 19 infection Zincum muriaticum alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Homoeocon Foundation India 2020-08-12 CTRI/2020/08/027005, ZIMCOV Phase 2 Clinical Not yet recruiting 1 96 Dr Anil Habbu, Dr Anil Khurana 2020-08-06
SIFRA-CBE: Evaluate the Efficacy of Siddha Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19) Coronavirus disease 19 infection Adathodai manapagu alone, Mahasudarsan chooranam alone, Maldevi chendooram alone, Nochi kudineer chooranam alone, Omatheeneeer alone, Siddha Medicine alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Indian Medicine and Homoeopathy Government Medical College and ESI Hospital India 2020-08-10 CTRI/2020/08/026999, SIFRA-CBE Phase 2 Clinical Not yet recruiting 1 100 Dr Salai Karthikaiyan, Dr Shanmugam MD SIDDHA 2020-08-07
Association of cardiac markers with severity of covid 19 Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Postgraduate Institute of Medical Education and Research India 2020-08-20 CTRI/2020/08/027001 Phase Not Applicable Not yet recruiting 1 70 Sunder Lal Negi 2020-08-07
Study of changes in levels of certain blood parameters in covid-19 patients Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gujarat Cancer Society Medical college hospital and research centre India 2020-08-14 CTRI/2020/08/026981 Phase Not Applicable Not yet recruiting 1 1000 Dr Utsav Parmar 2020-08-08
Sofosbuvir + Ledipasvir and Nitazoxanide for Treatment of COVID-19 Coronavirus disease 19 infection, Respiratory disorder, Respiratory failure, Viral pneumonia nitazoxanide alone, sofosbuvir + ledipasvir alone, standard care alone Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Assiut University Helwan University Egypt 2020-07-15 2020-12-30 COVID-19 TREATMENT, NCT04498936 Phase 4 Clinical Recruiting 2 5 Months 240 Haidi K Ramadan, PhD, Mohamed El Kassas, PhD, Mohamed El kassas, Mohammed A Medhat, PhD, Mohammed Medhat 2020-08-08
Effect Ayurveda decoctions, tablet and Panchagavya on COVID 19 Coronavirus disease 19 infection Variable regimens including Fresh zinger juice , Gojihvadi Kwath , Sanjeevani Vati , honey Pancha Gavya Ghrit Granules , milk Shunthi (Dry Ginger powder) Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Rashtriya Kamdhenu Aayog India 2020-08-10 CTRI/2020/08/026980 Phase 3 Clinical Not yet recruiting 1 180 Parameswarappa Byadgi 2020-08-07
An FDA compassionate use program of PSC-04 (Calidi Biotherapeutics Inc)for the treatment of covid-19 Coronavirus disease 19 infection PSC-04 (Calidi Biotherapeutics Inc) alone Calidi Biotherapeutics Inc, Personalized Stem Cells Inc Phase Not Applicable Planned 0 2020-08-06
A Phase II clinical trial of PSC-04 (Calidi Biotherapeutics Inc)for the treatment of covid-19 Coronavirus disease 19 infection PSC-04 (Calidi Biotherapeutics Inc) alone Calidi Biotherapeutics Inc, Personalized Stem Cells Inc Phase 2 Clinical Planned 0 2020-08-06
The MINDS study: Youth experiences during COVID-19 pandemic Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs) Melaka Manipal Medical College, India India 2020-08-14 CTRI/2020/08/026998, The MINDS study Phase Not Applicable Not yet recruiting 1 540 Varalakshmi Chandra Sekaran 2020-08-06
TIP: Talking in primary care: testing the impact of online training in empathy and optimism for healthcare professionals Coronavirus disease 19 infection, Osteoarthritis continue normal practice alone, online training alone Healthy volunteers accepted University Of Southampton National Institute for Health Research (NIHR) UK 2019-12-02 2021-03-31 CPMS 43793, ISRCTN21215037, TIP Phase Not Applicable Recruiting 1 15 Months 280 Dr Felicity Bishop, Mrs Broomfield 2020-08-08
GERAS Frailty Rehabilitation at Home During COVID-19 Coronavirus disease 19 infection Medication Review alone, Senior Isolation Prevention Partnership (SSIPP) program alone, multi-modal frailty rehabilitation alone, physiotherapy alone, protein supplement (protein + beta-hydroxy beta-methylbutyrate) alone, virtual nutrition consult alone Aged Adults (65-79 yrs), Elderly Adults (80 and over) McMaster University Canada 2020-09-30 2021-05-31 11408, NCT04500366 Phase Not Applicable Not yet recruiting 1 8 Months 70 Alexandra Papaioannou, MD, MSc, Sherri Smith 2020-08-08
Assessment of safety and efficacy of Kabasura kudineer in mild to moderate COVID-19 Coronavirus disease 19 infection Kabasura kudineer alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Chettinad Hospital And Research Institute India 2020-08-14 CTRI/2020/08/026985 Phase 2 Clinical Not yet recruiting 1 126 Dr Ruckmani A, Dr Vivek Valliappan 2020-08-08
Effectiveness of Ayurvedic Formulation for COVID 19 Coronavirus disease 19 infection YASH-T decoction alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Nepal Health Research Council India 2020-08-19 CTRI/2020/08/026978 Phase Not Applicable Not yet recruiting 1 100 Dr Pradip Gyanwali, Shristi Karki 2020-08-07
OPTYC: Online post-traumatic stress disorder treatment for young people and their carers Coronavirus disease 19 infection, Post traumatic stress disorder Internet-delivered Cognitive Therapy alone Children (6-12 yrs), Adolescents (13-17 yrs) South London and Maudsley NHS Foundation Trust Medical Research Council UK 2017-12-01 2022-02-26 IRAS 262807, CPMS 42768, ISRCTN16876240, OPTYC Phase Not Applicable Recruiting 4 50 Months 34 Dr Smith 2020-08-08
CPIT III: The smoking cessation in pregnancy incentives trial Coronavirus disease 19 infection, Nicotine dependence face to face counselling alone, £400 of shopping vouchers alone Female, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) NHS Greater Glasgow and Clyde Cancer Research UK, Chief Scientist Office, Northern Ireland Chest Heart & Stroke, Public Health Agency, Scottish Cot Death Trust, The Lullaby Trust UK 2017-09-01 2021-02-28 36323, CPIT III, ISRCTN15236311 Phase 3 Clinical No longer recruiting 3 42 Months 940 Prof MTappin 2020-08-12
Comparison of two online learning method of resuscitation training Cardiac arrest, Coronavirus disease 19 infection Flexible online learning alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) All India Institute of Medical Sciences India 2020-08-10 CTRI/2020/08/026977 Phase Not Applicable Not yet recruiting 1 20 Poonam Joshi 2020-08-07
OTC AND COVID19: Over-the-counter Medications And COVID-19 Coronavirus disease 19 infection University of Alberta Canada 2020-07-23 2023-03-31 NCT04500639, OTC AND COVID19, PRO00100243 Phase Not Applicable Recruiting 1 32 Months 14000 Scot H Simpson, PharmD, MSc, Scot Simpson, PharmD, MSc 2020-08-10
Evaluation of coronavirus self-isolation interventions Coronavirus disease 19 infection Call only alone, SMS only alone, SMS plus call alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Health Service Department of Health and Social Care UK 2020-07-01 2020-09-30 ISRCTN13455972, TP_2020065 Phase Not Applicable Recruiting 1 3 Months 10000 Ms Clare Delargy, Ms Hannah Burd 2020-08-08
An observational study of effect of positioning on either side on oxygen level in corona patient Coronavirus disease 19 infection lateral positioning alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) New Civil Hospital, Surat India 2020-08-09 CTRI/2020/08/026964 Phase Not Applicable Not yet recruiting 1 167 Dr Sunaina patel 2020-08-07
POCUS: Point of care ultrasound study in patients with respiratory illness during COVID-19 Coronavirus disease 19 infection, Respiratory tract infection Lung ultrasound alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Kasturba Medical College and Hospital India 2020-08-17 CTRI/2020/08/026983, POCUS Phase Not Applicable Not yet recruiting 1 100 Dr Sanjan 2020-08-07
Tomographic Findings in COVID-19 and Influenza H1N1 Coronavirus disease 19 infection, Influenza virus A infection, Viral pneumonia pulmonary tomography alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidad De Guanajuato University Medical Center Groningen Netherlands, Mexico 2020-08-15 2022-04-30 F-2020-1008-038, NCT04499378 Phase Not Applicable Not yet recruiting 2 20 Months 200 Jaime D Mondragon, M.D., Omar Jiménez-Zarazúa, M.D. 2020-08-08
Dexamethasone Versus Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 Adult respiratory distress syndrome, Coronavirus disease 19 infection dexamethasone alone, methylprednisolone alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Chattogram General Hospital Xi' An Medical University Bangladesh 2020-08-02 2020-11-30 10000753, NCT04499313 Phase 3 Clinical Recruiting 2 3 Months 60 Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD, Akter Kamal, MBBS, MD, PhD, Akter Kamal, MD, PhD, He Shuixiang, MD, PhD, Shubhashis Talukder, Shubhashis Talukder, MBBS, DO 2020-08-12
Incubation period of COVID-19 cases admitted in North Kerala, India Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Government Medical College Kannur India 2020-09-01 CTRI/2020/08/026962 Phase Not Applicable Not yet recruiting 1 30 Anitha S S 2020-08-07
MtS Dems: HF4Y: Research demonstration projects in youth homelessness Coronavirus disease 19 infection Housing First For Youth alone Adolescents (13-17 yrs), Young Adults (18-44 yrs) A Way Home Canada Employment Skills Development Canada Canada 2017-08-01 2021-03-31 1441994, ISRCTN10505930, MtS Dems: HF4Y Phase Not Applicable No longer recruiting 2 44 Months 140 Dr Stephen Gaetz, Ms MacDonald 2020-08-06
Evaluation of Knowledge, Attitude and Practice (KAP) of Pharmacists towards novel coronavirus pneumonia (COVID-19): A Cross-Sectional Study Coronavirus disease 19 infection, Viral pneumonia Online questionnaire alone Peking University Third Hospital China 2020-07-23 2021-07-22 ChiCTR2000035213 Phase Not Applicable Not yet recruiting 1 12 Months 480 Rongsheng ZHAO, Zaiwei SONG 2020-08-11
Mental Health Status and Related Factors Among Physical Medicine And Rehabilitation Physicians in the COVID-19 Pandemic Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression, Insomnia Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Dokuz Eylul University Turkey 2020-06-27 2020-10-01 NCT04500652, PMRMENTALCOVID Phase Not Applicable Recruiting 1 3 Months 310 Banu Dilek 2020-08-07
Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients Coronavirus disease 19 infection, Viral pneumonia hyperbaric oxygen alone, usual treatment alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ottawa Hospital Research Institute Climate Foundation Canada 2020-08-31 2022-08-31 NCT04500626, OHRI-HBOT-001 Phase 2/Phase 3 Clinical Not yet recruiting 1 24 Months 234 Joseph Burns, MSc, Sylvain Boet, MD, PhD 2020-08-13
ISARIC WHO CCP-UK: Clinical characterization protocol for severe emerging infection Coronavirus disease 19 infection, Infectious disease routine clinical samples alone University of Oxford Medical Research Council, NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research (NIHR), SPRINT-SARI NIHR Health Protection Research Unit (HPRU) in Respiratory Infection, Wellcome Trust UK 2013-03-12 2023-02-28 IRAS 126600, CPMS 14152, ISARIC WHO CCP-UK, ISRCTN66726260 Phase Not Applicable Recruiting 2 119 Months 100 Ms Hayley Hardwick, Prof Semple 2020-08-12
Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19 Coronavirus disease 19 infection Variable regimens including Anacyclus pyrethrum , Chloroquine phosphate , Ferrula asafoetida , Hydroxychloroquine , Senna , Terminalia chebula Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Tabriz University of Medical Sciences Iran 2020-07-31 2020-09-21 IR.TBZMED.REC.1399.126, IRCT20200522047545N1 Phase 2/Phase 3 Clinical Recruiting 1 1 Month 200 Mojtaba Varshouchi Fard, Ramin Mohammadzadeh 2020-08-08
A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls Acute stress disorder, Coronavirus disease 19 infection, Fever, Respiratory disease Inner Engineering Completion (Shambhavi Mahamudra kriya) alone, Inner Engineering Online alone, Shakthi Chalana Kriya alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Beth Israel Deaconess Medical Center US 2020-05-22 2020-12-31 2020P000433, NCT04498442 Phase Not Applicable Recruiting 1 7 Months 30000 Balachundhar Subramaniam, MD, MPH 2020-08-11
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia mosedipimod alone CCL26 gene inhibitor, TLR modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Enzychem Lifesciences Corp South Korea 2020-05-28 2022-05-31 EC-18-C201, NCT04500132 Phase 2 Clinical Recruiting 1 24 Months 60 Enzychem Lifescience, Hyewon Jeong 2020-08-10
A phase III trial to evaluate Metablok for the prevention of organ inflammation known to trigger acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) in patients infected with SARS-CoV-2 (COVID-19) Coronavirus disease 19 infection, Inflammatory disease, Renal injury, Respiratory distress syndrome Metablok alone Dehydropeptidase-1 modulator Arch Biopartners Inc Phase 3 Clinical Planned 0 2020-08-06
COVEN: Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) Coronavirus disease 19 infection, Lung injury, Respiratory distress syndrome electrical impedance tomography alone, pressure-controlled ventilation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo InCor Heart Institute Brazil 2020-05-08 2021-12-01 CAAE: 30938720800000068, COVEN, NCT04497454 Phase Not Applicable Recruiting 1 18 Months 128 Eduardo LV Costa, Eduardo LV Costa, PhD, Maria AM Nakamura, Maria AM Nakamura, PhD 2020-08-07
Novel Coronavirus infection among health workers Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) State of Parana/Health Department of Parana Brazil 2020-07-01 2021-07-01 33697720.0.0000.0107, 4,112,388, RBR-7nky44, U1111-1255-6093 Phase Not Applicable Recruiting 1 12 Months 703 Lirane Elize Ferreto 2020-08-08
A phase III human trial of Oxford vaccine by serum institute of India Coronavirus disease 19 infection Oxford vaccine alone Serum Institute of India Ltd India Phase 3 Clinical Planned 1 1600 2020-08-06
A phase II trial in India for the covid-19 vaccine candidate developed by University of Oxford Coronavirus disease 19 infection Oxford vaccine alone Healthy volunteers accepted Serum Institute of India Ltd India Phase 2 Clinical Planned 1 1600 2020-08-06
Pilot Study of Video and Telephone Primary Care Visits Coronavirus disease 19 infection Telemedicine-Internet-connected computer tablet alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Johns Hopkins University US 2020-09-01 2023-04-01 IRB00257994, NCT04496713 Phase Not Applicable Not yet recruiting 1 31 Months 200 Casey Overby Taylor, PhD, Jeremy A Epstein, MD 2020-08-14
The Effect of Aromatherapy on COVID-19-induced Anxiety Anxiety disorder, Coronavirus disease 19 infection Essential Oil Blend inhalation alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Franklin School of Integrative Health Sciences US 2020-08-01 2021-04-30 20-7-5600, NCT04495842 Phase Not Applicable Not yet recruiting 1 9 Months 65 Jessie Hawkins, PhD, PI 2020-08-10
Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19) Anxiety disorder, Coronavirus disease 19 infection Cognitive Behavioural Group Therapy alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) St Josephs Healthcare Hamilton 2020-08-10 2022-08-01 CBT-COVID, NCT04495803 Phase Not Applicable Not yet recruiting 0 23 Months 120 Sheryl Green, PhD, CPsych 2020-08-10
Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living' Coronavirus disease 19 infection, Suicide Brief Skills for Safer Living alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) St Michaels Hospital Canada 2020-08-31 2021-08-31 BSL-01, NCT04495543 Phase Not Applicable Not yet recruiting 1 12 Months 75 Aleksandra Lalovic, PhD, Michael Morton, HBSc, Sakina Rizvi, PhD, Sidney H Kennedy, MD, Yvonne Bergmans, PhD 2020-08-10
Co_Coping: Coping With 2020 - No Health Without Mental Health Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Psychiatric disorder Intensive Co-mestring alone, Ordinary Co-mestring alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Haukeland University Hospital Norway 2020-04-02 2021-12-31 126376, Co_Coping, NCT04421612 Phase Not Applicable Recruiting 1 20 Months 400 Tine Nordgreen, PhD 2020-08-10
The COVID-19 and Healthcare Workers: An Active Intervention Anxiety disorder, Coronavirus disease 19 infection, Depression, Phobia, Post traumatic stress disorder Video-Based intervention alone, written description alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Research Foundation for Mental Hygiene Inc US 2020-08-30 2021-01-30 8032, NCT04497415 Phase Not Applicable Not yet recruiting 1 5 Months 1200 Doron Amsalem, MD, Yuval Neria, PhD 2020-08-14
SignCov: Assesment of the Metabolomic Signature in COVID-19 Patients Coronavirus disease 19 infection blood and urine sampling alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire De Nice France 2020-08-07 2021-10-07 20-PP-18, NCT04497272, SignCov Phase Not Applicable Not yet recruiting 1 14 Months 150 OCCELLI Céline, OCELLI Celine 2020-08-06
Comparison of the Effectiveness of Compassionate Therapy and Positive Psychology with Well-being Approach on Alexithymia, Adaptive Behavior, Adherence of Treatment and Biological Factors in Patients with Diabetes Type 2 Coronavirus disease 19 infection, Non-insulin dependent diabetes, Psychiatric disorder Compassionate Therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Islamic Azad University Iran 2020-05-21 IR.HUMS.REC.1399.105, IRCT20191023045222N1 Phase Not Applicable No longer recruiting 1 100 Dr. Leila Moradi, Mahnaz Bahadori, Mahnaz Mehrabizadeh Honarmand 2020-08-06
Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 Coronavirus disease 19 infection F-652 alone IL-22 agonist, Interleukin 22 ligand Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Evive Biotech US 2020-08-10 2021-02-28 GC-652-04, NCT04498377 Phase 2 Clinical Not yet recruiting 1 6 Months 38 Christine M Bojanowski, MD, William L Daley, MD 2020-08-08
BLAZE-2: A Study of LY-3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff Coronavirus disease 19 infection LY-CoV555 alone COVID19 Spike glycoprotein modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Eli Lilly & Co AbCellera Biologics Inc, National Institute of Allergy and Infectious Diseases US 2020-08-02 2021-06-29 18063, BLAZE-2, COVPN #3501, J2X-MC-PYAD, NCT04497987 Phase 3 Clinical Recruiting 11 10 Months 2400 Carl Fichtenbaum, Christine Thai, Christopher Hall, David Wohl, G Taffet, Ian Frank, M C Patel, S Doblecki-Lewis, Srilatha Edupuganti, Stockton Mayer, Sue Ellen Abdalian 2020-08-14
COVID-19-Positive Outpatient Thrombosis Prevention in Adults Aged 40 to 79 Coronavirus disease 19 infection, Inflammatory disease, Thrombosis apixaban alone, aspirin alone Factor Xa antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) University of Pittsburgh National Heart Lung and Blood Institute US 2020-08-31 2021-03-31 ACTIV4-OUTPATIENT, NCT04498273 Phase 3 Clinical Not yet recruiting 1 7 Months 7000 Frank Sciurba, Jean Connors, Paul Ridker, M.D. 2020-08-08
CoCo-20: A Longitudinal Follow-up Study of the French Pediatric Population During and After the Coronavirus Pandemic COVID-19 Coronavirus disease 19 infection, Post traumatic stress disorder, Psychiatric disorder emergency semi-directed interview alone, mental health assessment alone Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) Fondation Lenval France 2020-04-27 2020-12-31 20-HPNCL-05, CoCo-20, NCT04498416 Phase Not Applicable Recruiting 1 8 Months 70 Arnaud FERNANDEZ, MD, Arnaud Fernandez, Aurélien Richez, Florence Gittard-Askenazy, Pr, Michèle Battista, Morgane GINDT, Morgane Gindt, Ophélie Nachon 2020-08-09
Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) Coronavirus disease 19 infection NT-17 alone, Standard of care treatment alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Washington University School of Medicine, US NeoImmuneTech Inc US 2020-09-30 2021-06-30 06-29-20-CAMPIAN, NCT04498325 Phase 1 Clinical Not yet recruiting 1 9 Months 42 Alexandre Lacasse, M.D., Erik R Dubberke, M.D., MSPH, Jian Campian, M.D., Ph.D., Mary McLennan, M.D. 2020-08-10
Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19) Coronavirus disease 19 infection, Psychiatric disorder, Sleep disorder Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Brugmann University Hospital Belgium 2020-05-29 2020-12-31 CHU-COVIDIMPACT, NCT04497246 Phase Not Applicable Recruiting 1 7 Months 5000 Maxime Windal, Murielle Surquin, Head of geriatry department, Sophie Levy, Sophie Levy, MD 2020-08-06
Psychosocial Outcomes in Families of COVID-19 ICU Patients Anxiety disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Liege Belgium 2020-04-16 2020-09-30 FAMILY COVID, NCT04498507 Phase Not Applicable Recruiting 1 5 Months 50 Anne-Françoise Rousseau, MD, PhD, Anne-Françoise Rousseau, PhD, Rousseau, MD, PhD 2020-08-06
Mask Usage and Exercise During the COVİD-19 Pandemic Coronavirus disease 19 infection, Dyspnea, Fatigue Exercise tests alone, Surgical mask alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) KTO Karatay University Turkey 2020-07-20 2021-09-30 KARATAYU3, NCT04498546 Phase Not Applicable Recruiting 1 14 Months 60 Büşra Alkan, MsC, PT, RA, Büşra Alkan, MsC, Pt, RA, Büşra Alkan, Research Assistant, Sevgi Özalevli, Prof, PT, Özlem Akkoyun Sert, Phd, PT 2020-08-07
TOMOCOVIDMX: Tomographic Findings in COVID-19 and Influenza Coronavirus disease 19 infection, Influenza virus A infection, Viral pneumonia pulmonary tomography alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidad De Guanajuato Hospital General Regional de León, University Medical Center Groningen Mexico 2020-06-15 2022-04-30 HGL-ENSE-00743-20, NCT04497311, TOMOCOVIDMX Phase Not Applicable Recruiting 1 22 Months 100 Jaime Daniel Mondragón Uribe, Medical researcher, Lourdes N Veléz-Ramírez, M.D., Lourdes N Vélez-Ramírez, M.D., Omar Jiménez-Zarazúa, M.D. 2020-08-07
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients Coronavirus disease 19 infection sofosbuvir + ledipasvir (fixed-combination/oral, HCV/HBV), Gilead alone, standard of care treatment alone, Variable regimens including daclatasvir , ribavirin , sofosbuvir Hepatitis C virus NS5B polymerase inhibitor, Hepatitis C virus protein NS5A inhibitor Tanta University Egypt 2020-07-01 2030-12-10 NCT04497649, TANTA SOFOSBUVIR COVID Phase 2/Phase 3 Clinical Recruiting 1 125 Months 200 Marwa Salama, Lecturer, Sherief Abd-Elsalam, ass. prof., sherief Abd-Elsalam, ass. Prof., sherief abd-elsalam, ass. prof, sherief abd-elsalan, ass. prof. 2020-08-08
A Study to Assess Safety, Tolerability, and Immunogenicity of V-591 (COVID-19 Vaccine) in Healthy Participants Coronavirus disease 19 infection MERS-Corona virus vaccine (recombinant live-attenuated measles virus vector), Themis alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Merck Sharp & Dohme Corp 2020-08-19 2022-03-16 2020-003493-46, NCT04498247, V591-001 Phase 1/Phase 2 Clinical Not yet recruiting 0 18 Months 260 Medical Director 2020-08-07
Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic Coronavirus disease 19 infection National Taiwan University Hospital Taiwan 2020-08-01 2020-12-31 202006225RINA, NCT04497467 Phase Not Applicable Recruiting 1 5 Months 1200000 Wan-Ching Lien, Wan-Ching Lien, PhD 2020-08-06
Clinical trial for the treatment of COVID-19 with Chloroquine and Colchicine Coronavirus disease 19 infection chloroquine plus colchicine Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital das Clinicas de Ribeirao Preto/USP Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Fundacao de Amparo a Pesquisa do Estado Sao Paulo 2020-04-11 2020-09-30 3.954.378, 30248420.9.0000.5440, 30248420.9.0000.5440, 30248420.9.3001.5403, 4.066.630, 4.112.255, RBR-8jyhxh, U1111-1255-6304 Phase 2/Phase 3 Clinical Recruiting 0 5 Months 60 Renê D. Ribeiro Oliveira 2020-08-06
Educational intervention by cell phone to increase informed choices at childbirth, in the context of the Covid-19 pandemic Coronavirus disease 19 infection, Pregnancy disorder PiniOn alone, educational communication intervention alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten, University of Sao Paulo Brazil 2020-08-28 32840920.7.0000.0071, 4.132.178, RBR-3g5f9f, U1111-1255-8683 Phase Not Applicable Not yet recruiting 1 20000 Carmen Simone Grilo Diniz, Edson Amaro Junior, Livia Sanches Pedrilio 2020-08-06
STRING-COVID: Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile Coronavirus disease 19 infection, Psychiatric disorder Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Pontificia Universidad Catolica De Chile Chilean Science Council Chile 2020-07-03 2021-01-31 170519004, NCT04497636, STRING-COVID Phase Not Applicable Recruiting 1 6 Months 1092 Antonia Errazuriz, PhD 2020-08-08
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients Coronavirus disease 19 infection, Inflammatory disease acellular sterile filtered human amniotic fluid alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Utah US 2020-08-15 2021-08-15 132922, NCT04497389 Phase 1/Phase 2 Clinical Not yet recruiting 1 12 Months 60 Alyssa Messina, MA, Craig Selzman, MD 2020-08-07
Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 Coronavirus disease 19 infection, Respiratory failure, Viral pneumonia Nasogastric tube alone, Proton pump inhibitor therapy alone, acalabrutinib alone Btk tyrosine kinase inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) AstraZeneca plc Acerta Pharma BV US 2020-07-31 2020-09-28 D822FC00005, NCT04497948 Phase 1 Clinical Not yet recruiting 3 1 Month 20 AstraZeneca Clinical Study Information Center 2020-08-07
Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individuals Coronavirus disease 19 infection Variable regimens including Pimpinela anisum hydroalcoholic extract , Ziziphus spina-cristi , cyclopeptide fraction , orange peel Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Bagheiat-allah University of Medical Sciences Iran 2020-04-20 IR.BMSU.REC.1399.250, IRCT20160131026298N4 Phase 2/Phase 3 Clinical Recruiting 1 60 AHMAD REZA SHARIFI OLOUNABADI, Gholamhosein Alishiri, Shiva Shamshiri, shiva shamshiri 2020-08-08
Effect of Corton on olfactory dysfunction in COVID-19 patients Coronavirus disease 19 infection, Dysomia mometasone alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Mashhad University of Medical Sciences Iran 2020-07-18 IR.MUMS.REC.1399.355, IRCT20200522047542N1 Phase 1 Clinical Recruiting 1 70 Masoumeh Hosseinpour 2020-08-07
COMS-19: COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients Coronavirus disease 19 infection, Multiple sclerosis Sars-CoV-2 RBD total antibody test (Sanquin) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) VU University Medical Center Netherlands 2020-08-06 2021-12-01 COMS-19, NCT04498286, NL74243.029.20 Phase Not Applicable Recruiting 1 15 Months 800 Joep Killestein, Zoé L van Kempen 2020-08-08
COVID-HEART study: COVID-19 effects on the heart Coronavirus disease 19 infection, Heart disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Leeds National Institute for Health Research (NIHR), United Kingdom Research & Innovation UK 2020-04-16 2022-07-31 CD20/133244, COVID-HEART study, ISRCTN58667920 Phase Not Applicable Recruiting 18 27 Months 370 Dr Laura Jones (public),, Kathryn Somers (public), Prof Greenwood 2020-08-10
SabanaHerons: Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory failure, Traumatic brain injury Unisabana-Herons ventilator alone, Volume-controlled mechanical ventilation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Fundación Neumologica Colombiana Clínica Universidad de La Sabana, Fundación Cardioinfantil-Instituto De Cardiología, Universidad de la Sabana Colombia 2020-07-28 2020-12-31 202006-25502, NCT04497623, SabanaHerons Phase 1 Clinical Not yet recruiting 3 5 Months 5 Alirio R Bastidas, MD, MSc, Fabio A Varon-Vega, MD, PhD(c), Luis F Giraldo-Cadavid, MD, PhD 2020-08-07
DOMY COVID: Myocardial Damages Related to COVID-19 Coronavirus disease 19 infection, Heart injury, Myocarditis Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire Dijon France 2020-03-01 2021-07-31 COTTIN AOIC 2020, DOMY COVID, NCT04498065 Phase Not Applicable No longer recruiting 1 17 Months 200 2020-08-07
An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test Coronavirus disease 19 infection, Respiratory disease FT-30 qualitative fitness test system (3M) alone, mask wearing alone, spray test alone Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Cardiovascular Institute and Fuwai Hospital China 2020-06-19 2020-08-31 2020-KZLXB-02-01, NCT04497675 Phase Not Applicable Recruiting 8 2 Months 10000 Bin Wen, Duo lin, Lin C Duo, Lin Duo, Lin H Duo, Pengxu H Kong, Rundi Deng, Xiang-Bin Pan 2020-08-13
EPI CV COVID: Epidemiological Approaches to the Cardiovascular Consequences of COVID-19 Coronavirus disease 19 infection, Myocardial infarction, Respiratory failure, Sepsis, Viral pneumonia Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire Dijon France 2020-03-15 2021-07-31 EPI CV COVID, NCT04498091, ZELLER AOIC 2020 Phase Not Applicable No longer recruiting 1 16 Months 35 2020-08-08
G-COV: Sex-Informed Data in the COVID-19 Pandemic Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universita degli Studi di Roma La Sapienza Italy 2020-09-01 2022-06-01 G-COV, NCT04497402, SAPIENZAGENDERCOVID Phase Not Applicable Not yet recruiting 1 21 Months 88 Claudio Mastroianni, MD, Guido Antonelli, MD, Lucia Stefanini, PhD, Marcella Visentini, MD, Maria Ciardi, MD, Roberto Cangemi, MD, Stefania Basili, Stefania Basili, MD, Stefano Corradini, MD, Valeria Raparelli, MD 2020-08-14
An Epidemiological Investigation on Correct Wearing of Mask by Hood Test Coronavirus disease 19 infection, Respiratory disease FT-30 qualitative fitness test system (3M company) alone, breathing test alone, fitness test spray reagent alone, hood wearing test alone, sensitivity test alone, suitability testing alone Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Cardiovascular Institute and Fuwai Hospital China 2020-06-19 2020-08-31 2020-KZLXB-02-02, NCT04497753 Phase Not Applicable Recruiting 8 2 Months 10000 Bin Wen, Duo H lin, Lin Duo, Pengxu Kong, Rundi Deng, Xiang-Bin Pan 2020-08-12
A randomized, double-blind trial to determine whether convalescent blood plasma therapy can effectively be used for the prevention of people who have been exposed to COVID-19 in their home or at work as health care providers Coronavirus disease 19 infection convalescent blood plasma therapy alone Johns Hopkins Technology Ventures US Department of Defense Phase Not Applicable Status not specified 0 500 2020-08-05
ECHO-vid: Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness Coronavirus disease 19 infection echocardiography alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Hospital Beneficencia Espanola de Puebla Mexico 2020-09-01 2020-11-30 CARDIOLOGY-004, ECHO-vid, NCT04498299 Phase Not Applicable Recruiting 1 3 Months 30 Consuelo Orihuela Sandoval, Jaime Hernandez-Montfort, Miguel Ayala León, Cardiolology, Miguel Ayala-Leon, Rosa Tzompantzi-Flores, Victoria Delgado, miguel ayala-leon 2020-08-07
A randomized, double-blind trial to determine whether convalescent blood plasma therapy can effectively be used to treat people in the early stage of COVID-19 illness Coronavirus disease 19 infection convalescent blood plasma therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Johns Hopkins Technology Ventures US Department of Defense Phase Not Applicable Status not specified 0 600 2020-08-05
Registry of COVID-19 Patients at AOUI Verona Coronavirus disease 19 infection Azienda Ospedaliera Universitaria Integrata Di Verona Italy 2020-03-01 2020-09-30 COVID19-VR, NCT04497194 Phase Not Applicable Recruiting 1 7 Months 500 Evelina Tacconelli, Evelina Tacconelli, Professor 2020-08-10
SARS-CoV-2 (COVID-19) Detection Using the Breath Analyzer TeraSystem Coronavirus disease 19 infection breath detector analyzer (TeraSystem) alone, rapid detection breath test alone Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Instituto Costarricense de Investigaciones Clínicas ICIC Costa Rica 2020-08-04 2020-08-15 NCT04497610, TERA-CR-1 Phase Not Applicable Not yet recruiting 1 1000 Dr. Guillermo Rodríguez Gómez, Guillermo Rodríguez Gomez, MD 2020-08-07
Virtual White Boards for Patient Satisfaction Coronavirus disease 19 infection virtual display screen (e-ink screen) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Brigham & Women's Hospital E Ink Corp US 2020-08-20 2021-04-17 2020P002382, NCT04497922 Phase Not Applicable Not yet recruiting 1 7 Months 100 Guruprasad D Jambaulikar, MBBS MPH, Peter R Chai, MD, Peter R Chai, MD MMS 2020-08-07
Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma Coronavirus disease 19 infection convalescent plasma alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) City of Hope Medical Center National Cancer Institute US 2020-08-21 2022-08-21 20204, NCI-2020-04000, NCT04497779, P30CA033572 Phase Not Applicable Not yet recruiting 1 24 Months 800 John Zaia 2020-08-08
Netizens' Perception of COVID-19 Information and Information Sources Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Qassim University Saudi Arabia 2020-06-10 2020-08-15 NCT04497441, QASSIMU3 Phase Not Applicable Recruiting 1 2 Months 385 Bugude Shiva Shankar, MDS, Shiva Shankar Bugude, MDS 2020-08-07
Correlation Fear of COVID-19 and Dental Treatment Anxiety Anxiety disorder, Coronavirus disease 19 infection, Tooth disease Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Qassim University Saudi Arabia 2020-06-16 2020-07-25 NCT04497818, QASSIMU2 Phase Not Applicable Completed 1 1 Month 385 Bugude Shiva Shankar 2020-08-07
An observational study of the treatment of patients with mild and moderate COVID-19 (including suspected patients) Coronavirus disease 19 infection Kampo medicine alone, Western medicine alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Tohoku University Hospital Japan 2020-07-04 UMIN000041301 Phase Not Applicable Recruiting 1 1000 Akiko Kuwabara, Shin Takayama 2020-08-07
Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers Coronavirus disease 19 infection hydroxychloroquine alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) University Medical Center Groningen Netherlands 2020-09-15 2020-11-15 CARRIED-01, NCT04497519 Phase 1 Clinical Recruiting 1 2 Months 12 Onno Akkerman, Onno Akkerman, MD 2020-08-07
RESTART-19: Risk prediction of indoor Sports And culture events for the Transmission of COVID-19 Coronavirus disease 19 infection conventional processes alone, culture events alone, hygiene-optimized processes alone, indoor Sports alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Wittenberg University Ministerium für Wirtschaft, Wissenschaft und Digitalisierung des Landes Sachsen-Anhalt, Sächsisches Staatsministerium für Soziales und Gesellschaftlichen Zusammenhalt Germany 2020-08-22 2020-095, DRKS00022790, RESTART-19 Phase Not Applicable Recruiting 1 4000 Angelika Ihling, Stefan Moritz 2020-08-12
COVID-19-101: Clinical Trial to Evaluate the Safety and Immunogenicitiy of the COVID-19 Vaccine Coronavirus disease 19 infection COVID-19 vaccine (measles vaccine vector technology), Institut Pasteur/Themis Bioscience/University of Pittsburgh alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Institut Pasteur, Themis Bioscience GmbH, University of Pittsburgh ABL Europe, Coalition for Epidemic Preparedness Innovations France, Belgium 2020-08-10 2021-10-31 2020-002973-89, 2020-016, COVID-19-101, NCT04497298 Phase 1 Clinical Recruiting 2 14 Months 90 Christiane GERKE, PhD, Cécile ARTAUD, Mohand AIT AHMED, Odile LAUNAY, MD, PhD, Robin ROGIERS, MD 2020-08-13
A study to assess OraSure’s OMNIgene oral device for SARS-CoV-2 Saliva Test Coronavirus disease 19 infection OMNIgene alone OraSure Technologies Inc Phase Not Applicable Status not specified 0 2020-08-06
Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers Coronavirus disease 19 infection hydroxychloroquine alone Isfahan University of medical Sciences Iran 2020-04-18 IR.MUI.MED.REC.1399.0.17, IRCT20200414047076N1 Phase 2 Clinical Recruiting 2 160 Elahe Nasri, elahe Nasri 2020-08-07
CCPSEI: Clinical Characterization Protocol for Severe Infectious Diseases Coronavirus disease 19 infection, Respiratory tract infection sampling alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Johns Hopkins University US 2020-04-09 2021-06-30 CCPSEI, IRB00245545, NCT04496466 Phase Not Applicable Recruiting 1 14 Months 500 Lauren Sauer, MS 2020-08-07
CO-FRAIL: Frailty and adverse outcomes in adults hospitalized for COVID-19 Cognitive disorder, Coronavirus disease 19 infection, Respiratory distress syndrome Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Brazil 2020-03-30 32037120.6.0000.0068, 4.050.650, CO-FRAIL, RBR-7w5zhr, U1111-1252-9993 Phase Not Applicable Recruiting 1 2000 Márlon Juliano Romero Aliberti, Thiago Junqueira Avelino-Silva 2020-08-06
Physical and Psychological Impact of the COVID-19 Pandemic in Germany- a Survey of General Practitioners Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sauerlandpraxis Medebach, Hallenberg, Winterberg Germany 2020-08-10 2020-449-f-S, DRKS00022157 Phase Not Applicable Not yet recruiting 1 500 Simon Wernhart 2020-08-06
PraeCoSa: Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSa Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) UniversitätsKlinikum Leipzig Deutsche Forschungsgemeinschaft (DFG) Germany 2020-08-01 196/20-ek, DRKS00021705, PraeCoSa Phase Not Applicable Not yet recruiting 1 100 Christian Seeber 2020-08-06
PsyCovART: Psychological Impact of COVID-19 Among Women Undergoing Infertility Treatment Coronavirus disease 19 infection, Psychiatric disorder Female, Young Adults (18-44 yrs) Hospices Civils De Lyon France 2020-07-31 2020-12-31 69HCL20_0577, NCT04496869, PsyCovART Phase Not Applicable Not yet recruiting 1 5 Months 600 Eloise FRAISON, MD, Océane LABLANCHE, Resident 2020-08-06
COVID-19 Anosmia Study Coronavirus disease 19 infection, Dysomia omega-3 fatty acid alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Mount Sinai Medical Center US 2020-07-15 2021-06-30 GCO 20-1132, NCT04495816 Phase 2 Clinical Recruiting 1 11 Months 126 Alfred-Marc Iloreta, MD, David K Lerner, MD 2020-08-06
A study of therapeutic effect of blood ozone therapy of severe Covid-19 patients Coronavirus disease 19 infection Variable regimens including IFN beta-1a , IFN beta-1b , atazanavir + ritanavir , chlroquine phosphate , dexamethasone , enoxaparin sodium , heparin , hydroxychloroquine , lopinavir + ritonavir , ozone HIV protease inhibitor, Low molecular weight heparin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ahvaz University of Medical Sciences Iran 2020-08-05 IR.AJUMS.REC.1399.217, IRCT20200616047792N1 Phase 2 Clinical Recruiting 1 60 Behnam Sheibani, Dr. Behnam Sheibani, Dr. Mohammad Badavi, Shokrollah Salmanzadeh Ramhormozi 2020-08-06
A study of the COVID-19 sequlae Coronavirus disease 19 infection chest CT alone, pulmonary function test alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Japanese Respiratory Society Japanese Ministry of Health, Labor and Welfare Japan 2020-08-01 UMIN000041168 Phase Not Applicable Not yet recruiting 1 1000 Akihito Yokoyama, Kazufumi Takamatsu 2020-08-06
COVID-19 Neurological Manifestation Coronavirus disease 19 infection, Neurological disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pittsburgh US 2020-04-13 2020-12-31 NCT04496128, STUDY20040037 Phase Not Applicable Recruiting 1 8 Months 300 Sherry H Chou, MD, MSc 2020-08-10
COVID-19 Brain Injury Brain hemorrhage, Cerebral hemorrhage, Coronavirus disease 19 infection, Ischemic stroke, Status epilepticus, Traumatic brain injury Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Pittsburgh US 2020-04-02 2020-12-31 NCT04496076, STUDY20030201 Phase Not Applicable Recruiting 1 8 Months 300 Sherry H Chou, MD, MSc 2020-08-10
COPE: Covid-19 progression in end-stage kidney disease Coronavirus disease 19 infection, End stage renal disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) DaVita Clinical Research 2020-08-01 2021-03-31 20-M-0047-00, COPE, NCT04495907 Phase Not Applicable Not yet recruiting 0 8 Months 1000 2020-08-06
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 Coronavirus disease 19 infection commercial SARS-CoV-2 antibody immunoassay alone Healthy volunteers accepted Hong Kong Sanatorium & Hospital Hong Kong 2020-07-27 2020-11-30 NCT04496141, RC-2020-12 Phase Not Applicable No longer recruiting 1 4 Months 70 Jonpaul Sze Tsing Zee, MBChB 2020-08-06
RePAiR: Registry of Sustained Immunity to COVID-19 Among ESKD Patients Coronavirus disease 19 infection, End stage renal disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) DaVita Clinical Research US 2020-07-20 2021-03-31 20-M-0044-00, NCT04495764, RePAiR Phase Not Applicable Recruiting 13 8 Months 2500 Aleah Freeman, Ali Stockness, Christina Fernandez, David Ellis, Dylan Marias, Francesca Tentori, MD, Helen Brickel, Helen Brickel, RN, Hoda Bashir, Jason Harvey, Marisol Ortega, Nicole Holquin, Tracy Mente 2020-08-13
A comparative study of the effects of Tocilizumab‎, interferon-gamma and vitamin C on the recovery of critically ill COVID-19 patients and cytokine storm Coronavirus disease 19 infection, Inflammatory disease routine medication alone, tocilizumab‎ alone, Vitamin C plus interferon gamma Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Tabriz University of Medical Sciences Iran 2020-07-31 IR.TBZMED.REC.1399.130, IRCT20200525047570N1 Phase 2 Clinical No longer recruiting 1 60 Mohammad Hossein Somi, Negin Hadisi 2020-08-12
Ethics of Behavioral Interventions during the Covid 19 Coronavirus disease 19 infection Ethics of Public Health Behavioral Interventions alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP) Seth GS Medical College India 2020-07-31 CTRI/2020/07/026926 Phase Not Applicable Not yet recruiting 5 400 Dr Yashashri C Shetty 2020-08-06
Desferal in COVID-19 Coronavirus disease 19 infection Desferal (Exirdaru Company) plus hydroxychloroquine sulfate (Amin Pharmaceutical company) Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Bandare-abbas University of Medical Sciences Iran 2020-08-10 IR.HUMS.REC.1399.227, IRCT20200506047323N4 Phase 2/Phase 3 Clinical Recruiting 1 60 Mohammad Fathalipour, Parivash Davoodian, Teamur Aghamolaei 2020-08-12
To see the effect of twakadi (tea made up of dalcheeni, tulasi pepper, clove, etc) tea on police worker who have a duty in covid 19 pandemic Coronavirus disease 19 infection Twakadi herbal tea (tulasi, Pippali, yashtimadhu, Ginger, Draksha, Dalchini) alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) PDEAs C.A.R.C India 2020-07-31 CTRI/2020/07/026925 Phase 3 Clinical Not yet recruiting 1 60 Dr Yogini Kulkarni 2020-08-06
A phase I clinical trial of JNJ-78436735 for the prevention of Coronavirus disease 19 infection Coronavirus disease 19 infection JNJ-78436735 alone Johnson & Johnson Japan Phase 1 Clinical Planned 1 2020-08-04
A phase IIa clinical trial of JNJ-78436735 for the prevention of Coronavirus disease 19 infection Coronavirus disease 19 infection JNJ-78436735 alone Johnson & Johnson Spain, Netherlands, Germany Phase 2a Clinical Planned 3 2020-08-04
Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system - a prospective, longitudinal, mixed methods study Angina, Cardiac failure, Chronic obstructive pulmonary disease, Coronary artery disease, Coronavirus disease 19 infection, Diabetes mellitus, Diabetic nephropathy, Heart valve disease, Idiopathic pulmonary fibrosis, Lung tumor, Motor neurone disease, Myocardial disease, Pneumonia dual-monitoring telenursing alone Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hamamatsu University School of Medicine, St. Luke's International University, Japan, Tokyo Healthcare University, Tokyoto Igaku Kenkyu Kiko Ministry of Education, Culture, Sports, Science and Technology of Japan Japan 2020-08-27 UMIN000041160 Phase Not Applicable Not yet recruiting 1 42 Tomoko Kamei 2020-08-11
Ayurvedic intervention in COVID-19 patients Coronavirus disease 19 infection Variable regimens including Ashwagandha (Withania somniferum) , Rasona Kalka , Samshamani Vati , Vyaghryadi kwatha Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Lok Bandhu Sri Raj Narayan Combined Hospital India 2020-08-04 CTRI/2020/07/026922 Phase 2 Clinical Not yet recruiting 1 30 Adil Rais 2020-08-14
BARCONA: BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Coronavirus disease 19 infection bardoxolone methyl (oral, pulmonary arterial hypertension/ diabetic nephropathy), Reata/ Kyowa Hakko Kirin alone I-kappa B kinase inhibitor, Kelch like ECH associated protein 1 modulator, NFE2L2 gene stimulator, Nuclear factor kappa B inhibitor, STAT3 gene inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) NYU Langone Health, Reata Pharmaceuticals Inc US 2020-08-01 2021-02-28 20-00591, BARCONA, NCT04494646 Phase 2/Phase 3 Clinical Not yet recruiting 1 7 Months 440 Alexander Slotwiner, MD, Atul Sharma, MD, Carlos Alviar, MD, Eugene Yuriditsky, MD, James Horowitz, MD, Juan Gaztanaga, MD, Kevin Chan, Kevin Marzo, MD, Norma Keller, MD, Sripal Bangalore, MD, MHA 2020-08-05
An integrated clinico-molecular-epidemiological approach to advance knowledge of COVID-19 Coronavirus disease 19 infection Monash University, Universiti Sains Malaysia Malaysia NMRR-20-1645-55277 Phase Not Applicable Not yet recruiting 5 Assoc. Prof Rosline Hassan, Associate Professor Qasim Ayub, DR Chan Yean Yean, DR HAJAH FAIZAN BINTI HAJI GHAZALI, Dr Murnihayati binti Hassan, Dr. Mohammad Ridhuan Bin Mohd Ali, Engku Nur Syafirah bt Engku Abd Rahman, Mr. Chua Wei Lian Chua Wei Lian, noor hafizan binti mat salleh 2020-08-06
KAP towards COVID-19 in RMCO, Sarawak Coronavirus disease 19 infection Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sarawak General Hospital Malaysia 2020-08-01 2020-08-31 NMRR-20-1643-55867 Phase Not Applicable Not yet recruiting 1 1 Month Dr. Benjamin Sachdev A/L Manjit Singh 2020-08-06
A Clinical trial to evaluate the effect of a combination of treatment of Reginmune capsule and Immunofree tablets in the treatment of mild to moderate COVID-19 patients Coronavirus disease 19 infection Immunofree alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Corival Lifesciences Private Limited India 2020-08-07 CTRI/2020/08/026957 Phase 4 Clinical Not yet recruiting 4 100 Dr Abhijit Munshi, Dr Vijaykumar Kamat 2020-08-05
Telemedicine effectiveness during COVID-19 Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Prasanna School of Public Health India 2020-08-10 CTRI/2020/08/026956 Phase Not Applicable Not yet recruiting 1 Brayal DSouza 2020-08-03
COVID-19 Drug Utilization Coronavirus disease 19 infection, Influenza virus infection, Respiratory tract infection COVID-19 treatment alone Ministry of Health, Malaysia Malaysia 2020-08-01 55865, NMRR-20-1648-55865 Phase Not Applicable Status not specified 1 Dr Abdul Haniff bin Mohamad Yahaya, Dr Nor Ilham Ainaa Binti Muhsin 2020-08-06
COVID-19 Preparedness and Response in Malaysia Coronavirus disease 19 infection Hospital Sungai Buloh Malaysia 2020-07-31 2020-08-07 55974, NMRR-20-1646-55974 Phase Not Applicable Status not specified 1 Dr Kalaiarasu Peariasamy, Dr Kuan Pei Xuan 2020-08-06
Comparison of three homoeopathic drugs for covid-19 immune boosters against standard treatment Coronavirus disease 19 infection Arsenicum album 30c alone, Camphora officinalis alone, Sarcolactic acid 30 alone, Variable regimens including Zinc Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ministry of Ayush, National Institute of Homoeopathy India 2020-08-03 CTRI/2020/07/026953 Phase 3 Clinical Not yet recruiting 1 704 Dr. Prasanta rath 2020-08-05
Survey and Management of depression, Anxiety and Stress due to COVID-19 fear Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression Brahmi (Bacopa monnieri (L.) Pennell) capsule alone Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) SDM College of Ayurveda and Hospital India 2020-08-01 CTRI/2020/07/026952, DAS-COVID-19-AYU Phase 2/Phase 3 Clinical Not yet recruiting 1 200 Dr Prasanna N Rao, Dr Shailaja U 2020-08-05
Effects of revised COVID-19 specific infection control protocol on the well being of dental professionals Coronavirus disease 19 infection personal protective equipment (PPE) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Manipal College of Dental Sciences India 2020-08-03 CTRI/2020/07/026943 Phase Not Applicable Not yet recruiting 1 300 Dr Shruthi Acharya 2020-08-05
A clinical trail of SARS-CoV-2 vaccine (protein subunit, outer membrane vesicle (OMV)-based peptide), Intravacc/ Epivax for the prevention of Covid-19 Coronavirus disease 19 infection SARS-CoV-2 vaccine (protein subunit, outer membrane vesicle (OMV)-based peptide), Intravacc/ Epivax alone COVID19 Spike glycoprotein modulator Intravacc Celonic AG Phase Not Applicable Planned 0 2020-08-03
Study of COVID-19 suspected pregnant women Coronavirus disease 19 infection Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Kasturba Medical College, Manipal India 2020-08-03 CTRI/2020/07/026942 Phase Not Applicable Not yet recruiting 1 200 Nivedita Hegde 2020-08-05
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian, Multicenter Study Coronavirus disease 19 infection, Kidney transplantation Hospital do Rim e Hipertensao Brazil 2020-05-21 2022-04-02 30631820.0.1001.8098, NCT04494776 Phase Not Applicable Recruiting 1 22 Months 500 Helio Tedesco, Jose Osmar Medina, Monica Nakamura 2020-08-05
What are risk factors associated with disease severity and length of hospital stay in patients admitted with COVID-19 in GCS Medical College, Hospital And Research Center, Ahmedabad? Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gujarat Cancer Society Medical college hospital and research centre India 2020-08-15 CTRI/2020/07/026955 Phase Not Applicable Not yet recruiting 1 910 Arpit C Prajapati 2020-08-04
Study of blood tests findings in patients of COVID 19 in a tertiary care center Coronavirus disease 19 infection Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gujarat Cancer Society Medical college hospital and research centre India 2020-08-10 CTRI/2020/07/026954 Phase Not Applicable Not yet recruiting 1 150 Dr Himali Thakkar 2020-08-04
Clazakizumab versus Placebo - COVID-19 Infection Coronavirus disease 19 infection, Lung disease, Lung injury, Respiratory distress syndrome, Viral pneumonia clazakizumab alone IL-6 receptor antagonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Houston Methodist US 2020-07-13 2021-07-31 NCT04494724, PRO00025969 Phase 2 Clinical Recruiting 1 12 Months 60 Ahmad Goodarzi, MD, Ahmed O Gaber, MD, Alex Rogers, PharmD, Darrel Cleere, BSN, Faisal Zahiruddin, MD, Howard Huang, MD, Howard J Huang, MD, Isioma Agboli, MD, Linda W Moore, PhD, Simon Yau, MD, Yihad G Youssef, MD 2020-08-10
A clinical study to evaluate the translational insights to better understand the immune response in COVID-19 patients ie, association of COVID-19 inflammation with activation of the C5a-C5aR1 Coronavirus disease 19 infection Innate Pharma SA Phase Not Applicable Status not specified 0 2020-08-05
Observational study of SARS-CoV-2 antibody test positive rate Coronavirus disease 19 infection SARS-CoV-2 antibody test alone SOUSEIKAI Japan 2020-08-01 UMIN000041262 Phase Not Applicable Recruiting 1 4000 Shin Irie, Tatsuya Yoshihara 2020-08-05
ULSC: Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS Coronavirus disease 19 infection, Respiratory distress syndrome umbilical cord lining stem cells alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Restem LLC US 2020-07-23 2021-11-30 NCT04494386, ULSC, ULSC-CV-01 Phase 1/Phase 2 Clinical Recruiting 1 16 Months 60 Central Contact, Jason Knudtson, MD, William C Spanos, MD 2020-08-14
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM-005 in Patients With COVID-19 Coronavirus disease 19 infection INM-005 alone Immunoglobulin agonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Inmunova Argentina 2020-07-27 2020-11-30 CT-INM005-01, NCT04494984 Phase 2/Phase 3 Clinical Recruiting 6 4 Months 242 Augusto Perez, MD, Beatriz Firmenich, Estela Izquierdo, MD, Fernando Grittini, MD, Gustavo Chaparro, MD, Ines Zapiola, Mariana Colonna, MSc., Santiago Sanguineti, Ph.D. 2020-08-10
COVID-19 Core Warming Coronavirus disease 19 infection, Respiratory failure EnsoETM alone, core warming alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Advanced Cooling Therapy Inc, Attune Medical Sharp HealthCare US 2020-08-31 2020-12-31 COVID CORE WARMING, COVID-19 Core Warming, NCT04494867 Phase Not Applicable Recruiting 1 4 Months 20 Ahmed Salem, MD, David Willms, MD, Katie Miller 2020-08-06
Multicenter, registry study of Japanese patients with inflammatory bowel disease with COVID-19 Behcets disease, Coronavirus disease 19 infection, Crohns disease, Inflammatory bowel disease, Ulcer, Ulcerative colitis Japanese Ancestry Sapporo Medical University School of Medicine Japanese Ministry of Health, Labor and Welfare Japan 2020-08-01 UMIN000040656 Phase Not Applicable Not yet recruiting 1 200 DAISUKE HIRAYAMA, HIROSHI NAKASE 2020-08-05
ImmuneRACE: Immune Response Action to COVID-19 Events Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Adaptive Biotechnologies Corp Covance Inc US 2020-04-24 2021-01-31 ADAP-006, ImmuneRACE, NCT04494893 Phase Not Applicable Recruiting 1 9 Months 1000 Emily A Svejnoha, BS, Emily Svejnoha, BS, Jen N Dines, MD 2020-08-10
IFN Beta-1b and Ribavirin for Covid-19 Coronavirus disease 19 infection standard care alone, interferon beta-1b plus ribavirin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) The University of Hong Kong Hospital Authority,Hong Kong Hong Kong 2020-07-29 2022-08-01 NCT04494399, UW 20-513 Phase 2 Clinical Recruiting 1 24 Months 96 Ivan FN Hung, MD FRCP, Kelvin KW To, MD FRCPath, Kelvin To, MD MRCP 2020-08-05
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy Breast tumor, Colorectal tumor, Coronavirus disease 19 infection standard adjuvat chemotherapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universita degli Studi di Firenze Italy 2021-01-31 2022-12-31 ALTERTASTE, NCT04495387 Phase Not Applicable Not yet recruiting 1 23 Months 100 Giandomenico Roviello 2020-08-05
Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients Coronavirus disease 19 infection Immunofree plus Reginmune Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Nutrin GmbH India 2020-08-07 2020-09-30 MGCTS/20/105, NCT04494204 Phase 2/Phase 3 Clinical Not yet recruiting 4 1 Month 100 A Gopal Rao, MD, Abhijit Munshi, Apurve Mehra, PUNEET MITTAL, Puneet Mittal, Vidyadhar G Vaidya, Vijaykumar Kamat 2020-08-11
CABS: COVID-19 cancer attitudes and behaviour study Cancer, Coronavirus disease 19 infection online survey alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry, African Ancestry Cardiff University United Kingdom Research & Innovation UK 2020-06-30 2021-12-29 CABS, ISRCTN17782018 Phase Not Applicable Not yet recruiting 2 18 Months 3535 Ms Moriarty 2020-08-06
Neonatal complications of coronavirus disease (COVID-19) study Coronavirus disease 19 infection Newborn Infants (up to 5 months) University of Oxford National Institute for Health Research (NIHR) UK 2020-03-01 2021-09-30 IRAS 282127, ISRCTN60033461 Phase Not Applicable Recruiting 2 19 Months Dr Gale, Prof Jenny Kurinczuk 2020-08-06
Evaluation of the Patient-Doctor-Relationship during the COVID-19 pandemia Coronavirus disease 19 infection Survey-based Assessment alone, traditional face mask alone, transparent face mask alone University of Munster Germany 2020-08-03 2020-498-f-S, DRKS00022305 Phase Not Applicable Recruiting 1 500 Kristian Nikolaus Schneider 2020-08-04
A prospective (compassionate), open-label, single-center study to evaluate efficacy of remdesivir in patients with SARS-CoV-2 pneumonia Coronavirus disease 19 infection, Pneumonia remdesivir alone COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator Ospedale Luigi Sacco Azienda Ospedaliera Polo Universitario, Universita degli Studi di Milano Italy 2020-02-23 Phase 2 Clinical Status not specified 1 35 2020-08-04
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Coronavirus disease 19 infection, Hypoxia, Inflammatory disease, Respiratory failure, Viral pneumonia mavrilimumab alone C-reactive protein inhibitor, Chemokine CC22 ligand inhibitor, GM-CSF receptor antagonist, Hemoglobin scavenger receptor antagonist, Metalloprotease-1 inhibitor, Metalloprotease-3 inhibitor, Small inducible cytokine A17 ligand inhibitor, VEGF gene inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Cincinnati Kiniksa Pharmaceuticals Ltd US 2020-05-20 2021-05-31 IND 149353, NCT04492514 Phase 2 Clinical Recruiting 1 12 Months 60 Autumn Cresie, Kristin Hudock, MD 2020-08-03
Cyclosporine For The Treatment Of COVID-19(+) Coronavirus disease 19 infection ciclosporin, Novartis alone, standard of care alone Calcineurin inhibitor Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Baylor College of Medicine Brigham & Women's Hospital US 2020-08-20 2025-08-20 H-48163, NCT04492891 Phase 2a Clinical Not yet recruiting 1 60 Months 75 Bryan Burt, MD, Michelle Almarez, BBA 2020-08-03
HOME-COVID-19: Mental Health Circumstances Among Healthcare Workers and General Public Under the Pandemic Situation of COVID-19 Coronavirus disease 19 infection, Psychiatric disorder online survey alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Chiang Mai University Thailand 2020-04-21 HOME-COVID-19, TCTR20200425001 Phase Not Applicable Recruiting 1 2500 Surapon Nochaiwong 2020-08-03
Effect of CRP blood test in management of COVID 19 patients Coronavirus disease 19 infection CRP test alone Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gujarat Cancer Society Medical college hospital and research centre India 2020-08-05 CTRI/2020/07/026902 Phase Not Applicable Not yet recruiting 1 100 Impact of CRP test in management of COVID 19 2020-08-03
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan Coronavirus disease 19 infection, Hypoxia, Respiratory failure, Viral pneumonia Fresh frozen Plasma alone, Variable regimens including Fresh frozen Plasma , convalescent Plasma , mesenchymal stem cell therapy , remdesivir , tocilizumab COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) United Nations International Children's Fund Pak Emirates Military Hospital Pakistan 2020-04-01 2020-07-20 NCT04492501, SULTAN MEHMOOD KAMRAN 3 Phase 2 Clinical Completed 1 3 Months 600 Sultan mehmood kamran, Sumaira Irum, MIT 2020-08-03
Virtual exercise for older persons during COVID-19 pandemic Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression Exercises alone Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Malaya Malaysia 2020-06-01 2020-08-15 55960, NMRR-20-1629-55960 Phase Not Applicable No longer recruiting 1 2 Months AMIRAH FATIN BINTI IBRAHIM, Dr Tan Maw Pin, Mrs Chong Mei Chan 2020-08-05
Impact of COVID-19 Pandemic on Genetic Services across Asia Coronavirus disease 19 infection telegenetics alone Genetic Counselling Society of Malaysia Malaysia 2020-07-28 2020-08-31 55195, NMRR-20-1640-55195 Phase Not Applicable Not yet recruiting 2 1 Month 30 Ms Juliana Lee Mei Har, Ms Yoon Sook-Yee, Prof Dr Thong Meow Keong 2020-08-05
Detection of Antibodies to COVID-19 Coronavirus disease 19 infection VITROS 3600 system alone, VITROS 5600 system alone, VITROS CoV2T assay alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ortho Clinical Diagnostics India Private Limited India 2020-08-03 CTRI/2020/07/026759 Phase Not Applicable Not yet recruiting 1 175 Dr Smita Sarma 2020-08-03
Vitamin-D levels in COVID-19 Patients and their relationship with other bone metabolism markers Coronavirus disease 19 infection, Metabolic bone disease, Vitamin D deficiency Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) All India Institute of Medical Sciences, Raipur India 2020-08-03 181 R4, AIIMSRPR/IEC/2020/553, CTRI/2020/07/026794 Phase Not Applicable Not yet recruiting 1 100 Alok Chandra Agrawal 2020-08-05
ACTT-3: Adaptive COVID-19 Treatment Trial 3 Coronavirus disease 19 infection recombinant interferon beta-1a, Merck Serono plus remdesivir COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, Interferon beta ligand, RNA polymerase modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Institute of Allergy and Infectious Diseases Merck & Co Inc US 2020-08-04 2023-11-01 20-0006 ACTT-3, ACTT-3, NCT04492475 Phase 3 Clinical Recruiting 31 38 Months 1038 20-0006 Central Contact 2020-08-13
MICI-Covid-19: Inflammatory Bowel Disease (IBD) and Covid-19 Infection Coronavirus disease 19 infection biological testing alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hopitaux Universitaires de Strasbourg France 2020-07-07 2021-01-07 7930, MICI-Covid-19, NCT04492267 Phase Not Applicable Recruiting 1 6 Months 700 Bénédicte CARON, MD, Jean-Marie REIMUND, MD, PhD, Saïd CHAYER, PhD, HDR, Yves ARONDEL, MD 2020-08-04
An independent study to evaluate the performance of MosaiQ COVID-19 Antibody Microarray in the detection of COVID-19 antibodies in patients with COVID-19 infection Coronavirus disease 19 infection MosaiQ COVID-19 Antibody Microarray alone Quotient Ltd Phase Not Applicable Status not specified 0 500 2020-08-03
GSK-3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers Coronavirus disease 19 infection, HIV infection GSK-3739937 alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) GlaxoSmithKline plc 2020-07-31 2021-02-17 212548, NCT04493684 Phase 1 Clinical Not yet recruiting 0 6 Months 48 EU GSK Clinical Trials Call Center, GSK Clinical Trials, US GSK Clinical Trials Call Center 2020-08-03
A phase III clinical trial of TY-027 in patients with COVID-19 Coronavirus disease 19 infection TY-027, Tychan alone Tychan Pte Ltd Phase 3 Clinical Planned 0 2020-08-03
Affect in surgical care in children due to COVID 19 in India: a online survey of surgeons Coronavirus disease 19 infection online survey alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Chacha Nehru Bal Chikitsalya India 2020-07-30 CTRI/2020/07/026792 Phase Not Applicable Not yet recruiting 1 200 Niyaz Khan 2020-08-05
Panchgavya Therapy in prophylaxis and as an adjuvant therapy in management of Covid 19. Coronavirus disease 19 infection Panchgavya Therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ionisation Filtration Industries PvtLtd India 2020-07-31 CTRI/2020/07/026793, MHC/CT/20-21/010 Phase 2 Clinical Not yet recruiting 1 120 Dilip Kulkarni, Gayatri Ganu, Vivek Joshi 2020-08-03
RESIST Trial: Statin and Aspirin in SARS-CoV-2 infection Coronavirus disease 19 infection Aspirin alone, atorvastatin alone HMG CoA reductase inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) All India Institute of Medical Sciences India 2020-08-01 CTRI/2020/07/026791, RESIST Trial Phase 2/Phase 3 Clinical Not yet recruiting 1 800 Dr Deepti Siddharthan 2020-08-05
Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center Coronavirus disease 19 infection, Dyspnea, Respiratory failure, Upper respiratory tract infection, Viral pneumonia colchicine plus prednisone Aged Adults (65-79 yrs), Elderly Adults (80 and over) Fundacion Clinic per a la Recerca Biomédica Spain 2020-09-30 2021-10-31 2020-002462-14, NCT04492358 Phase 2/Phase 3 Clinical Not yet recruiting 1 13 Months 144 Maria Joyera Rodríguez 2020-08-03
A trial to evaluate the effect of cotton face-masks and other behavioral factors on COVID-19 risk in rural Telangana Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Synergy India 2020-08-03 CTRI/2020/07/026796 Phase Not Applicable Not yet recruiting 1 10000 Teena Desai 2020-08-03
Plasma of donors convaling by COVID-19, for the management of patients with SARS-CoV-2 illness by in Stage II (moderate) and Stage III (Severe): Multicenter, Double-blind, Randomized Study Coronavirus disease 19 infection convalescent plasma alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Naval Medical Center at San Diego Mexico 2020-05-18 CE/168/20 Phase 2 Clinical Recruiting 1 50 NAVAL MEDICAL CENTER 2020-08-03
Clinical Trial of Treatment in Adult Patients with Pneumonia by COVID-19 Coronavirus disease 19 infection, Viral pneumonia tocilizumab alone, Variable regimens including azithromycin , hydroxychloroquine , lopinavir + ritonavir HIV protease inhibitor American British Cowdray Medical Center Mexico 2020-07-10 ABC-20-07 Phase 2 Clinical Recruiting 1 36 PAULINA TRÁPAGA SÁNCHEZ 2020-08-03
Efficacy and safety of convalescent plasma donors by COVID-19 in patients with severe acute respiratory infection syndrome due to the SARS-COV-2 virus Coronavirus disease 19 infection, Respiratory distress syndrome convalescent plasma alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Health Research Council of Mexican Institute of Social Security Mexico 2020-04-22 2020-785-029 Phase 3 Clinical Recruiting 4 400 2020-08-03
TARGET-COVID: The Evaluation of Hemostasis in Hospitalized COVID-19 Patients Bleeding, Coronavirus disease 19 infection, Thrombosis, Viral pneumonia TEG6s hemostasis analyzer alone, biological sampling alone, genotyping alone, phlebotomy alone, thrombelastography alone Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) LifeBridge Health Chrono-Log Corp, Haemonetics Corp, Inflammatory Markers Laboratory, Precision Biologics Inc US 2020-06-30 2021-06-30 1602903, NCT04493307, TARGET-COVID Phase Not Applicable Recruiting 1 12 Months 100 Ashwin Dharmadhikari, MD, Cescelle B Barbour, MSN, Cescelle Barbour, MSN, Jaime Barnes, DO, Kevin P Bliden, B.S. MBA, Paul A Gurbel, MD, kevin bliden, MBA 2020-08-03
An observational study of lying down flat on chest in treatment of corona patient who breath on their own and on oxygen therapy Coronavirus disease 19 infection Oxygen therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) New Civil Hospital, Surat India CTRI/2020/07/026797 Phase Not Applicable Not yet recruiting 1 111 Shweta Apatel 2020-08-05
SCCT: Singapore COVID-19 Chemosensory Tracking (SCCT) Study Coronavirus disease 19 infection, Respiratory disease home-use standardized smell and taste test alone, online software (CompuSense) alone, taste test alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Clinical Nutrition Research Centre, Singapore National University Hospital (Singapore) Pte Ltd Singapore 2020-07-23 2021-03-31 2020/00810, NCT04492904, SCCT Phase Not Applicable Recruiting 1 8 Months 5000 Ciaran Forde, Phd, Vicki Tan 2020-08-03
SWITCH-COVID: Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 Coronavirus disease 19 infection, Hypertension anti-hypertensive class drug therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Sao Paulo Brazil 2020-07-25 2022-02-14 33575220.9.0000.0068, NCT04493359, SWITCH-COVID Phase 2/Phase 3 Clinical Recruiting 1 18 Months 240 Bruno Caramelli, Bruno Caramelli, MD.PHD, Bruno F Caramelli, MD.PHD, Caio A Tavares, MD 2020-08-03
COVITA: Containment Measures and Eating Disorders Coronavirus disease 19 infection, Eating disorder Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Hospital, Montpellier Inserm U1061 France 2020-04-01 2020-06-30 COVITA, NCT04492189, RECHMPL20_0220 Phase Not Applicable Completed 1 3 Months 40 Ariane SULTAN, PR 2020-08-03
In this study selenium levels would be determined in both normal volunteers as well as patients suffering from COVID-19 Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sami Labs Ltd India 2020-07-24 CPL/88/EPL_COVD/I/JUL/20,V2.0, CTRI/2020/07/026747 Phase Not Applicable Not yet recruiting 2 60 Dr Kalpesh Shah, Dr S Krishnamoorthy, Dr Santhan Perithambi Sadagopal 2020-08-03
ACTIV: Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients Asthma, Chronic obstructive pulmonary disease, Coronavirus disease 19 infection, Diabetes mellitus, End stage renal disease, Vascular disease Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Eurasian Association of Therapists Russian Federation 2020-06-11 2022-01-15 ACTIV, ACTIV11062020, NCT04492384 Phase Not Applicable Recruiting 1 19 Months 3500 Alexander Arutyunov, professor, Anastasia Rud, Anastasia Rud, master, Tamara Kriukova, Tamara Kriukova, master 2020-08-04
Using Neuromodulation to Improve Parkinson's Disease Coronavirus disease 19 infection, Parkinsons disease ThermoNeuroModulation device (Scion Neurostim Llc) alone, time-varying caloric vestibular stimulation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Wake Forest University Health Sciences, US Scion Neurostim Llc US 2020-09-30 2022-09-30 IRB00067408, NCT04493697 Phase Not Applicable Not yet recruiting 1 24 Months 20 Christopher T Whitlow, MD, Richarlette C Hightower 2020-08-03
MSCT Chest in Suspected COVID-19 Patients Coronavirus disease 19 infection, Respiratory disease, Viral pneumonia RT-PCR alone, multi spiral computed tomography (MSCT) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Assiut University Egypt 2020-07-30 2020-10-30 CTCOV, NCT04492865 Phase Not Applicable Not yet recruiting 1 3 Months 150 Abeer Ali, M D, Dalia Kamal, M D, Gehan S Seifeldein, M.D., Gehan S. Seifeldein, Marwa Khairallah, M D, Salwa Seif Eldein, PhD, Salwa Seif Eldin, PhD, Sara Hassanin, MD, Walaa Ali, M D 2020-08-03
To Observe Whether Isoflurane Can Treat COVID-19 Patients Coronavirus disease 19 infection, Viral infection, Viral pneumonia isoflurane alone, mechanical ventilation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Massachusetts General Hospital US 2020-04-20 2020-07-20 2020P001048, NCT04492943 Phase 4 Clinical Recruiting 1 3 Months 40 Zhongcong Xie, Zhongcong Xie, M.D., Ph.D, Zhongcong Xie, PhD, MD 2020-08-04
A cohort study to evaluate the impact of COVID-19 infection on neurological integrity using Simoa NF-light kit on the Simoa HD-X Analyzer in adult patients with mild to moderate COVID-19 infection Coronavirus disease 19 infection, Neurological disease Simoa HD-X Analyzer alone, Simoa NF-light kit alone University Hospital Basel, University Hospital Regensburg Switzerland, Germany Phase Not Applicable Status not specified 2 100 Jens Kuhle 2020-08-03
Knowledge Attitude and Practice of Nurses towards Hand hygiene in COVID-19 care units Coronavirus disease 19 infection Healthy volunteers accepted Government Medical College Kannur India 2020-08-10 CTRI/2020/07/026758 Phase Not Applicable Not yet recruiting 1 100 Dr Venugopalan A K 2020-08-04
An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19 Coronavirus disease 19 infection Eupatorium perfoliatum 30 C alone Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ministry of Ayush India 2020-07-31 CTRI/2020/07/026757 Phase 3 Clinical Not yet recruiting 1 200 Dr Tapan Nath, Prof Dr PK Goswami 2020-08-04
Turkish of the SARS-CoV-2 Anxiety Scale Anxiety disorder, Coronavirus disease 19 infection survey work alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Eskisehir Osmangazi University Turkey 2020-07-24 2020-12-24 AYFER AÇIKGÖZ, DENİZ YİĞİT, DSAYIK2, ERTUĞRUL ÇOLAK, NCT04490473, ÖZLEM MUMCU Phase Not Applicable Recruiting 1 5 Months 300 AYFER AÇIKGÖZ, DENIZ YIGIT, DILEK SAYIK 2020-08-04
FGG: Fear learning during pandemic fear: how COVID-19 perception affects classical fear conditioning Coronavirus disease 19 infection, Psychiatric disorder Healthy volunteers accepted, Young Adults (18-44 yrs) Universitat des Saarlandes Germany 2020-08-02 DRKS00022761, FGG Phase Not Applicable Recruiting 1 120 Mr. M.Sc. Alexander Hauck 2020-08-04
KiTaCoviDD19: SARS-CoV-2 Surveillance in Day Care Centers (COVID-19) Coronavirus disease 19 infection University Hospital Carl Gustav Carus Germany 2020-07-15 DRKS00022729, KiTaCoviDD19 Phase Not Applicable Recruiting 1 750 Dr. med. Jakob Armann 2020-08-04
EMN-COVID: COVID-19 Infection and Multiple Myeloma Coronavirus disease 19 infection, Multiple myeloma Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) European Myeloma Network Fondazione EMN Italy Greece, Czech Republic, Austria, UK, Germany, Netherlands, Italy, Belgium 2020-07-01 2021-07-31 EMN-COVID, EMN-COVID, NCT04492371 Phase Not Applicable Recruiting 8 13 Months 500 Evangelos Terpos, Prof., Gordon Cook, Prof., Hermann Einsele, Prof., Maria Krauth, Prof., Marie-Christiane Vekemans, Prof., Mario Boccadoro, Prof., Roman Hajek, Prof., Sonja Zweegman, Prof. 2020-08-04
A phase II clinical trial of TXA-127 for the potential treatment of COVID-19 infection Coronavirus disease 19 infection TXA-127 alone Angiotensin II receptor modulator Constant Therapeutics LLC Israel Phase 2 Clinical Planned 2 2020-08-03
A phase II clinical trial of TXA-127 for the potential treatment of COVID-19 infection Coronavirus disease 19 infection TXA-127 alone Angiotensin II receptor modulator Constant Therapeutics LLC Italy Phase 2 Clinical Planned 1 2020-08-03
The effect of Cognitive behaviour therapy on adult mental health during the COVID-19 pandemic Anxiety disorder, Coronavirus disease 19 infection, Depression CBT self-help guide immediately alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Curtin University, Government of Western Australia Department of Health Australia ACTRN12620000779976p, RES-62642 Phase Not Applicable Not yet recruiting 1 100 Dr Sarah Egan 2020-08-04
CORE-THROMBOSIS: Covid-19 registry on thrombosis complications associated with hospitalization Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Johannes Gutenberg Universitat Mainz Netherlands, Germany, Belgium, Italy, UK 2020-04-15 2020-14990-retrospektiv, CORE-THROMBOSIS, CTH C010, DRKS00022277 Phase Not Applicable Recruiting 5 5000 Stavros Konstantinides 2020-08-04
Persistent lung and arterial inflammation following COVID-19 pneumonia Arteritis, Coronavirus disease 19 infection, Lung inflammation, Viral pneumonia 18F-FDG PET/CT scan alone Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sir Charles Gairdner Hospital Australia 2020-08-03 ACTRN12620000778987p Phase Not Applicable Not yet recruiting 3 30 A/Prof Roslyn Francis, Ms Elaine Campbell 2020-08-04
COVID-VTE follow-up study: COVID-VTE follow-up study Coronavirus disease 19 infection, Thromboembolism Application of the patient pathway alone Leiden University Medical Center The Netherlands Organisation for Health Research and Development, Trombosestichting Nederland 2020-06-01 2020-052, COVID-VTE follow-up study, NL8787 Phase Not Applicable Recruiting 0 400 Erik Klok 2020-08-04
COVID-19: Yoga for Nurses (COVID-19) Coronavirus disease 19 infection Deep Relaxation Technique alone, Yoga alone, stretch breathing excercise alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Sri Devaraj Urs Academy of Higher Education and Research India 2020-08-04 COVID-19, CTRI/2020/07/026799 Phase 2/Phase 3 Clinical Not yet recruiting 1 60 Patil NJ 2020-08-04
A study to assess the effiacy of RTB-101 in preventing symptom development and downstream hospitalizations among positive, asymptomatic patients as well as any cohabitants of patients diagnosed with COVID-19 in community/outpatient setting Coronavirus disease 19 infection dactolisib alone Phosphoinositide 3-kinase inhibitor, mTOR complex 1 inhibitor, mTOR complex 2 inhibitor TrialSpark, resTORbio Inc Phase Not Applicable Planned 0 2020-08-03
A study to campare various blood investigations in COVID-19 positive patients Coronavirus disease 19 infection Inflammatory markers analysis alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Max Superspeciality Hospital Vaishali India 2020-08-03 CTRI/2020/07/026800 Phase Not Applicable Recruiting 1 72 Dhananjay Batwara 2020-08-04
EPI-COVID-POP: COVID-19 Seroprevalence Study in French Guiana Coronavirus disease 19 infection Blood sample alone Healthy volunteers accepted Institut Pasteur de Guyane Centre Hospitalier de Cayenne, Eurofins Guyane Laboratory in Rémire-Montjoly, Kourou Medical Biology Laboratory, French Guiana 2020-07-15 2021-07-15 2020-048, EPI-COVID-POP, NCT04490850 Phase Not Applicable Recruiting 5 12 Months 1500 Claude Flamand, PhD, Didier Didier, Emmanuel Belliard, Jean-François Carod, Thierry Carage, Véronique Servas 2020-08-04
COVID-19EXO: Evaluation of safety and efficiency of method of exosome inhalation in SARS-COV-2 associated pneumonia Coronavirus disease 19 infection, Viral pneumonia EXO 1 inhalation alone, EXO 2 inhalation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Clinical Center of Cellular Technologies Samara Regional Clinical Hospital Russian Federation 2020-07-20 2021-01-30 COVID-19 EXO, COVID-19EXO, NCT04491240 Phase 1/Phase 2 Clinical Recruiting 1 6 Months 90 2020-08-05
CoV-PICS: A Virtual Post-ICU Clinic Coronavirus disease 19 infection Medical Record Review - Inpatient Treatment alone, Online Questionnaires alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Washington University School of Medicine, US US 2020-08-01 2021-07-30 202007053, NCT04490278 Phase Not Applicable Not yet recruiting 1 11 Months 80 Beth Taylor, DCN, Chris Palmer, MD 2020-08-04
A prospective, open-label study to evaluate the safety and efficacy of ExoFlo in the treatment of critically ill patients with moderate to severe ARDS caused by COVID-19 Coronavirus disease 19 infection, Respiratory distress syndrome ExoFlo alone Christ Hospital US Phase 2 Clinical Status not specified 3 Angel Lazo, Jr, Sascha Sengupta, Vikram Sengupta 2020-08-03
COACH: Student-delivered Telehealth Program for COVID19 Education and Health Promotion Coronavirus disease 19 infection Telehealth coaching sessions alone Healthy volunteers accepted, Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of British Columbia Canada 2020-07-28 2021-07-31 COACH, COACH, NCT04492527 Phase Not Applicable Recruiting 1 12 Months 75 Brodie Sakakibara, PhD, Cam Clayton, MSc, Chelsea Pelletier, PhD, Devin Harris, MD, Jill Zwicker, PhD, Julia Schmidt, PhD, Michelle C Yang, BSc 2020-08-05
NEOSCREENCOVID: COVID-19 Infection Screening in Cancer Patients Coronavirus disease 19 infection rapid serological test alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Antoine Lacassagne (Nice) France 2020-07-21 2021-03-31 2020/23, NCT04492410, NEOSCREENCOVID Phase Not Applicable Recruiting 1 8 Months 500 Sandrine CHELI, PhD 2020-08-10
ketocovidiet: Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome Coronavirus disease 19 infection, Respiratory distress syndrome Ketogenic diet alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) IRCCS AOU San Martino – IST Italy 2020-09-01 2021-05-30 KETOCOV-1, NCT04492228, ketocovidiet Phase Not Applicable Not yet recruiting 1 8 Months 100 Samir G Sukkar, MD 2020-08-05
Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Istinye Universitesi Turkey 2020-08-01 2020-12-10 00010, NCT04492202 Phase Not Applicable Not yet recruiting 1 4 Months 200 Aysegul Asalioglu, Yasemin ÇIRAK, Assoc. Prof. 2020-08-04
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (COVID-19) Coronavirus disease 19 infection hydroxychloroquine alone, Variable regimens including Panadol , vitamin C , vitamin D , zinc Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) United Nations International Children's Fund Pak Emirates Military Hospital Pakistan 2020-04-10 2020-05-31 NCT04491994, SULTAN MEHMOOD KAMRAN 2 Phase 2 Clinical Completed 1 1 Month 500 Imran m Fazal, FCPS, Sultan mehmood kamran 2020-08-04
Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis Coronavirus disease 19 infection, Viral pneumonia low dose whole lung radiotherapy alone Aged Adults (65-79 yrs), Elderly Adults (80 and over) Kantonsspital Graubuenden US, Switzerland 2020-11-30 2021-12-31 IGRG01, NCT04493294 Phase 1/Phase 2 Clinical Not yet recruiting 2 13 Months 500 Brigitta G Baumert, M.D.Ph.D, Nam Nguyen, Nam p Nguyen, MD 2020-08-04
Ayurveda strength and immunity enhancing protocol and immunity in health care workers : clinical trial of an Ayurveda Intervention Coronavirus disease 19 infection AYUSH Kadha alone, Anu taila alone, Chyavanprash alone, Pranayama alone, Shanshamni Vati alone, Yoga alone, rock salt alone, turmeric alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) All India Institute of Ayurveda India 2020-07-28 CTRI/2020/07/026756 Phase Not Applicable Not yet recruiting 1 425 Dr Santosh Kumar Bhatted, Dr Tanuja Manoj Nesari 2020-08-04
Clinical severity and outcome among COVID-19 infected patients in respect to viral load and immune and inflammatory response Coronavirus disease 19 infection Healthy volunteers accepted, Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) RUHS College of Medical Sciences India 2020-07-27 CTRI/2020/07/026755 Phase Not Applicable Not yet recruiting 1 200 Sonali Sharma 2020-08-04
Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection Coronavirus disease 19 infection, Periodontal disease Healthy volunteers accepted, Female, Adolescents (13-17 yrs), Young Adults (18-44 yrs) University of Sao Paulo Bauru School of Dentistry Brazil 2020-09-30 2022-12-31 FOBPREGNAT, NCT04492449 Phase Not Applicable Not yet recruiting 1 27 Months 260 2020-08-04
Hyponatremia in covid-19 patients Coronavirus disease 19 infection, Hyponatremia, Inflammatory disease Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital Nacional Profesor Alejandro Posadas Argentina 2020-03-07 2020-07-21 HYPONATREMIA IN COVID PATIENTS, NCT04493268 Phase Not Applicable Completed 1 4 Months 250 CARLOS EGHI, physician, Ladislao Diaz Ballve, GRADUATE IN KINESIOLOGY 2020-08-04
An observational, retrospective study to evaluate the impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia Coronavirus disease 19 infection, Pneumonia, Respiratory failure standard of care alone, tocilizumab alone Montichiari hospital Italy Phase Not Applicable Status not specified 1 85 2020-08-03
Multicenter, randomized, controlled, open-label study to study the efficacy and safety of asunercept in patients with severe COVID-19 disease Coronavirus disease 19 infection asunercept alone, standard of care alone CD95 antagonist Apogenix GmbH Russian Federation, Spain 2020-07-24 2021-12-31 APG101_CD_017 Phase 2 Clinical Not yet recruiting 8 17 Months 400 2020-08-04
The impact of coronavirus on mental health and well-being in Wales Acute stress disorder, Coronavirus disease 19 infection, Psychiatric disorder, Suicidal ideation online survey alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Swansea University, Wales UK 2020-05-04 2020-07-13 ISRCTN21598625 Phase Not Applicable Completed 2 2 Months 15469 Prof Gray 2020-08-05
EXIT COVID-19: Extracellular Vesicle Infusion Therapy for Severe COVID-19 Coronavirus disease 19 infection, Hypoxia, Respiratory distress syndrome, Respiratory failure ExoFlo, Direct Biologics LLC alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Direct Biologics LLC US 2020-09-01 2020-12-31 DB-001, EXIT COVID-19, NCT04493242 Phase 2 Clinical Not yet recruiting 1 4 Months 60 Vikram Sengupta, Principal Investigator 2020-08-04
The epidemiological characteristic of real-time covid-19 cases in north-eastern peninsular Malaysia: Jan to July 2020 Coronavirus disease 19 infection Jabatan Kesihatan Negeri Kelantan 2020-07-30 NMRR-20-1624-55900 Phase Not Applicable Status not specified 0 Dr HAZLIENOR BINTI MOHD HATTA 2020-08-06
Good-NIGHT COVID: Nasal washout and gargling for healthcare staff in Care Homes during the COVID-19 pandemic: The Good-NIGHT COVID pilot study Coronavirus disease 19 infection Gargling alone, Nasal lavage alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Of Southampton NIHR Applied Research Collaboration Wessex Malaysia ACTRN12620000737932, Good-NIGHT COVID, U1111-1252-7005 Phase Not Applicable Not yet recruiting 1 250 Dr Thomas Daniels 2020-08-06
Evaluation of the effect of chronic use of Antimalarials on the frequency of infection with the New Corona Virus 2019 (Severe Acute Respiratory Syndrome Coronavirus 2 - SARS-CoV-2) in patients with Immunomedical Rheumatic Diseases Connective tissue disease, Coronavirus disease 19 infection, Inflammatory disease, Myopathy, Osteoarthritis, Rheumatoid arthritis, Scleroderma, Sjoegrens syndrome, Systemic lupus erythematosus Chloroquine alone, Hydroxychloroquine alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sociedade Brasileira de Reumatologia Ministério da Saúde – Departamento de Ciência e Tecnologia (MS-DECIT) Brazil 30246120.3.1001.5505, RBR-9ktwx6 Phase Not Applicable Recruiting 1 9000 Cláudia diniz lopes marques, Marcelo Pinheiro 2020-08-05
Status of management of surgery in Beijing during COVID-1 Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Beijing Friendship Hospital, Capital Medical University ChiCTR2000033198 Phase Not Applicable Recruiting 0 500 Kai Pang, Zhongtao Zhang 2020-08-04
Intranasal Heparin Tolerability Study Coronavirus disease 19 infection heparin sodium alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) University of Mississippi US 2020-08-31 2020-09-30 INTRANASAL HEPARIN, NCT04490239 Phase 0 Clinical Not yet recruiting 1 1 Month 6 Bill Gurley, PhD, Joshua S Sharp, PhD, Joshua Sharp 2020-08-05
Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19 Coronavirus disease 19 infection, Gastrointestinal disease Assiut University Egypt 2020-07-31 2020-09-30 COVID GASTRO INTESTINAL, NCT04490772 Phase Not Applicable Not yet recruiting 1 2 Months 200 Haidi Karam 2020-08-04
YCOVID: Rapid Diagnostic Test for COVID-19 Based on Antibody Detection Coronavirus disease 19 infection ELISA test alone, rapid diagnostic test alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Corporacion Parc Tauli Spain 2020-06-22 2020-09-30 2020/587, NCT04490837, YCOVID Phase Not Applicable No longer recruiting 1 3 Months 3500 Juan Francisco Delgado de la Poza 2020-08-04
Comprehensive mental and physical health assessment and intervention studies for novel coronavirus pneumonia (COVID-19) patients Coronavirus disease 19 infection, Viral pneumonia mental and physical health assessment alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Wuhan Jinyintan Hospital China 2020-07-20 2022-03-31 ChiCTR2000035060 Phase Not Applicable Not yet recruiting 1 20 Months 2000 LIU YING, Liu Zhengkui, Wang Qiongya 2020-08-05
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals Coronavirus disease 19 infection KELEA excellerated water intake alone Institute of Progressive Medicine US 2020-08-10 2020-11-30 KELEA-1, NCT04490824 Phase Not Applicable Recruiting 1 3 Months 100 W John Martin, MD, PhD 2020-08-12
An Observational Study of Integrated Chronic Pain Management in a Community Health Center Coronavirus disease 19 infection, Pain NextGen (NextGen EHR) alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Washington University School of Medicine, US Logan University (US) US 2018-08-01 2020-05-25 NCT04490291, RD04240531 Phase Not Applicable Completed 1 21 Months 42 Chrisotpher Prater 2020-07-31
AmbcoviDD19: Assessment of disease progression, infection chains and seroprevalence of Covid-19 infections in Saxony Coronavirus disease 19 infection University Hospital Carl Gustav Carus Germany 2020-04-09 AmbcoviDD19, BO-EK-137042020, DRKS00022549 Phase Not Applicable Recruiting 1 250 Jakob Armann 2020-07-31
Efficacy and outcomes of Lian-Hua Qing-Wen capsule in the treatment of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study Coronavirus disease 19 infection, Viral pneumonia Lian-Hua Qing-Wen capsule alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) 920th Hospital of Jiont Logistic Support Force,Chinese PLA China 2020-02-04 ChiCTR2000035046 Phase Not Applicable Recruiting 1 147 Liu Zhiyong, Zhang Shurong 2020-08-03
A clinical trial of allogeneic bone marrow-derived mesenchymal stem cells for treatment of adult COVID-19 patients Coronavirus disease 19 infection allogeneic bone marrow-derived mesenchymal stem cells, Stemedica Cell Technologies alone Promedica Inc, Stemedica Cell Technologies Inc Phase 2 Clinical Status not specified 0 8 2020-07-30
A phase III clinical trial of COVID-19 vaccine for potential treatment of COVID-19 infection Coronavirus disease 19 infection SARS-CoV-2 vaccine (COVID-19), Sanofi Pasteur/GlaxoSmithKline alone COVID19 Spike glycoprotein modulator GlaxoSmithKline plc, Sanofi SA 2020-12-31 Phase 3 Clinical Planned 0 2020-08-04
A phase I/II clinical trial of COVID-19 vaccine for potential treatment of COVID-19 infection Coronavirus disease 19 infection SARS-CoV-2 vaccine (COVID-19), Sanofi Pasteur/GlaxoSmithKline alone COVID19 Spike glycoprotein modulator GlaxoSmithKline plc, Sanofi SA 2020-09-30 Phase 1/Phase 2 Clinical Planned 0 2020-08-04
FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals Coronavirus disease 19 infection favipiravir alone, lopinavir + ritonavir alone, favipiravir plus lopinavir + ritonavir HIV protease inhibitor, RNA polymerase inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) University College London, University of London LifeArc UK 2020-08-17 2021-03-01 132084, 2020-002106-68, CTU/2020/354, FLARE, NCT04499677 Phase 2a Clinical Not yet recruiting 1 6 Months 240 David Lowe, FLARE Trial Team UCL CCTU 2020-08-06
PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 Coronavirus disease 19 infection, Respiratory insufficiency convalescent plasma alone, standard of care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidad Peruana Cayetano Heredia Peru 2020-08-20 2020-12-31 20997, NCT04497324, PER-016-20, PERUCONPLASMA Phase 2b Clinical Not yet recruiting 2 4 Months 100 Alonso Soto, MD, Fiorella Krapp Lopez, MD, MSc, Patricia Garcia Funegra, MD 2020-08-13
AP-PEDCOVID: Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Assistance Publique Hopitaux de Paris France 2020-04-09 2021-12-31 AP-PEDCOVID, HNECKERNM, NCT04490811 Phase Not Applicable Recruiting 2 20 Months 800 Isabelle Sermet-Gaudelus, Professor, Philippe Tourenne, SERMET Isabelle, Professor 2020-07-31
Convalescent plasma as treatment for COVID-19 Coronavirus disease 19 infection convalescent plasma alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) SEGURO SOCIAL DE SALUD- ESSALUD Peru 2020-06-01 ESSALUD-012020, PER-013-20 Phase 2 Clinical Not yet recruiting 1 192 ARTURO SAGASTEGUI SOTO, AUSBERTO CHUNGA CHUNGA, CHIRISTIAN Villanueva GONZALES, IBETH MELANIA NEYRA VERA, JORGE MAGUIÑA QUISPE, LEDA YAMILEE HURTADO ROCA, PERCY SOTO BECERRA, ROGER VLADIMIR ARAUJO CASTILLO 2020-07-31
What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders Coronavirus disease 19 infection, Temporomandibular joint syndrome Physiotherapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Italian Institute Stomatologico The University of Birmingham Italy 2019-06-14 2020-12-31 NCT03990662, PREDICTORSOUTCOMETMD2019GA Phase Not Applicable Recruiting 1 18 Months 100 Giacomo Asquini 2020-08-01
The Fenland COVID Study: A study to understand the progression and early signs of COVID-19 infection Coronavirus disease 19 infection smartphone app alone Huma University of Cambridge 2020-07-23 The Fenland COVID Study Phase Not Applicable Recruiting 0 2020-07-30
A clinical trial of anti-SARS-CoV-2 spike protein mAb (COVID-19), Adagio Therapeutics for the potential treatment and prevention of SARS-CoV-2 infection (COVID-19) Coronavirus disease 19 infection anti-SARS-CoV-2 spike protein mAb (COVID-19), Adagio Therapeutics alone COVID19 Spike glycoprotein modulator Adagio Therapeutics 2020-12-31 Phase Not Applicable Planned 0 2020-07-30
A randomized, double-blind, placebo-controlled, pilot study to evaluate the feasibility of RTB-101 compared to placebo for COVID-19 post-exposure prophylaxis in older adults Coronavirus disease 19 infection dactolisib alone Phosphoinositide 3-kinase inhibitor, mTOR complex 1 inhibitor, mTOR complex 2 inhibitor Aged Adults (65-79 yrs), Elderly Adults (80 and over) resTORbio Inc Harvard Medical School, National Institute on Aging, University of Connecticut Health Center Phase Not Applicable Planned 0 60 2020-07-30
Serological Surveillance for COVID-19 in Central North Carolina Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) National Institute Of Environmental Health Sciences National Institutes of Health Clinical Center US 2020-08-18 2022-06-01 20-E-0143, 200143, NCT04490174 Phase Not Applicable Recruiting 1 21 Months 2500 Nicole Edwards, Stavros Garantziotis, M.D. 2020-08-14
Post-ICU Follow-up in Patients With Severe SARS-CoV-2 Infection (COVID-19) Coronavirus disease 19 infection Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Université De Strasbourg France 2020-07-24 2021-07-27 7890, NCT04491214 Phase Not Applicable Recruiting 1 12 Months 131 Walid Dr OULEHRI, PH, Walid OULEHRI 2020-08-11
SCEI: Stress Induced by the COVID-19 Pandemic and Non-confinement: Study of Anxiety Factors and Potential Effects on Immunity Anxiety disorder, Coronavirus disease 19 infection, Post traumatic stress disorder COVID-19 questionnaire alone, Experiences in Close Relationship Scale questionnaire (ECR-S) alone, Generalized Anxiety Disorder-7 (GAD 7) alone, Patient Health Questionnaire (PHQ-9) alone, Post Traumatic Stress Disorder questionnaire (PTSD-8) alone, mental health questionnaire alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire de Saint Etienne UK, France 2020-08-31 2020-12-31 20CH129, NCT04491071, SCEI Phase Not Applicable Not yet recruiting 2 4 Months 405 Claude LAMBERT, MD PhD HDR, Fleur PETIT, CRA 2020-08-12
This is the comparative study between two protective boxes which can be used by the doctors while managing critical COVID 19 patients in addition to personal protective equipment Coronavirus disease 19 infection, Surgical procedure new modified aerosol box alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) All India Institute Of Medical Sciences, Rishikesh India 2020-08-03 CTRI/2020/07/026790 Phase Not Applicable Not yet recruiting 1 21 Dr Ankit Agarwal, Dr Mohammad Hashim 2020-08-05
A clinical trial of universal SARS-CoV-2 vaccine (peptide vaccine, COVID-19), MyNEO for the potential prevention of COVID-19 Coronavirus disease 19 infection universal SARS-CoV-2 vaccine (peptide vaccine, COVID-19), MyNEO alone COVID19 Spike glycoprotein modulator, COVID19 envelope small membrane protein modulator, COVID19 nucleoprotein modulator, COVID19 structural glycoprotein modulator MyNEO Phase Not Applicable Planned 0 2020-08-01
HemoCov: COVID-19 Quarantine on Musculoskeletal Status in Hemophilia Bleeding, Coronavirus disease 19 infection, Factor IX deficiency, Factor VIII deficiency, Joint disease, Pain Healthy volunteers accepted, Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidad Europea De Madrid Spain 2020-07-01 2020-07-29 HEMOCOV, HemoCov, NCT04491318 Phase Not Applicable Recruiting 1 27 Rubén Cuesta-Barriuso, PhD 2020-07-31
A single-center, cohort observational study to evaluate clinical characteristics and short-term outcome of kidney transplant patients admitted for SARS-CoV2 pneumonia Coronavirus disease 19 infection, Pneumonia anti-viral therapy alone, hydroxychloroquine alone, methylprednisolone alone, tocilizumab alone Azienda Ospedaliera Spedali Civili di Brescia, Universita degli Studi di Brescia Phase Not Applicable Status not specified 0 20 2020-07-31
VESTA: Effectiveness of a Novel Respirator With Chitosan Nanoparticles Coronavirus disease 19 infection VESTA respirator alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) University of Brasilia Centro de Pesquisa em Biotecnologia Ltda, Hospital Regional da Asa Norte, Universidade Estadual de Campina, University Hospital of Brasilia Brazil 2020-08-30 2021-07-31 32862320.0.0000.0030, NCT04490200, VESTA, VESTA TRIAL Phase Not Applicable Not yet recruiting 1 11 Months 1000 Aline M Toledo, PhD, Glécia V Silva Luz, PhD, Graziella A Joanitti, PhD, Henry M Peixoto, PhD, Marcella L Brettas Carneiro, PhD, Mario Fleury Rosa, PhD, Rodrigo L Carregaro, PhD, Suelia S Fleury Rosa, PhD 2020-08-04
A clinical trial of SARS-CoV-2 vaccine program (COVID-19), Avidin for the prevention of Covid-19 Coronavirus disease 19 infection SARS-CoV-2 vaccine program (COVID-19), Avidin alone COVID19 Spike glycoprotein modulator Avidin Biotechnology Phase Not Applicable Planned 0 2020-08-04
Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 Coronavirus disease 19 infection, Hypoxia, Lung inflammation, Respiratory distress syndrome umbilical cord-derived mesenchymal stem cells (iv, COVID-19/lung inflammation/acute lung injury/ADRS), University of Miami alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) KCNQ2 Cure Alliance Foundation, University of Miami, University of Miami Miller School of Medicine US 2020-08-01 2024-06-01 20200575, NCT04490486 Phase 1 Clinical Not yet recruiting 3 46 Months 21 Camillo Ricordi, M.D, Joshua M Hare, MD, Yvenie Desire, BS 2020-08-04
Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 Coronavirus disease 19 infection AirWay Scope S-100 (Pentax) alone, Laerdal Airway Management Trainer (Laerdal Medical Japan Ltd) alone, Macintosh laryngoscope (Riester) alone, McGRATH MAC (Aircraft Medical Ltd) alone, SealGuard Evac cuffed tracheal tube (Covidien) alone, Shiley Intubation Stylet (Covidien) alone, Splash Guard CG:SGCG aerosol box alone, mask ventilation alone, tracheal intubation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Tokyo Women's Medical College Japan 2020-05-01 UMIN000040289 Phase Not Applicable No longer recruiting 1 30 Idei Masafumi, Masafumi Idei 2020-07-31
On-line Neuromuscular Exercise and Education for Knee Osteoarthritis Coronavirus disease 19 infection, Osteoarthritis GLA:D exercise and education program alone, on-line NEMEX-TJR neuromuscular exercise alone, on-line education alone, on-line stretching exercise alone, on-line warm-up exercise alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Slagelse Hospital Region Zealand Denmark 2020-06-12 2021-12-31 J.NR. 20-000013, NCT04437134, SLAGELSEH Phase Not Applicable Recruiting 4 18 Months 500 Pætur M Holm, PhD, Søren T Skou, Professor 2020-07-31
ALADDIN: Quality of Life and Addiction Among Hospital Night Workers Coronavirus disease 19 infection, Drug dependence, Post traumatic stress disorder, Psychiatric disorder Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Universite Denis Diderot Assistance Publique Hopitaux de Paris, INSERM France 2020-06-15 2023-06-01 ALADDIN, ALADDIN-QOLHOSPWORK, NCT04291534 Phase Not Applicable Not yet recruiting 1 35 Months 1800 Dr Martin Duracinsky 2020-08-02
Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study Coronavirus disease 19 infection, Gastrointestinal disease esophagogastroduodenoscopy alone Chinese University of Hong Kong Hong Kong 2020-05-07 2021-01-31 2020.200, NCT04400734 Phase Not Applicable Recruiting 1 8 Months 60 Chan Shannon Melissa, Philip Chiu, FRCSEd, Shannon Chan, FRCSEd 2020-08-02
A trial to evaluate ADEXUSDx COVID-19 Antibody Test to measure the presence of SARS-CoV-2 antibodies for the diagnosis of COVID-19 Coronavirus disease 19 infection ADEXUSDx COVID-19 Antibody Test alone NOWDiagnostics Inc Phase Not Applicable Planned 0 2020-07-30
CMDA-SURVEY2: National Survey of the Impact of COVID-19 Pandemics Coronavirus disease 19 infection customized questionnaire alone, social software WeChat alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry Peking Union Medical College Hospital China 2020-07-27 2020-09-27 CMDA-SURVEY2, CMDA-SURVEY2, NCT04491201 Phase Not Applicable Recruiting 1 2 Months 6000 Lei Li, M.D., Lei Li, MD 2020-08-02
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce Coronavirus disease 19 infection online questionnaire alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) MD Anderson Cancer Center National Cancer Institute US 2020-05-18 2021-04-30 2020-0428, NCI-2020-04259, NCT04491292 Phase Not Applicable Recruiting 1 11 Months 20000 Priya R Bhosale, Priya R. Bhosale 2020-08-02
A Qualitative study regarding stress and coping in Front-line Health Care Doctors at a tertiary-care hospital Acute stress disorder, Coronavirus disease 19 infection, Psychiatric disorder depth interview alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) B. J. Medical College, Pune India 2020-08-17 CTRI/2020/07/026788 Phase Not Applicable Not yet recruiting 1 20 Dr Ivan Stanley Netto 2020-08-04
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection Coronavirus disease 19 infection, End stage renal disease, Renal disease, Renal injury Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of California San Diego Chile, India, Canada, UK, Bolivia, US 2020-05-05 2023-03-31 000295, NCT04491227 Phase Not Applicable Recruiting 12 34 Months 2000 Ravindra L Mehta 2020-08-01
R4VaD: Understanding cognitive decline after stroke and the impact of COVID-19 Cognitive disorder, Coronavirus disease 19 infection, Stroke, Vascular dementia Blood analysis alone, Routine bran imaging (CT or MRI) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Academic and Clinical Centre Office for Research and Development [ACCORD], UK Alzheimers Society, British Heart Foundation, The Stroke Association, United Kingdom UK 2018-07-01 2023-06-30 AC18001, ISRCTN18274006, R4VaD Phase Not Applicable Recruiting 10 60 Months 2000 Prof Wardlaw 2020-08-06
INHALE: Inhale work package 3 - rapid versus standard testing to diagnose lung infections in intensive care, including COVID-19 observational sub-study Coronavirus disease 19 infection, Lower respiratory tract infection, Viral pneumonia BioFire FilmArray alone, standard care alone University College London NIHR Central Commissioning Facility UK 2018-10-01 2021-06-30 41211, INHALE, ISRCTN16483855 Phase Not Applicable Recruiting 12 33 Months 466 Dr Enne 2020-08-03
postcorona: Postcorona care Coronavirus disease 19 infection, Heart disease, Inflammatory disease, Lung disease, Psychotic disorder, Pulmonary fibrosis Leiden University Medical Center Netherlands 2020-07-13 2020-12-22 NL8775, postcorona Phase Not Applicable Recruiting 1 5 Months 90 Geert Groeneveld 2020-07-31
A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 (Turmeric extract) drops in patients with Corona virus infection Coronavirus disease 19 infection Haldi 30 alone, Standard of care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sahyadri Hospitals India 2020-08-03 CTRI/2020/07/026841 Phase 2 Clinical Not yet recruiting 2 260 Dr Sarang Phadke 2020-08-02
Determination of dandelion capsule on patient with COVID-19 virus Coronavirus disease 19 infection Variable regimens including Dandelherb (Booali Daro Pharmaceutical Factory) , dexamethasone , interferon beta-1b , remdesivir COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Ghoum University of Medical Sciences Iran 2020-07-26 IR.MUQ.REC.1399.148, IRCT20180513039641N2 Phase 3 Clinical Recruiting 1 80 Ehsan Sharifipour, Hoda Abolhasani, Reihaneh Tabaraie, hoda Abolhasani 2020-08-03
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients Coronavirus disease 19 infection Variable regimens including IVIG (Biotest) , hydroxychloroquine (Tehran Daroo) , lopinavir + ritonavir (Hetero Labs Limited) Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Shaheed Beheshti Medical University Iran 2020-07-09 IR.SBMU.NRITLD.REC.1399.143, IRCT20151227025726N20 Phase 2/Phase 3 Clinical No longer recruiting 1 80 Afshin Zarghi, Farzaneh Dastan, Payam Tabarsi, Zahra Mirshafiei Langari 2020-08-12
Safety and Efficacy of EDP-1815 in the Treatment of Patients Hospitalized With COVID-19 Infection Coronavirus disease 19 infection EDP-1815 alone, standard of care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Evelo Biosciences Inc, Robert Wood Johnson University Hospital, Rutgers University US 2020-08-07 2020-12-21 EDP1815-205, NCT04488575 Phase 2 Clinical Not yet recruiting 4 4 Months 60 Daniela Walker, Deborah McCloskey, Douglas Maslin, MD, Keith Guevarra, MD, Randall Teeter, Reynold A. Panettieri, Jr., M.D 2020-07-31
PERSO-COVID: Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. Coronavirus disease 19 infection Serology test follow-up alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Groupe Hospitalier Paris Saint-Joseph France 2020-07-01 2021-12-31 NCT04488484, PERSO-COVID, PERSO-COVID Phase Not Applicable No longer recruiting 1 18 Months 450 2020-08-13
STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers Coronavirus disease 19 infection Long-List Choice Group alone, No Choice Group alone, Short List Choice Group alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University of Western Ontario Duke University Canada 2020-09-30 2020-12-31 116127, NCT04488796 Phase Not Applicable Not yet recruiting 1 3 Months 135 Kirsten Dillon, MA, Madison S Hiemstra, BSc, Marc Mitchell, PhD, Marc Mittchell, PhD 2020-08-08
COVAP: Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Groupe Hospitalier Paris Saint-Joseph Centre Hospitalier Victor Dupouy France 2020-05-06 2020-11-30 COVAP, COVAP, NCT04488510 Phase Not Applicable No longer recruiting 1 6 Months 150 2020-08-04
DECOR-19: Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic Colorectal tumor, Coronavirus disease 19 infection Treviso Regional Hospital Universita degli Studi di Roma La Sapienza, Universita' Degli Studi "Magna Graecia" Di Catanzaro Italy 2020-05-20 2020-06-10 DECOR-19, NCT04488549, TREVISO Phase Not Applicable Completed 1 1051 Gaetano Gallo, Gian Luca Di Tanna 2020-07-30
Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective, Comparative Study Coronavirus disease 19 infection Masimo Radical 7 alone, Welch Allyn Connex Vital Signs Monitor alone, Welch Allyn Vital Signs Monitor alone, remote photoplethysmography (rPPG) vital sign acquisition alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Lady Davis Institute Carebook Technologies Inc Canada 2020-08-01 2020-11-30 2021-2376, NCT04489407 Phase Not Applicable Not yet recruiting 1 4 Months 350 Noura Hassan, Noura Hassan, MD, MPH 2020-07-29
Study of skin, hair and nail changes after COVID 19 illness Coronavirus disease 19 infection, Dermatological disease Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Gujarat Cancer Society Medical college hospital and research centre India 2020-08-24 CTRI/2020/07/026821 Phase Not Applicable Not yet recruiting 1 500 Dr Nayan H Patel 2020-08-03
BET: A NIAID-sponsored Big Effect trial (BET) to assess the combination of lenzilumab and remdesivir on treatment outcomes versus placebo and remdesivir in hospitalized COVID-19 patients Coronavirus disease 19 infection lenzilumab plus remdesivir COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, GM-CSF ligand inhibitor, Immunoglobulin G1 modulator, Immunoglobulin kappa modulator, RNA polymerase modulator Humanigen Inc, National Institute of Allergy and Infectious Diseases BET Phase Not Applicable Status not specified 0 2020-07-29
Curcumin for COVID-19 Pre Exposure Prophylaxis Coronavirus disease 19 infection curcumin alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) All India Institute Of Medical Sciences, Rishikesh India 2020-08-09 CTRI/2020/07/026820 Phase 4 Clinical Not yet recruiting 1 200 Rohit Walia 2020-07-30
Comparison of two different types of simple non-invasive oxygen therapy devices in coronavirus lung infection Coronavirus disease 19 infection, Lung infection, Respiratory failure, Viral pneumonia High Flow Nasal Oxygen alone, Optiflow alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) All India Institute of Medical Sciences India 2020-07-27 CTRI/2020/07/026835 Phase 3 Clinical Not yet recruiting 1 100 Dalim Kumar Baidya 2020-07-30
A clinical trial of anti-coronavirus vaccine,State Research Center of Virology and Biotechnology VECTOR for the treatment of COVID-19 Coronavirus disease 19 infection anti-coronavirus vaccine,State Research Center of Virology and Biotechnology VECTOR alone State Research Center of Virology and Biotechnology VECTOR Phase Not Applicable Not yet recruiting 0 2020-07-29
Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Assiut University Egypt 2020-03-15 2020-07-01 ASSIUTU17, NCT04488588 Phase Not Applicable Completed 2 3 Months 1064 Aliae Mohamed-Hussein, MD 2020-07-30
Open Skies: Use of new technology for rapid detection of SARS-CoV2 Coronavirus disease 19 infection NAOR platform alone, Terasystem Breath Analyser test alone, VIRION test alone, Voice Pattern test alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry Defence Research & Development Organisation Defence Institute of Physiology and Allied Sciences (DIPAS) India 2020-08-05 CTRI/2020/07/026843, Open Skies, Open Skies Phase Not Applicable Recruiting 4 10000 Dr Ambuj Garg, Dr Anil Gurtoo, Dr Desh Deepak, Dr Naresh Kumar, Dr Reena Mariya 2020-07-31
Nimesulide in COVID-19 infection Coronavirus disease 19 infection, Viral pneumonia Variable regimens including azithromycin , enoxaparin sodium , nimesulide , sucralfate Cyclooxygenase 2 inhibitor, Low molecular weight heparin Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Iran 2020-07-28 IRCT20200723048178N1, No.F.1-1//2015/ERB/SZABMU/605 Phase 2 Clinical Recruiting 1 60 Ahmed Farhan 2020-07-30
REaCHing to you with listening ears: A friendly telephonic interaction program for the DDU-GKY members Coronavirus disease 19 infection Assertive linkage with community resources alone, Proactive Engagement and Crisis Intervention alone, Problem-solving oriented supportive therapy alone Healthy volunteers accepted, Young Adults (18-44 yrs) Rajagiri college of Social Sciences UK India Education Research Initiative (UKIERI) India 2020-08-07 CTRI/2020/07/026834 Phase Not Applicable Not yet recruiting 26 1480 Dr Saju M D 2020-07-30
Artificial intelligence and machine learning for Covid 19 Coronavirus disease 19 infection Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Visvesvaraya Technological University (VTU) India 2020-07-13 CTRI/2020/07/026832 Phase 1 Clinical Not yet recruiting 1 100 Dr DwajaniS, Dr Mukesh PR 2020-07-30
Sildenafil in COVID-19 Coronavirus disease 19 infection, Ischemia sildenafil alone PDE 5 inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universidad Andres Bello Hospital Naval Almirante Nef Chile 2020-08-31 2021-03-31 NCT04489446, UNAB-003 Phase 1/Phase 2 Clinical Not yet recruiting 1 7 Months 40 Cesar Reyes, MD, Dominique Boisier, MD, Eduardo Labarca, MD, Felipe M Martinez, MD, MSc, Felipe Martinez, MD, MSc, Jaime Vidal, MD, Jorge Vega, MD, Mario Santamarina, MD, Miguel Gutierrez, MD, Monica Gutierrez, MD, Nicole Retamal, Roberto Contreras, MD, Sebastian Ahumada, MD 2020-07-31
COVID-19: Attitude Toward Quarantine Coronavirus disease 19 infection Taibah University Saudi Arabia 2020-07-15 2020-08-15 55834, NMRR-20-1574-55834 Phase Not Applicable Status not specified 1 1 Month Noordin othman, Suhana Jawahir 2020-07-30
Hydroxychloroquine for COVID-19 Coronavirus disease 19 infection hydroxychloroquine alone National Institutes of Health Malaysia Malaysia 2020-08-03 2020-09-03 54669, NMRR-20-1593-54669 Phase Not Applicable Status not specified 1 1 Month dr Nor Asiah Muhamad 2020-07-30
A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 cases Coronavirus disease 19 infection Guduchi Ghan Vati alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Ministry of Ayush India 2020-07-28 CTRI/2020/07/026840 Phase 2 Clinical Recruiting 1 30 Dr Nitin Ujjaliya, Dr Vivek Khare, Prof Umesh Shukla 2020-08-02
Facts on Bear Bile Use in Coronavirus Disease 2019 (COVID-19) Coronavirus disease 19 infection Bear Bile alone Institute For Medical Research (Inc In Malaysia) Malaysia 2020-04-01 2020-06-01 55957, NMRR-20-1604-55957 Phase Not Applicable Status not specified 1 2 Months Ms. Lim Xin Yi, Terence Tan Yew Chin 2020-07-31
LUS: lung ultrasound Coronavirus disease 19 infection ultrasound alone Hospital Sungai Buloh Malaysia 2020-07-27 2020-12-31 55711, NMRR-20-1599-55711 Phase Not Applicable Status not specified 1 5 Months Dr ELISA AUDREY EDDIE, Dr Mahathar Abdul Wahab 2020-08-02
Antibody, RT-PCR, COVID-19 Coronavirus disease 19 infection RT-PCR alone Hospital Sungai Buloh Malaysia 2020-07-31 2021-07-30 55832, NMRR-20-1598-55832 Phase Not Applicable Not yet recruiting 1 12 Months DR THARMINI A/P RAVI, Dr Suresh Kumar 2020-07-31
A phase II/III clinical trial of CodaVax-COVID for the prevention of Covid-19 Coronavirus disease 19 infection CodaVax-COVID alone Codagenix Inc, Serum Institute of India Ltd hVIVO plc Phase 2/Phase 3 Clinical Planned 0 2020-07-29
A trial to evaluate rigosertib for the treatment of patients with COVID-19 disease Coronavirus disease 19 infection rigosertib sodium (iv, MDS/solid tumors), Onconova/SymBio alone AKT protein kinase inhibitor, BCL2L11 gene stimulator, Cyclin D1 inhibitor, Cyclin-dependent kinase-1 inhibitor, Jun N terminal kinase modulator, MAP kinase inhibitor, Phosphoinositide 3-kinase inhibitor, Polo-like kinase 1 inhibitor, Raf protein kinase inhibitor Onconova Therapeutics Inc Phase Not Applicable Planned 0 2020-07-29
HOMECOMIN': Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands Coronavirus disease 19 infection, Pulmonary fibrosis spirometer (Spirobank Smart) alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Erasmus University Medical Center Rotterdam Dutch Society of Physicians for Pulmonology and Tuberculosis, Leiden University Medical Center, VU University Medical Center Netherlands 2020-05-08 2021-12-31 HOMECOMIN', MEC-2020-0318, NCT04488562 Phase Not Applicable Recruiting 3 19 Months 150 C.C. Moor, drs, Cintha Klop, E.J. Nossent, Esther van der Kaay, G Nakshbandi, G. Nakshbandi, drs, Gizal Nakshbandi, drs, J.J.M. Geelhoed, dr, M.S. Wijsenbeek, dr 2020-07-30
Impact of Isolation in Patients With IBD During the COVID-19 Crisis Coronavirus disease 19 infection, Inflammatory bowel disease Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sheffield Teaching Hospitals NHS Foundation Trust UK 2020-06-30 2022-06-30 NCT04488471, STH21414 Phase Not Applicable Recruiting 1 24 Months 232 Alan Lobo, MD, Luke Barron, MSc 2020-07-30
Clinical trial of Annual SZ drug in Covid-19 Coronavirus disease 19 infection Anval SZ plus azithromycin Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Shaheed Beheshti Medical University Iran 2020-06-09 IR.SBMU.RETECH.REC.1399.158, IRCT20200607047682N1 Phase 2/Phase 3 Clinical No longer recruiting 1 60 Afshin Zarghi, Hamid Chegini, Mohammad Farhbakhsh, Zuhair Sarraf 2020-07-30
Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patients Coronavirus disease 19 infection magnesium sulfate alone, standard treatment alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Shaheed Beheshti Medical University Iran 2020-07-27 IR.SBMU.NRITLD.REC.1399.148, IRCT20191211045691N1 Phase 3 Clinical Recruiting 1 100 Guitti Pourdowlat, Seyed Ruhollah Mousavinasab, ‪Parissa Farnia 2020-07-30
Tele-health Enabled Clinical Trial for COVID19 Coronavirus disease 19 infection, Immune disorder Doctella device alone, cholecalciferol alone, telehealth monitoring alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Hospitals of Cleveland Northwestern University US 2020-08-01 2021-08-01 NCT04489628, STUDY20200461 Phase 1/Phase 2 Clinical Not yet recruiting 1 12 Months 110 Amanda Davies, Kevin Cooper, MD, Kurt Lu, MD, Lyndsey O'Hara, BSN, Wesley Yu, MD 2020-08-04
CoronaKids: CoronaKids - Epidemiological data acquisition SARS-CoV2/Covid-19 Coronavirus disease 19 infection epidemiological data analysis alone Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Univ Witten / Herdecke Germany 2020-03-27 61/2020, CoronaKids, DRKS00021229 Phase Not Applicable Recruiting 1 900 Stefan Wirth 2020-07-30
CCHROMO: COVID19 Chronic Morbidity: Follow-up of patients with COVID19 and non-COVID19 pneumonia with respect to clinical status, pulmonary function and radiologic findings Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Universitätsklinikum Frankfurt Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Hannover Medical School Germany 2020-07-27 20-748, CCHROMO, DRKS00022475 Phase Not Applicable Not yet recruiting 1 500 Gernot Rohde 2020-08-06
CovPall: Improving palliative care for people affected by the COVID-19 pandemic by sharing learning - the national and international response Coronavirus disease 19 infection palliative care alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) King's College London Cicely Saunders International, Kings College Hospital NHS Trust, National Institute for Health Research (NIHR) India, Brazil, South Africa, Netherlands, Portugal, Switzerland, Argentina, Australia, Ireland, Canada, UK 2020-04-01 2021-04-24 CovPall, ISRCTN16561225, LRS-19/20-18541, IRAS 282824 Phase Not Applicable Recruiting 13 12 Months Miss Cripps 2020-07-30
Study of Shreepad Shree Vallabh SSV Formulation in management of COVID-19 Coronavirus disease 19 infection SSV Formulation alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) SSV Phytopharmaceuticals India 2020-08-05 CTRI/2020/07/026839, SSV-SF-07/2020 Phase 3 Clinical Not yet recruiting 1 150 Dr Sagar Mandlik, Dr Yogesh Dound 2020-07-30
PREDISCAN: Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images Coronavirus disease 19 infection, Pulmonary fibrosis, Viral pneumonia Chest CT scan alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Association Marie Lannelongue France 2020-06-08 2021-11-08 2020-A01322-37, NCT04483752, PREDISCAN Phase Not Applicable Recruiting 3 17 Months 100 CAROLINE CARAMELLA, MD, Corinne Institut Gustave Roussy (IGR), MD, Marie De Torcy 2020-07-30
Antibody response to COVID-19 in health care workers Coronavirus disease 19 infection LIAISON SARS-CoV-2 S1/S2 IgG test alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) DiaSorin Healthcare India Private Limited, Ortho Clinical Diagnostics India Private Limited India 2020-08-04 Phase Not Applicable Not yet recruiting 1 Dr Smita Sarma 2020-07-29
Effect of COVID - 19 pandemic researchers Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Manipal Academy of Higher Education India 2020-08-10 CTRI/2020/07/026836 Phase Not Applicable Not yet recruiting 1 1850 Elsa Sanatombi Devi 2020-07-30
Encouraging behavior to reduce the spread of COVID-19 Coronavirus disease 19 infection Impact Others, Cooperative Linear Production (IOCLP) message alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Yale University US 2020-05-01 2020-07-24 1312013102, ISRCTN17896927 Phase Not Applicable Completed 2 2 Months 3000 Prof Huber 2020-07-30
N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia Coronavirus disease 19 infection, Hypoxia, Respiratory failure, Viral pneumonia Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Cairo University Kasr El Aini Hospital Egypt 2020-07-01 2021-01-01 2020-7-1, NCT04487951 Phase Not Applicable Recruiting 1 6 Months 100 Akram Abdelbary, Prof., Noha A. Radwan, Noha A. Radwan, Lecturer, Noha A. Radwan, Lecturer of Chemical pathology, Noha Radwan, Lecturer, Yasmine Elshiwy, Ass. Prof. 2020-08-05
Complementary Intervention for COVID-19 Coronavirus disease 19 infection conventional therapy alone, Boswellia Serrata gum plus Licorice extract Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) Assiut University Egypt 2020-01-01 2021-01-31 0925-0586, NCT04487964 Phase Not Applicable Recruiting 1 13 Months 70 Adel A. Gomaa, Ph.D., Adel Gomaa, Ph.D., Hamdy S Mohamed, MD, Mostafa Hamdy, Ph.D. 2020-07-30
SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) Coronavirus disease 19 infection, Kidney transplantation, Pancreas transplantation Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) IRCCS San Raffaele Italy 2020-07-15 2021-01-15 COVID-SIERO TRAPIANTI, NCT04487197 Phase Not Applicable Recruiting 1 6 Months 300 Antonio Secchi, MD, Federica Pazzi, Paola Maffi, Rossana Caldara 2020-08-05
A Phase I, Prospective, Open-labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Coronavirus disease 19 infection MVC-COV1901 alone COVID19 Spike glycoprotein modulator, TLR-9 agonist Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Medigen Vaccine Biologics Corp Taiwan 2020-09-01 2021-12-31 CT-COV-11, NCT04487210 Phase 1 Clinical Not yet recruiting 1 16 Months 45 Criss Cheng, Szu-Min Hsieh, MD 2020-07-30
Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2 Coronavirus disease 19 infection, Respiratory distress syndrome positive end-expiratory pressure therapy alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Sanatorio Anchorena San Martin Argentina 2020-07-01 2020-10-20 10.2020, NCT04486729 Phase Not Applicable Recruiting 1 3 Months 15 Javier H Dorado, PT, Joaquin Pérez, PT, Matias Accoce 2020-07-30
Exploring the Impact of a Sleep App on Sleep Quality Coronavirus disease 19 infection, Insomnia sleep app (Pro version) alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University College London University of California Los Angeles UK 2020-02-13 2020-08-15 NCT04487483, SLEEPAPPEVALUATION Phase Not Applicable No longer recruiting 1 6 Months 101 Abi Fisher 2020-08-12
DAMPEN-CI: Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) Coronavirus disease 19 infection, Inflammatory disease, Viral pneumonia duvelisib alone Phosphoinositide-3 kinase delta inhibitor, Phosphoinositide-3 kinase gamma inhibitor Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Emory University University of Pennsylvania, Verastem Oncology US 2020-08-31 2022-02-28 DAMPEN-CI, NCT04487886, STUDY00000701 Phase 2 Clinical Not yet recruiting 3 18 Months 80 Aneesh Mehta, MD, Edmund Waller, MD, PhD 2020-07-29
Hematology and Clinical Picture in Pediatric COVID-19 Infection Coronavirus disease 19 infection, Hematological disease Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) Benha University Egypt 2020-07-26 2020-08-21 NCT04487119, RC 6-7-2020 Phase Not Applicable Not yet recruiting 1 30 Effat H Assar, MD, Rana A Khashaba, MD, Shaimaa R Abdelmaksoud, MD 2020-07-29
PLEXIT: Therapeutic Plasma Exchange (TPE) for COVID-19 Cytokine Release Storm (CRS) Coronavirus disease 19 infection, Hypoxia, Respiratory distress syndrome, Respiratory failure, Sepsis, Viral pneumonia COBE Spectra Apheresis machine version 7 (TERUMO BCT) alone, anticoagulation therapy alone, corticosteroids therapy alone, ulcer prophylaxis alone, Variable regimens including Fresh frozen Plasma (FFP) , aspirin , methylprednisolone Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) United Nations International Children's Fund Pak Emirates Military Hospital Pakistan 2020-04-01 2020-06-30 NCT04485169, PLEXIT, SULTAN MEHMOOD KAMRAN Phase 2 Clinical Completed 1 3 Months 280 Imran m Fazal, FCPS, Sultan mehmood kamran 2020-07-29
A pan-India phase IV trial of itolizumab in COVID-19 patients Coronavirus disease 19 infection itolizumab alone T-cell differentiation antigen CD6 inhibitor Biocon Ltd Phase 4 Clinical Planned 0 200 2020-07-30
FERTICOVID: Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients? Cancer, Coronavirus disease 19 infection RT- qPCR alone, nasopharyngeal swab test alone, serological test alone Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) University Hospital Clermont-Ferrand Biomedicine Agency France 2020-07-10 2021-07-31 2020-A01409-30, FERTICOVID, NCT04487639, RNI 2020 BRUGNON Phase Not Applicable Recruiting 15 12 Months 250 Amélie BREBION, PharmD, Anne MAYEUR, MD, PhD, Anne-Sophie CANEPA, MD, Arthur LUTON, MD, Audrey MIRAND, PharmD, PhD, Aurélie RIVES-FERAILLE, MD, Badria BENNANI SMIRES, MD, Béatrice DELEPINE, MD, Carole Carole, MD, Caroline AIMONE VIANNA, MD, Catherine DILIGENT, MD, PhD, Catherine GUILLEMAIN, MD, Catherine PATRAT, MD, Charlotte DUPONT, MD, PhD, Charlotte MAUROY, MD, Cécile GREZE, MD, Cécile HENQUELL, PharmD, PhD, Céline BOUILLON, MD, Céline BRUNO, MD, Céline CHALAS, MD, Diane RIVET-DANON, MD, Elsa LABRUNE, MD, Emmanuel DULIOUST, MD, PhD, Fanny JUMEAU, MD, Florence BOITRELLE, MD, PhD, Florence BRUGNON, MD, PhD, Florence EUSTACHE, MD, Hanae Pons-Rejraji, PhD, Isabelle KOSCINSKI, MD, PhD, Isabelle LICHTBLAU, MD, Jacqueline LORNAGE, MD, PhD, Jacqueline SAIAS-MAGNAN, MD, Jessika MOREAU, MD, Julie BARBERET, MD, Julien BESSONAT, MD, Laetitia LADUREAU-FRITSCH, MD, Laure CHAPUT, PD, Laëtitia HESTERS, PharmD, Lise LACLAUTRE, Pharm D, Louis BUJAN, MD, Marion BENDAYAN, MD, Marius TELETIN, MD, PhD, Myriam DAUDIN, MD, Nathalie MOINARD, MD, Nathalie RIVES, MD, Nelly FRYDMAN, PharmD, PhD, Olivier BINOIS, MD, Patricia FAUQUE, MD, PhD, Pierre DI PIZIO, MD, Rachel LEVY, MD, Rahaf HAJ HAMID, MD, Sandrine GISCARD D'ESTAING, MD, PhD, Sara KOUIRI, MD, Solmaz SARANDI, MD, Solène VORILHON, MD, PhD, Sylvianne HENNEBICQU, MD, PhD, Thomas BOUEILH, MD, Virginie BARRAUD-LANGE, MD, PhD, Véronique DROUINEAUD, MD 2020-07-29
Impact Nerium Oleander on Symptoms and Mortality: A Feasibility Study Coronavirus disease 19 infection Nerium oleander proprietary extract alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) HealthQuilt Baylor College of Medicine, Texas A&M University System, The Hildebrand Fund at the Greater Houston Community Foundation, The Schull Institute, University of Maryland College Park, University of Texas Health Science Center Houston US 2020-05-20 2020-09-01 052020, NCT04486144 Phase 2 Clinical Recruiting 1 3 Months 100 Kim Dunn, MD, Ph.D. 2020-07-29
Online 1-day CBT-based Workshops for PPD Coronavirus disease 19 infection, Postnatal depression cognitive behavioural therapy based workshop alone, standard postnatal care alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) McMaster University Canada 2020-04-20 2020-12-31 NCT04485000, ONLINE1DAYCBT Phase Not Applicable Recruiting 1 8 Months 388 Ryan Van Lieshout, MD, PhD 2020-07-29
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection (Ta1) Coronavirus disease 19 infection, Lymphocytopenia standard of care alone, thymalfasin alone Thymosin receptor agonist Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Rhode Island Hospital US 2020-07-31 2021-04-30 NCT04487444, SCN-16130571-2 Phase 2 Clinical Not yet recruiting 1 9 Months 80 Eleftherios Mylonakis, MD PhD FIDSA, Fadi Shehadeh 2020-07-30
I-SPY COVID-19: An Adaptive Platform Trial for Critically Ill Patients Coronavirus disease 19 infection, Respiratory distress syndrome ARDS supportive care alone, anticoagulation treatment alone, lung protective ventilation alone, Variable regimens including apremilast , cenicriviroc , icatibant , razuprotafib , remdesivir Bradykinin B2 receptor antagonist, CCR2 chemokine antagonist, CCR5 chemokine antagonist, COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, PDE 4 inhibitor, Protein tyrosine phosphatase beta inhibitor, RNA polymerase modulator, Tek tyrosine kinase receptor stimulator Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) QuantumLeap Healthcare Collaborative, US, University of California San Francisco Aerpio Pharmaceuticals Inc, Columbia University, Emory University, Montefiore Medical Center, Sanford Health, University of Alabama at Birmingham, University of California San Diego, University of Colorado, Denver, US, University of Minnesota, University of Pennsylvania, University of Southern California, Wake Forest University Health Sciences, US, Yale University US 2020-07-31 2022-11-01 I-SPY COVID-19, I-SPY-COVID, NCT04488081 Phase 2 Clinical Recruiting 10 27 Months 1500 Amy Clark, MD, Angela Howell, MD, Carolyn Calfee, MD, Carolyn Carolyn, MD, D. Clark Files, MD, Derek Russell, MD, Ellen Burnham, MD, Jeremy Beitler, MD, Jonathan Koff, MD, Julie Lang, MD, Karl Thomas, MD, Karyn DiGiorgio, MS, Kathleen D Liu, MD, Kathleen Liu, MD, Kristy Watkins, RN, Laura Esserman, MD, Lauren Bayne, Leslie Segal, MPH, Michelle Gong, MD, Paul Berger, MD, Paul Henderson, PhD, Sheetal Gandotra, MD, Tessa Mcspadden, Trisha Burello, MS, Valerie Caterinicchia, RN, BSN 2020-08-13
LUS-COVID: Lung Ultrasound in COVID-19 Patients Coronavirus disease 19 infection invasive ventilation alone, lung ultrasound examination alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Academic Medical Center, University of Amsterdam Centre Hospitalier Universitaire Saint Pierre, Ospedale generale regionale F. Miulli, Acquaviva delle Fonti, Universita di Bari, Universita' Degli Studi Di Foggia Netherlands 2020-06-01 2020-10-31 LUS-COVID, LUS-COVID, NCT04487769 Phase Not Applicable Recruiting 1 5 Months 30 Charalampos Pierrakos, MD, Lieuwe D Bos, MD PhD, Luigi Pisani, MD, Marcus J Schultz, MD, Marcus J Schultz, MD PhD 2020-07-30
COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic Anxiety disorder, Bronchiectasis, Coronavirus disease 19 infection, Phobia Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) Hacettepe University Turkey 2020-07-23 2020-12-01 GO 20/602, NCT04487873 Phase Not Applicable Not yet recruiting 1 4 Months 28 Aslıhan Cakmak, MSc, Deniz İnal-İnce, Professor, Ebru Calik-Kütükcü, PhD, Melda Saglam, PhD, Merve Firat, MSc, Naciye Vardar-Yagli, PhD 2020-07-30
COVIE-19/20: Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic Coronavirus disease 19 infection, Postnatal depression Edinburgh Postnatal Depression Scale alone, Mother-to-Infant Bonding Scale alone, State-Trait Anxiety Inventory alone Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Centre Hospitalier Universitaire D Amiens Centre Hospitalier Compiègne, Centre hospitalier de Beauvais, Hospital Center De Saint-Quentin France 2020-07-21 2021-08-31 COVIE-19/20, NCT04487171, PI2020_843_0049 Phase Not Applicable Recruiting 1 13 Months 248 Arthur FOULON, MD, Arthur Foulon, MD, MD, Xavier BENAROUS, MD 2020-07-31
ISAM-COVID: Survey on COVID-19 Airway Management Coronavirus disease 19 infection, Respiratory failure Healthy volunteers accepted Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor Spain 2020-04-22 2020-09-30 ISAM-COVID, ISAM-COVID, NCT04487977 Phase Not Applicable Recruiting 1 5 Months 5000 Dr. Manuel Granell Gil, Manuel Granell Gil, Manuel Granell Gil, Dr, Manuel Granell Gil, PhD 2020-08-04
Addressing COVID-19 Mental Health Problems Among US Veterans Acute stress disorder, Coronavirus disease 19 infection short video intervention alone, vignette intervention alone Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Research Foundation for Mental Hygiene Inc US 2020-07-06 2020-09-10 8006, NCT04484207 Phase Not Applicable Recruiting 1 2 Months 200 Doron Amsalem, MD, Yuval Neria Neria, PhD, Yuval Neria, PhD 2020-07-29
Study of acute stroke with COVID-19 Coronavirus disease 19 infection, Stroke Japan Stroke Society, Nippon Medical School Hospital Japan 2020-07-08 UMIN000041226 Phase Not Applicable Recruiting 1 100 Kazumi Kimura, Yasuhiro Nishiyama 2020-07-31
Nebulized PL for Post-COVID-19 Syndrome Coronavirus disease 19 infection, Dyspnea, Respiratory disease, Respiratory distress syndrome, Viral pneumonia nebulized platelet lysate alone Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Regenexx LLC US 2020-08-03 2021-12-30 NCT04487691, RGX2020-RCT01 Phase 1 Clinical Not yet recruiting 1 16 Months 40 Christopher Centeno, MD, Ehren Dodson, PhD, Neven Steinmetz, PhD 2020-08-06
A trial to evaluate sbk-001 for the treatment of SARS-CoV-2 infection (COVID-19) Coronavirus disease 19 infection sbk-001 alone Angiotensin converting enzyme 2 inhibitor Chengdu Shibeikang Biological Medicine Technology Co Ltd Phase Not Applicable Planned 0 2020-07-28
Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicenter Study Coronavirus disease 19 infection Young Adults (18-44 yrs) Cairo University Egypt 2020-09-15 2020-12-15 8791, NCT04487665 Phase Not Applicable Not yet recruiting 1 3 Months 50 Dina mounir elkady 2020-07-29
Immune responses in the convalescence stage of COVID-19 patients Coronavirus disease 19 infection Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Yokohama City University Japan 2020-09-01 UMIN000041227 Phase Not Applicable Not yet recruiting 1 140 Atsushi Goto, Takeharu Yamanaka 2020-07-30
J-DESIRE: Japan COVID-19 Survey and Questionnaire in inflammatory bowel disease Anxiety disorder, Coronavirus disease 19 infection, Psychiatric disorder questionnaire survey alone Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Japanese Ancestry Sapporo Medical University School of Medicine Japanese Ministry of Health, Labor and Welfare Japan 2020-07-28 J-DESIRE, UMIN000041191 Phase Not Applicable Not yet recruiting 2 2500 Hiroshi Nakase, Kohei Wagatsuma 2020-07-30
CoV-Hep: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 Coronavirus disease 19 infection, Renal injury continued venovenous hemodialysis alone, polysulfone dialyzer alone, sodium citrate plus unfractionated heparin Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Brazil 2020-06-29 2021-07-31 33351120.0.0000.0068, 4.081.688, CoV-Hep, NCT04487990, RBR-45kf9p, U1111-1252-0194 Phase 2 Clinical Recruiting 1 13 Months 90 Camila Rodrigues, MD, PhD, Paulo Lins, MD 2020-07-30